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A new family of spirooxindole amides were synthesized by a sequence of hydrozirconation, 
acylation, and intramolecular cyclization reactions. Three of the four possible diastereomers can 
be obtained as the major isomers through this process. The spirooxindole structure has many 
points for diversification, and a 37-membered library was synthesized through this approach by 
collaborators. A comparison with known compound collections showed that this new 
spirooxindole library possessed good chemical diversity.  
Cyanohydrin alkyl ethers, the key intermediate in the above multi-component 
hydrozironation reaction, were effectively synthesized through a Brønsted acid-mediated 
hydrocyanation of vinyl ethers. The enantiomerically enriched product can be obtained by 
asymmetric hydrocyanation of vinyl ethers catalyzed by a chiral Brønsted acid, and the catalyst 
can be regenerated by PhOH. As far as we know, this research represents the first example of 
chiral Brønsted acid mediated intermolecular addition of silylated nucleophiles with vinyl ethers. 
The ion pair interaction between the conjugate base of the chiral Brønsted acid and the 
oxocarbenium ion was revealed by computational modeling, which explained the origin of the 
enantioselectivity and the substrate scope of this reaction. 
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1.0  STEREOSELECTIVE SYNTHESIS OF SPIROOXINDOLE AMIDES THROUGH 
NITRILE HYDROZIRCONATION 
1.1 INTRODUCTION 
The spirooxindole unit, characterized by a unique spiro fusion of a heterocycle or carbocycle at 
the C3 position of an oxindole, is present in numerous biologically active natural products such 
as gelsemine,1 and spirotryprostatin B2 (Figure 1.1). In addition, the rigid spirooxindole core 
provides a good template for the synthesis of natural product-like compounds as potential 
medicinal agents. Many elegant methods have been developed to construct the spirooxindole  
core structure,3 which further promotes structure-activity studies, and preparation of diverse 
  
 
Figure 1.1 Structures of important spirooxdindoles 
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spirooxindole structures. Schreiber and co-workers developed a spirooxindole library through 
diversity-oriented synthesis (DOS), and found lead compound 1.4 as an adjuvant of the actin 
polymerization inhibitor latrunculin B.4 Wang and co-workers applied structure-based design to 
develop MI-219 (1.3) as an anti-cancer drug candidate that operates through MDM2 inhibition.5 
In accord with our continued interest in preparing structurally diverse amides, we sought to 
develop a new protocol for diastereoselective synthesis of spirooxindoles. 
1.2 Multicomponent amide synthesis through nitrile hydrozirconation 
Diversity oriented synthesis, which could possibly play a vital role in drug discovery, requires 
access to a collection of many compounds with molecular complexity and structural diversity.6 
While the complexity of a molecule is important to its possible biological activity, the structural 
diversity, which can be achieved by altering building blocks, stereochemistry, and molecular 
scaffolds, is essential to identify new protein targets and their regulators.6 The Floreancig 
group’s multicomponent method towards syntheses of structurally diverse amides is one of these 
approaches.7 Nitriles (1.5) react readily with the Schwartz reagent (Cp2Zr(H)Cl) to form 
metalloimines (1.6) that add into acyl chlorides to yield acylimines (1.7). A wide range of amide-
containing structures can be obtained when different nucleophiles react with these acylimines 
(Scheme 1.1).  
 
 
Scheme 1.1 Diverse amides formation through nitrile hydrozirconation 
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1.2.1 Previous work on amides formation from nitrile hydrozirconation 
Dr. Shuangyi Wan first demonstrated that heteroatom nucleophiles, such as water, methanol, 
phenol, thiophenol, and tert-butyl alcohol, are suitable nucleophiles to attack acylimines to 
generate “oxidized” amides in good yield and moderate to good diastereoselectivity (Scheme 1.2, 
reaction 1).7d Following that work, Mr. Mikkel DeBenedetto showed that π-nucleophiles add 
diastereoselectively into nitrile-derived acylimines to give α-branched amides (Scheme 1.2, 
reaction 1).7c It is worth noting that unlike alcohols and thiols, weakly reactive π-nucleophiles 
require acylimine activation by a Lewis acid to promote addition. Zinc bromide led to the 
formation of the syn-isomer, and gave single diastereomer for methallyl trimethylsilane. 
Enolsilanes and indoles also gave good selectivity when used as nucleophiles with this reaction. 
Dr. Qing Xiao further expanded the scope of the reaction by developing a Lewis acid-mediated 
intramolecular Friedel-Crafts alkylation reaction (Scheme 1.2, reaction 2).7b Indanyl and 
tetrahydronaphthyl amides can be formed with good to excellent levels of diastereocontrol. In 
addition to substituted benzene derivatives, indole can also be used as a nucleophile to generate 
bicylic β-alkoxy amides (Scheme 1.2, reaction 3).  
 4 
 
Scheme 1.2 Previous work on amides formation through nitrile hydrozirconation 
 
The nucleophilic addition to acylimines through nitrile hydrozirconation is also a 
powerful approach to access biologically active natural products. Our group successfully used 
this method for the total synthesis of pederin and psymberin, which are potent cytotoxins 
towards a number of cancer cell lines with IC50 values at nanomolar or lower concentrations 
(Figure 1.2).8 By using different alcohols, acid chlorides and nitriles, a number of analogs were 
readily prepared through this late stage multicomponent approach for construction of N-acyl 
aminal linkages. The structure-activity relationships were further elucidated, and a number of 
more potent cytotoxins were identified (Figure 1.2).  
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Figure 1.2 Pederin, psymberin and their analogs 
 
This approach can also be applied to build compounds for drug delivery. As shown in 
Scheme 1.3, α-alkoxy carbamate 1.15 was synthesized, which consist of a cargo, a triggering 
group and a targeting group. Upon peroxide stimulus, the boronate is oxidized to phenoxide, 
which then initiates the breakdown of acyl aminal to release alcohols. Pentamethyl chromanol 
could be released from carbamate 1.15, and can mitigate damages caused by active oxygen 
species.9   
 6 
 
Scheme 1.3 Synthesis of alkoxy carbamate 1.15 
 
1.2.2  Previous work on spirooxindole synthesis through nitrile hydrozirconation 
We concluded that indoles are good nucleophiles for nitrile-derived acylimine for intermolecular 
addition and intramolecular Friedel-Crafts reaction, based on our previous study.7b Furthermore, 
we envisioned that nucleophilic attack from 3-position of 2-haloindoles, followed by water 
addition to the iminium ion intermediate would lead to spirooxindole structure. Therefore, nitrile 
hydrozirconation should be applicable for spirooxindole synthesis.  
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Scheme 1.4 Previous work on spirooxindole synthesis through nitrile hydrozirconation 
 
Dr. Qing Xiao first used isobutyryl chloride as the electrophile and 2-bromoindole 1.19 
as the oxindole surrogate to demonstrate the feasibility of this idea (Scheme 1.4). Two 
diastereomers were obtained in good yield, with the C2-center of the oxindole of the major 
diastereomer adopts an axial orientation. Additionally 2-silyloxyindole 1.22 was synthesized to 
study whether steric bulk at the 2-position influenced stereoselectivity (Scheme 1.4). Unlike 2-
bromoindole 1.19, 2-silyloxyindole 1.22 needed one full equivalent of Lewis acid to promote the 
reaction, and different Lewis acids were screened for their effects on diastereoselectivity. The 
results showed that the diastereoselectivity at the quaternary center was inverted with the C-2 
center of the oxindole of the major diastereomer adopting an equatorial orientation. When 
Sc(OTf)3 was used as the Lewis acid, the major diastereomer adopted the trans relationship 
between the amide and the methoxy groups (diastereomer 1.24). In contrast, the cis relationship 
(diastereomer 1.25) is favored when ZnCl2 was employed to the reaction, possibly due to the 
stronger chelating ability of ZnCl2 relative to Sc(OTf)3.   
 8 
1.3 SPIROOXINDOLE SYNTHESIS THROUGH NITRILE HYDROZIRCONATION  
The spirooxindole structure built by Dr. Xiao is structurally unique. The synthesis sequence 
featured by hydrozirconation, acylation and intramolecular addition leads to the complex 
spirocyclic structure with two new stereocenters in one pot from acyclic indolyl cyanohydrin 
ethers. In addition to the building block diversity made possible by the addition of different acid 
chlorides, the stereochemical diversity is also possible because it is influenced by different 
oxindole surrogates and Lewis acids chelating abilities. Therefore, this synthetic sequence is a 
promising diversity oriented synthesis (DOS) strategy. We sought to optimize the substrate and 
reaction conditions to pursue improved stereocontrol as well as the possibility for further 
structural modification. Different acid chlorides will also be examined to explore the scope of 
this reaction.  
 
 
Scheme 1.5 Horne’s spirooxindole synthesis through 2-chloroindole 
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Studies by Horne and co-workers provided guidance for improving diastereoselectivity.10 
As shown in Scheme 1.5, condensation of 2-chlorotryptamine (1.26) with isovaleraldehyde 
affords imine 1.27, which then cyclizes under acidic conditions to give spirooxindole 1.28 with 
good yield and high stereoselectivity. The author implied that the stereoselectivity is highly 
influenced by the steric interaction between the substituent on the spiro-pyrrolidine ring and the 
substituent at the 2-position of indole. This finding is in accord with Dr. Xiao’s observation on 
the reverse of stereoselectivity by using 2-bromoindole and 2-silyloxyindole. Therefore, the 2-
chloroindole subunit was chosen as the new oxindole surrogate for spirooxindole synthesis, with 
the expectation that the smaller chlorine group will lead to improved diastereoselectivity. The 2-
triisopropylsiloxyl group was selected as the bulky counterpart of the chlorine group for further 
stereocontrol. 
A benzyl group was chosen as the protecting group for the cyanohydrin instead of methyl 
group in the previous study to facilitate further structure modification. Methoxymethyl (MOM) 
and benzyl groups were chosen as the protecting groups on the nitrogen of the indole substrate. 
These protecting groups can be easily removed after spirooxindole formation.11 Additionally the 
different electronic and physical properties of these two protecting groups may lead to different 
stereochemical outcomes. Thus, the following substrates (Figure 1.3) were selected for the study 
of nitrile hydrozirconation sequence. 
 
 
Figure 1.3 Design of the substrate 
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1.3.1 Substrate Synthesis  
The substrate synthesis follows Dr. Qing Xiao’s protocol. As shown in Scheme 1.6, aldehyde 
1.32 was obtained by Swern oxidation of mono-tert-butyldiphenylsilyl (TBDPS) protected of 
1,6-hexanediol (1.31). Benzyl alcohol (BnOH) was condensed with aldehyde 1.32 under p-
toluenesulfonic acid (PTSA) catalysis to yield benzyl acetal 1.33, which was then treated with 
trimethylsilyl cyanide (TMSCN) and bismuth tribromide (BiBr3) to afford benzyl cyanohydrin 
ether 1.34. After TBDPS group deprotection and Swern oxidation, aldehyde 1.35 was obtained in 
good yield. Aldehyde 1.35 then reacted with phenylhydrazine to construct indole 1.36, which 
underwent chlorination and benzylation to give 2-chloroindole 1.37.  
 
 
Scheme 1.6 Substrate synthesis for nitrile hydrozirconation 
 
Even though the above method started from cheap starting material, 9 steps were required 
to prepare the desired substrate. Therefore, further efforts were made to improve the efficiency of 
this synthetic sequence (Scheme 1.7). Aldehyde 1.39, prepared through a known periodate 
mediated cleavage of commercially-available 7-octene-1,2-diol (1.38),12 was converted to 
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cyanohydrin ether 1.40 through a one-pot sequential acetalization reaction with BnOTMS and 
BiBr3 followed by TMSCN addition7a. Ozonolysis and Fischer indole synthesis with 
commercially available benzyl phenylhydrazine hydrochloride provided 1.41, which then reacted 
with NCS to afford the cyclization substrate 1.37. It is worth noting that this sequence also 
facilitated the synthesis of the 2-silyloxyindole substrate. The corresponding silyloxyindole 
substrate 1.42 was prepared by oxidizing 1.41 to form the oxindole followed by silylation with 
TIPSOTf and Et3N (Scheme 1.7)13. The established indole oxidation protocol using DMSO and 
HCl14 was not effecient for the oxidation step. The conversion was low even after stirring for 24 
h. However, good yield and quick conversion was achieved when AcOH was used as the co-
solvent.15 
 
 
Scheme 1.7 Modified substrate synthesis for nitrile hydrozirconation 
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The MOM protected 2-haloindole substrates 1.43 and 1.44 were synthesized by 
halogenation of indole 1.36, followed by MOM protection of the indole fragment (Scheme 1.8). 
6-Chloroindole substrate 1.48 was chosen because of the significant biological activity 
enchancement observed by Wang and co-workers for this substituent in the spirooxindole 
structure.5b 1.46 and its regioisomer 1.47 were obtained in a combined yield of 45% (1.46:1.47 = 
5:4) by using the commercially available 3-chlorophenylhydrazine hydrochloride for Fisher 
indole synthesis. Even though these two isomers have similar polarity, they are separable by 
flash chromatography, and the application of medium pressure liquid chromatography (MPLC) 
can greatly facilitate the separation. These results indicated that indoles with different 
substitution patterns should be accessible by the following the same sequence featured by Fisher 
indole synthesis, halogenation and protection. 
 
N
H
Cl NH2 N
H
CN
OBn3
Cl
N
H
CN
OBn3
Cl
++ HOAc
Reflux, 3h, 45%
1. NCS, CCl4
2. NaH, MOMCl, THF N
MOM
CN
OBn3
Cl
Cl
N
MOM
CN
OBn3
Cl
Cl
1.35
1.45 1.46 1.47
1.46:1.47 = 5:4
1.46
1.47
47% over two steps1.48
43% over two steps1.49
1. NCS, CCl4
2. NaH, MOMCl, THF
. HCl
1.36
N
MOM
CN
OBn3
X
1. NCS or NBS, CCl4
2. NaH, MOMCl, THF
1.43 X = Cl, 63% over two steps
1.44 X = Br, 71% over two steps
 
Scheme 1.8 Synthesis of diverse 2-haloindole substrates 
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1.3.2 Spirooxindole formation from acyclic indole substrates 
Spirooxindole formation is demonstrated in Scheme 1.9. Treatment of 2-chloroindole 1.37 with 
Cp2Zr(H)Cl followed by acylation with hydrocinnamyl chloride formed an acylimine that folded 
preferentially into a reactive conformation (1.50) in which the benzyloxy and acylimine groups 
adopted pseudoequatorial orientations and the C2-center of the indole occupied a pseudoaxial 
orientation. The minor conformation (1.51) placed the C2-center of the indole in a 
pseudoequatorial orientation. Nucleophilic addition at the 3-position of the indole followed by 
hydrolysis of the chloroiminium ion intermediate provided spirooxindoles 1.52 and 1.53 in 73% 
and 10% yields respectively. This selectivity indicates that the aryl group is sterically more 
demanding than the chloro substituent in the transition states, consistent with observations by 
Overman and Panek.16  
 
 
Scheme 1.9 Spirooxindole formation through nitrile hydrozirconation, acylation, and intramolecular addition 
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The structures of the products were assigned based on extensive analyses of their 
NOESY and COSY spectra (Figure 1.4). Four characteristic hydrogens in these diastereomers 
were instructive for stereochemistry determination: H1 – the hydrogen on 
the tertiary carbon connected to the amido group; H2 – the hydrogen on 
the tertiary carbon connected to the benzyloxy group; H3 – the amide 
hydrogen; H4 – the hydrogen in the 4-position of the oxindole. The 
stereochemical orientations of the alkoxy and amide groups in the six-membered ring were 
determined by the coupling constants and splitting pattern of H1 and H2. For compounds 1.52 
and 1.53, which adopted the trans relationship between the amide and benzyloxy groups, the 
coupling constant between these two hydrogens is around 10 Hz, with H1 being an apparent 
triplet, and H2 being an apparent doublet of triplets. The stereochemistry of the quaternary 
carbon can be deduced from the NOE signals. An NOE signal between H1 and H4 was observed 
for compound 1.52, with C2-center of the oxindole in an axial orientation. Conversely, an NOE 
signal between H2 and H4 was observed for compound 1.53, which placed C2-center of the 
oxindole in the equatorial orientation. In addition, NOE studies also provided information about 
the conformation of amide. For both diastereomers, an NOE signal between H2 and H3 was 
observed, indicating a defined amide structure with H1 and H3 trans to each other as shown by 
structure 1.54. 
 
N O
Bn
OBn
R
H1
H2
H4
NOE
dt
7.40
R = NH3C(O)CH2CH2Ph
H1
N
H3H
2
BnO
NOE
CH2CH2Ph
O
N R
OBn
O
H4
Bn
H1
H2
NOE
dt
7.60
1.52 1.53 1.54
 
Figure 1.4 Structure determination for diastereomers 1.52 and 1.53 
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Based on this study, 2-chloroindole 1.37 was used to examine the scope of the reaction as 
shown in Table 1.1. Aliphatic, branched aliphatic, ,-unsaturated, and heteroatom-
functionalized acid chlorides serve as suitable electrophiles for the transformation.  
 
Table 1.1 Acid chloride scope for spirooxindole synthesisa 
entry substrate acid chloride Yield (%)cmajor product drb
Cl
O
N O
Bn
OBn
HN O
N O
Bn
OBn
HN O
OMe
N O
Bn
OBn
HN O
Cl
OMe
O
Cl
O
1
2
3
3.6:1 87
9.1:1d 46
20:1 53
a Representative procedure: Cp2Zr(H)Cl (1.25 eq) was added to a 0.1 M solution of the indole nitrile in CH2Cl2
under Ar. After stirring at rt for 15 min the acid chloride was added. The mixture stirred overnight at rt. b Ratio of
isolated, purified diastereomers. c Combined yield of diastereomers. d Single isomer at the quaternary center - dr
refers to the ratio of trans and cis amido ethers.
1.37
1.37
1.37
1.55
1.56
1.57
 
 
N-Methoxymethylindoles are also effective substrates as shown in Table 1.2. As 
expected, 2-chloroindoles showed better diastereoselectivity than 2-bromoindoles (entries 1 and 
2), which may be attributed to a more favored transition conformation caused by the smaller size 
of the chlorine atom. N-Methoxymethylindoles are not as reactive as N-benzylindoles due to the 
inductive attenuation of indole nucleophilicity by the methoxy group and in some cases a 
catalytic amount of Sc(OTf)3 was required to promote the cyclization (entries 4 and 5). For 
acryloyl chloride (entry 4), the acyliminium ion generated after addition of the acid chloride was 
 16 
Table 1.2 Cyclization with N-methoxymethylindolesa 
 
 
 
 17 
not sufficiently electrophilic to promote attack from the indole to form the cyclized product in 
the absence of a Lewis acid. Cyclization can occur efficiently for 3-bromopropionyl chloride 
(entry 5), but stirring overnight under these conditions led to halogen exchange of bromine with 
chlorine (confirmed by mass spec). In the presence of a catalytic amount of Sc(OTf)3, these two 
problems were resolved, and a minor amount of stereoisomer that has a cis-relationship between 
the amide and benzyloxy groups was obtained (compound 1.61’, Figure 1.5), presumably 
resulting from a chelation-controlled transition state. Chlorination on the benzene ring of the 
indole, in anticipation of further structural manipulations of the spirooxindole products, is 
compatible with the reaction conditions (entries 6 and 7). These substrates reacted somewhat less 
efficiently than the corresponding non-halogenated substrate due to inductive deactivation by the 
chloro group and, in the case of 1.49, steric interactions in the transition state. However useful 
quantities of the products could be isolated.  
 
 
Figure 1.5 Structure determination for 1.61' 
 
The structure of the minor diastereomer 1.61’ was determined by NMR studies. The cis 
relationship between the amide and benzyloxy groups was deduced from the coupling constant 
and splitting pattern of H1 and H2. The coupling constant of these two protons is approximately 4 
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Hz, with H1 being a doublet of doublets, and H2 being a doublet of triplets. In addition, the NOE 
signal between H1 and H4 implies the C2-center of the oxindole core occupies the axial position. 
As an expansion of Dr. Xiao’s work to invert the stereochemistry of the quaternary 
carbon using 2-silyloxyindoles, substrate 1.42 was utilized for cyclization reactions, and the 
results of this study are shown in Table 1.3. Several issues related to these transformations are 
worth noting. The overall yield of spirooxindole products from these reactions is comparable to 
the yields from the chloroindole substrates, indicating that the potentially labile enolsilane 
moiety is compatible with the reaction conditions. The reactions of 1.42 are slower than the 
reactions of the chloroindole substrates and require a full equivalent of Lewis acid despite the 
presence of the strongly donating silyloxy group. We attribute this effect to the steric demands in 
the cyclization transition states. Control of the quaternary center is good to excellent, though the 
trans:cis ratio between the benzyloxy and amide groups is lower than what was observed for the 
chloroindole substrates. The trans and cis stereoisomers were separable by flash 
chromatography, with the cis isomer reproducibly being the less polar stereoisomer. On the basis 
of the unusually downfield 1H NMR chemical shift (7.89 ppm) of the C4 hydrogen in the cis-
isomer (compound 1.67, Table 1.3), we postulate that the polarity arises from a hydrogen bond 
between the oxygen and the arene hydrogen.17 Changing the Lewis acid from Sc(OTf)3 to ZnCl2 
results in the cis-isomer being the major product (entry 5) as a result of chelation between the 
acylimine and the benzyloxy groups.  
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Table 1.3 Cyclizations with silyloxyindole substratesa 
entry substrate acid chloride Yield (%)cmajor product drb
Cl
O
Cl
OMe
O
Cl
O
Cl
O
Ph
Cl
O
1
2
3
4
5d
4.1:1 (2.1:1) 68 (46)
12:1 (1.7:1) 67 (42)
7.2:1 (3.7:1) 38 (30)
4.5:1 (2.4:1) 66 (47)
18:1 (1.8:1) 58 (37)
N HN
OBn
O
Bn
O
N HN
OBn
O
Bn
O
OMe
N HN
OBn
O
Bn
O
N HN
OBn
O
Bn
O
N HN
O
OBn
O
Ph
Ph
Ph
1.42
1.42
1.42
1.42
1.42
1.64
1.65
1.66
1.53
1.67
a Representative procedure: Cp2Zr(H)Cl (1.25 eq) was added to a 0.1 M solution of the indole nitrile in CH2Cl2
under Ar. After stirring at rt for 15 min the acid chloride and Sc(OTf)3 were added. The mixture stirred overnight
at rt. bThe ratio refers to the quaternary center. The value in parentheses refers to the ratio of the major
stereoisomer to all other stereoisomers. c Combined yield of all stereoisomers. The yield of the major stereoisomer
is in parentheses. d ZnCl2 was used instead of Sc(OTf)3.
Bn
H4 7.89
 
 
1.3.3 Further structure modification of the spirooxindole products 
The spirooxindole products were designed to have numerous points for structural diversification 
as a prelude to library synthesis. Several of these opportunities are shown in Scheme 1.10. 
Regioselective oxindole bromination can be achieved with NBS, and the resulting aryl bromide 
1.68 engages in a Suzuki reaction,18 as seen in the preparation of 1.69 from 1.52. Acrylamides 
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1.57 and 1.60 are highly versatile, undergoing Heck reaction19 to form 1.71, and cross 
metathesis20 to form 1.70, and thiolate addition to form 1.72.21 Benzyl ether cleavage was 
effected through standard hydrogenolysis conditions to afford the corresponding alcohol 1.73, 
which underwent subsequent acylation to afford 1.74. 
 
N O
Bn
OBn
HN O
Ph
Br
NBS
DCM, r.t. 59 %
(PPh3)4Pd(0), Na2CO3
B(OH)2MeO
THF/H2O, 66 C, 89 %
N O
Bn
OBn
HN O
Ph
MeO
N O
MOM
OBn
HN O
SPr
PrSH, NaH
THF, r.t., 71 %
N O
Bn
OBn
HN O
Ph
PPh3, Cs2CO3
I
DMF, 120 C, 72 %
N O
MOM
OH
HN O
Ph
N O
MOM
OBz
HN O
Ph
Pd/C, H2
r.t. to 60 C,
72 %
EtOH/EtOAc, r.t., 71 %
N O
Bn
OBn
HN O
DCM, 41 C, 40 %,
51% brsm
Ph
allylbenzene,
Hoveyda-Grubbs II
1.52
1.691.68
1.57
1.711.70
1.72
1.60
1.59
1.73 1.74
, Pd(OAc)2,
Benzoyl chloride,
DMAP, Pyridine,
 
Scheme 1.10 Spirooxindole functionalizations 
 
1.3.4 Construction of a spirooxindole amide library 
The spirooxindole products are structurally unique, and diversification can be easily achieved 
either by using different acid chlorides during the reaction sequence or modifications after 
spirooxindole formation. In addition, good stereocontrol at the spirooxindole quaternary carbon 
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can be achieved by choosing different acyclic indoles as the starting material. As an application 
of our methodology to diversity oriented synthesis, a spirooxindole amide library was 
synthesized by the University of Pittsburgh Center for Chemical Methodologies and Library 
Development (UP-CMLD), and I participated in the synthetic route development part.  
As shown in Scheme 1.11, the benzyl protecting group of 1.52 on the alcohol was 
selectively removed by hydrogenation, and the free alcohol 1.75 can be acylated with different 
acid chlorides or acids to give new esters 1.76. Furthermore, the free alcohol can also be used to 
generate more stereoisomers. After Swern oxidation, the ketone 1.77 was obtained, and it was 
then selectively reduced (d.r. > 20:1) to generate 1.78, in which the hydroxyl group is in the axial 
position opposite to starting material 1.75. The subsequent acylation reaction then led to the syn-
amido ester 1.79, which is complementary to the original trans-amido ester 1.76. It is worth 
noting that the configuration of 1.79 could not be obtained as the major isomer in the previous 
hydrozirconation, acylation and nucleophilic addition sequence. Thus, all four possible 
diastereomers of the spirooxindole structure can be selectively produced as major isomers. In 
addition, this stereochemistry inversion strategy can also be employed to the diastereomer 1.53, 
which is the epimer of 1.52 at the 3-position of the spirooxindole core. Additional structure 
complexity can be achieved by Suzuki coupling with 1.80. N-Debenzylation of the spirooxindole 
core under dissolving metal conditions22 gave more polar product 1.83. This spirooxindole 
structure with lower molecular weight is expected to have improved pharmacological property, 
according to Lipinski’s rule of five.23 Additionally, the free N-H bond of the spirooxindole could 
provide different biological properties through hydrogen bonding with protein targets.5b Finally, 
the single X-ray crystallography of 1.84 was obtained (Figure 1.6), confirming the previous 
structure assignments by NOE studies.  
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Scheme 1.11 Spirooxindole library synthesis 
 
N HN
O
O
O
PhBn
O
NO2
1.84
 
Figure 1.6 X-ray structure of 1.84 
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Using the above diversification methods, a library of 37-membered spirooxindoles was 
synthesized by Dr. Tsegay and Dr. Hong at UP-CMLD. The structural novelty of this library was 
studied by Dr. Xie and coworkers through chemistry space BCUT metrics as well as 2D finger-
print calculations.24 The results showed that this library has good chemical novelty when 
compared against NIH MLSMR (Molecular Libraries Small Molecule Repository), and 
Maybridge compound collections. These spirooxindoles have been deposited to NIH MLSMR, 
and some of these compounds were identified biologically active after preliminary high 
throughput screening (Appendix C).  
1.4 CONCLUSIONS 
We have demonstrated that the acyclic indolyl cyanohydrin ethers can be transformed to 
spirooxindole amides through a sequence of hydrozirconation, acylation and intramolecular 
nucleophilic addition. Three of the four possible diastereomers can be prepared as major 
products through this process. The quaternary stereocenter can be controlled by adjusting the 
steric bulk of the substituent at the 2-position of the indole substrate. Meanwhile, by using a 
chelating or non chelating Lewis acid, the relative stereochemistry between the amide and 
benzyloxy groups can also be influenced. Furthermore, the stereochemistry of the benzyloxy 
group can also be inverted through hydroxyl group oxidation and stereoselective reduction 
sequence. The novel spirooxindole structure has many sites for diversification, and a 37-
membered library was synthesized. A comparison with known compound collections showed 
that the new spirooxindoles possessed good chemical diversity.  
 24 
2.0  STEREOCONTROLLED CYANOHYDRIN ETHER SYNTHESIS THROUGH 
CHIRAL BRØNSTED ACID-MEDIATED VINYL ETHER HYDROCYANATION 
2.1 INTRODUCTION 
The stereocontrolled spirooxindole amide synthesis has demonstrated that cyanohydrin alkyl 
ethers are important building blocks for the amide formation through hydrozirconation, 
acylation, and nucleophilic addition. The direct formation of enantiomerically enriched 
cyanohydrin alkyl ethers has not been reported despite its synthetic utility. Major efforts for the 
synthesis of chiral nitrile containing compounds have focused on the asymmetric cyanohydrin 
formation. Excellent enantioselectivity can be achieved by cyanide addition to an aldehyde or 
ketone,25 and many catalysts are effective to mediate this transformation.26 Chiral cyanohydrins 
can be transferred to silyl ethers,27 esters,28 and acetals29 without loss of stereochemistry. 
However, the alkylation of cyanohydrins to yield cyanohydrin alkyl ethers are implausible, 
because cyanohydrins are not stable under basic conditions, and cyanohydrins are weak 
nucleophiles for direct alkylation due to the strong inductive effect of the cyano group. 
Therefore, a new strategy is needed towards the direct synthesis of enaniomerically enriched 
cyanohydrin alkyl ethers. 
Racemic cyanohydrin alkyl ethers can be generated by Lewis acid catalyzed acetal 
ionization reactions followed by quenching the resulting oxocarbenium ions with TMSCN.30 
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Absolute stereocontrol in these reactions is rare for acyclic substrates, though a good level of 
diastereocontrol was achieved by Rychnovsky and co-workers.31 In their study, TMSCN added 
diastereoselectively to the α-(trimethylsilyl)benzyl-substituted oxocarbenium ion to yield the 
cyanohydrin alkyl ether in 5:1 d.r.. Even though the complicated auxiliary and substrate 
syntheses limit the application of this strategy, it demonstrates the feasibility of enantioselective 
synthesis of cyanohydrin alkyl ethers through stereoselective cyanide addition to oxocarbenium 
ions. 
 
O
TMSPh
OAc
O
TMSPh
CN
TMSCN, TMSOTf
PhCH3, –78 °C
97%, 5:1 d.r.
2.1 2.2  
Scheme 2.1 Rychnovsky’s diastereoselective cyanide addition to oxocarbenium ions 
 
Encouraged by our previous application of cyanohydrin alkyl ethers in target-, diversity-, 
and function-oriented synthesis, we initiated a study directed towards the enantioselective 
synthesis of cyanohydrin alkyl ethers through catalytic asymmetric cyanide addition to 
oxocarbenium ions.  
2.2 SYNTHESIS OF ACHIRAL CYANOHYDRIN ALKYL EHTER THROUGH 
CYANATION OF ENOL ETHER 
In the previous spirooxindole synthesis, the Lewis acid catalyzed ionization of acetals and the 
following cyanation was used as the established protocol for the synthesis of cyanohydrin alkyl 
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ethers. However, if the substrate contains structurally complex or valuable alkoxy groups, this 
approach will become inappropriate for the synthesis of such cyanohydrin alkyl ethers. Enol 
ethers are attractive substrates for the synthesis of cyanohydrin alkyl ethers without loss of 
precious alkoxy groups. Oxocarbenium ions can be generated upon protonation, and the 
following cyanation should give cyanohydrin alkyl ethers. These substrates are readily accessed 
through cross-coupling32 or vinyl transfer reactions.33 Despite these benefits, examples of enol 
ethers as precursors to cyanohydrin alkyl ethers are quite rare in the literature. Our initial 
attempts of using this substrate for the cyanohydrin ether synthesis illustrated the obstacle to its 
application in synthesis (Scheme 2.2, reaction 1).  Adding anhydrous HCl to a mixture of benzyl 
vinyl ether (2.3) and TMSCN provided cyanohydrin ether 2.4 in only 18% yield. The remainder 
of the material ended up oligomerized through nucleophilic enol ether addition into the 
oxocarbenium ion intermediates. 
The oligomerization pathway could be alleviated by converting the enol ether to an 
electrophile prior to the addition of TMSCN. This was accomplished through quantitatively 
forming α-chloro ether 2.5 from 2.3 and HCl (Et2O solution, 1.1 equiv). The addition of TMSCN 
(2 equiv) to the crude chloro ether led to the formation of 2.4 in 81% yield for the one pot 
transformation (Scheme 2.2, reaction 2). The mechanism of this transformation could proceed 
through chloride ionization by a Brønsted acid or direct addition by TMSCN. 2,6-di-tert-
Butylpyridine was added to the in situ generated chloro ether before the addition of TMSCN to 
elucidate the mechanism, and no cyanohydrin ether was generated. The suppressed cyanation 
step suggested that the oxocarbenium ion 2.6 arises from Brønsted acid-mediated ionization of 
choloro ether 2.5, which was in accord with observations from the Jacobsen group.34 Woerpel 
and co-workers demonstrated that the nuclophilic addition of TMSCN to oxocarbenium ions 
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involved an ionic pentacoordinate siliconate as the real nucleophile.35 We propose that chloride 
adds to TMSCN to create the activated cyanide species 2.7, which then adds to the 
oxocarbenium ion 2.6 to form 2.4 (Scheme 2.2). 
 
 
Scheme 2.2 Cyanohydrin ether formation through vinyl ether hydrocyanation 
 
 
Scheme 2.3 General vinyl ether substrate synthesis 
 
The scope of this reaction is shown in Table 2.1. Vinyl ether substrates were readily 
synthesized by using different alcohols via mercury acetate catalyzed vinyl transfer reaction with 
ethyl vinyl ether (Scheme 2.3).33 Vinyl ethers with longer alkenyl groups (2.18 and 2.20, Table 
2.1) were synthesized through metal-catalyzed coupling reactions.36 Substrates with longer 
alkoxy groups react smoothly (entry 1), and functional groups such as alkenes, silyl ethers and 
sulfides are tolerated (entries 2-4). Vinyl ethers with branched alkoxy groups react smoothly, but 
little stereocontrol is observed (entry 5). The vinyl group can be extented (entries 6 and 7), and 
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cyclic enol ethers react well (entry 8). The ester gives decreased yield (entry 9) possibly due to 
the instability of the ester group to the oxocarbenium ion intermediate. These transformations 
demonstrate that cyanohydrin alkyl ethers can be formed through Brønsted acid-mediated vinyl 
ether hydrocyanation, and this method is superior to the convential acetal ionization approaches 
toward synthesis of cyanohydrin ethers with complex alkoxy groups. 
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Table 2.1 Scope of the enol ether hydrocyanation reaction 
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2.3 ASYMMETRIC CYANOHYDRIN ALKYL ETHER SYNTHESIS MEDIATED BY 
CHIRAL BRØNSTED ACID 
2.3.1 Chiral Brønsted acid mediated cyanation of α-chloro ethers 
The Brønsted acid mediated hydrocyanation reaction in the previous chapter prompted us to 
explore the potential of replacing HCl with a chiral Brønsted acid37, with the expectation that the 
chiral ion pair38 formed between the oxocarbenium ion and the conjugate base of chiral Brønsted 
acid would lead to enantioselective cyanide addition. Thus we prepared α-chloroether 2.5 and 
added TMSCN at 0 °C in the presence of thiophosphoryl triflimide 2.2639 (3 mol%). This 
reaction provided 2.4 with an enantiomeric ratio (er) of 57.5:42.5. Even though the results are 
not preparatively useful, it demonstrates that the tight ion pair strategy could lead to some degree 
of enantiocontrol. After examining the possible reaction mechanism, we noticed that HCl could 
be released from the ionization of the α-chloro ethers mediated by the chiral Brønsted acid. In 
order to achieve high enantioselectivity, the liberated HCl must engage in a fast exchange 
reaction with the silylated catalyst to regenerate the chiral Brønsted acid and form TMSCl. If this 
process is not rapid or is not thermodynamically viable, HCl will promote the non-selective 
pathway and lead to low enantioselectivity. Therefore, the chiral Brønsted acid mediated 
cyanation of α-chloroethers is not effective to achieve high enantioselectivity.   
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Scheme 2.4 Chiral Brønsted acid-mediated choride ionization and cyanation 
 
2.3.2 Chiral Brønsted acid catalyzed hydrocyanation of vinyl ethers 
The non-selective background reaction catalyzed by HCl led us to reexamine vinyl ethers alone 
as substrates. However, there are not many examples using vinyl ethers as oxocarbenium ion 
precursors for asymmetric synthesis. Terada and co-workers developed an enantioselective aldol-
type reaction catalyzed by chiral phosphoric acid 2.30 (Scheme 2.5, reaction 1).40 Vinyl ethers 
were protonated by 2.30 to give oxocarbenium ions, which then reacted with the enol form of the 
azlactone to produce the addition product. Tu and co-workers reported that chiral Brønsted acids 
promote a semipinacol rearrangement of vinyl ethers to give spiroethers (Scheme 2.5, reaction 
2).41 Recently, Nagorny42 and List43 demonstrated separately the asymmetric spiroacetalization 
of cyclic vinyl ethers catalyzed by chiral Brønsted acid (Scheme 2.5, reaction 3 and 4). These 
examples show that oxocarbenium ions can be readily generated through chiral Brønsted acid 
catalyzed protonation of vinyl ethers, and the acid can be regenerated from the protons lost from 
nucleophiles, such as active methylene compounds or alcohols.  
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Scheme 2.5 Chiral Brønsted acid mediated vinyl ether transformations 
 
Silylated nucleophiles can be utilized for the asymmetric addition to oxocarbenium ions 
when a silyl group scavenger is generated upon formation of oxocarbenium ions. Jacobsen and 
co-workers developed a thiourea-catalyzed enantioselective addition reaction to oxocarbenium 
ions in which silyl ketene acetals were used as nucleophiles and 1-chloroisochroman was 
employed as the oxocarbenium precursor (Scheme 2.6, reaction 1).34a Our group recently 
demonstrated that a chiral Brønsted acid can mediate asymmetric addition of allyl trimethylsilane 
(2.44) to benzopyrylium ions, which were generated by 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone (DDQ) oxidation of 2H-chromene (2.43) (Scheme 2.6, reaction 2).44 All the above 
 33 
reported cases of intermolecular additions to oxocarbenium ions utilized sterically hindered 
nucleophiles40 or highly specific electrophiles34a, 44. 
 
 
Scheme 2.6 Addition of silylated nucleophiles to oxocarbenium ions through organocatalysis 
 
The Brønsted acid-catalyzed asymmetric addition of silylated nucleophiles to vinyl ether-
derived oxocarbenium ions has not been explored. The generation of oxocarbenium ions and the 
following nucleophilic addition are feasible, but the consumption of the Brønsted acid will 
terminate the catalytic cycle. Because there is no other silyl group scavengers generated in the 
reaction, the catalyst will be silylated, which subsequently blocks the oxocarbenium ion 
formation pathway. Yamamoto and co-workers developed an enantioselective protonation 
reaction of enolsilanes using a chiral Brønsted acid as the catalyst (Scheme 2.7, reaction 1).45 In 
this reaction, phenol functions as both the proton source and the silyl group scavenger, and only 
catalytic amount of chiral Brønsted acid is necessary for the transformation. List and co-workers 
recently demonstrated that methanol could serve as proton source for the asymmetric protonation 
of silyl ketene imine (Scheme 2.7, reaction 2).46 Therefore, we envisioned that alcohols could be 
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used to regenerate the chiral Brønsted acid from its silylated form and to quench silyl 
electrofuges upon silylated nucleophile addition to oxocarbenium ions.  
 
 
Scheme 2.7 Asymmetric protonation reactions mediated by chiral Brønsted acid and alcohols 
 
A proposed catalytic cycle for the asymmetric addition of TMSCN to vinyl ether-derived 
oxocarbenium ions is shown in Scheme 2.8. Protonation of the enol ether will generate a chiral 
ion pair. The TMSCN will be activated by complexation with an alcohol in accord with 
Woerpel’s studies.35 The subsequent cyanide transfer yields the cyanohydrin ether and an ion 
pair between the protonated silyl ether and the conjugate base of the catalyst. The chiral Brønsted 
acid is then regenerated by the proton transfer and a silyl ether is also produced.  
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Scheme 2.8 Direct enol ether hydrocyanation with catalyst regeneration 
 
Catalysts were first screened for reactivity and selectivity. The reaction was conducted 
with 2.3 as the substrate in CH2Cl2 at rt, and phenol was used as the stoichiometric proton 
source. The results are shown in Table 2.2. Thiophosphoryl triflimide 2.26 provided an 
enantiomeric ratio of 65:35 (entry 1), indicating that this protocol is superior to the asymmetric 
cyanation of α-chloroethers. Changing the substitution pattern of the aryl groups (2.52, entry 2) 
and introducing a triphenylsilyl group onto the binaphthyl core (2.53, entry 3) led to almost no 
stereoselectivity. This implied that the diisopropyl group at the 2,6-positions of the 
triisopropylphenyl group is essential for the stereocontrol. Selectivity was further improved by 
introducing more steric demanding groups at the 4-position of the triisopropylphenyl group 
(entry 4-5) and the optimal selectivity was achieved by using biary-substituted catalyst 2.55 
(entry 5). The triflimide group proved to be essential for the reactivity, with phosphoric acid 2.56 
(entry 6) and thiophosphoric acid 2.57 (entry 7) proving to be ineffective catalysts. Phosphoryl 
triflimide 2.58 led to decomposition of the substrate (entry 8), demonstrating the importance of 
the sulfide group in this process. Thus acid 2.55 was selected as the lead catalyst for this process. 
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Table 2.2 Catalyst screening 
 
 
The synthesis of chiral Brønsted acid 2.55 shown in Scheme 2.9, represents the general 
procedure for the synthesis of sterically bulky chiral Brønsted acids. Acid 2.55 was first reported 
by Yamamoto,47 however no synthetic details were included. Thus, herein we provided the 
synthetic sequence towards this acid. The intermediate 2.6048 and 2.6449 were synthesized 
according to the reported procedure. Even though the Kumada coupling50 between 2.61 and 2.64 
proceeded smoothly in both THF and Et2O for the preparation of catalyst 2.26, the coupling 
reaction towards the synthesis of sterically bulky BINOL derivative 2.65 must be conducted in 
Et2O. THF can promote the generation of Grignard reagent 2.62, but no coupling product 
between 2.62 and 2.64 was obtained. The Grignard reagent 2.62 is difficult to form in Et2O 
possibly due to the steric bulk of its bromide precursor. However, the reaction proceeded when 
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magnesium strip was successfully activated by dibromoethane. Once Grignard reagent 2.62 is 
generated, the bulky BINOL derivative 2.65 can be obtained by nickel-catalyzed Kumada 
coupling51 and methyl ether cleavage. The subsequent formation of triflimide and sulfur 
oxidation gave chiral Brønsted acid 2.55 in good yield.47  
 
 
Scheme 2.9 Synthesis of chiral Brønsted acid 2.55 
 
The reaction conditions were optimized after identifying the suitable catalyst (Table 2.3). 
HCN was tested for this reaction as it is the most direct proton and cyanide source.52 The 
cyanohydrin ether 2.4 was isolated in 35% yield with 69:31 er (entry 1) when HCN was used at 
−40 °C alone. However, when a 1:1 mixture of TMSCN and HCN was used as the cyanide 
source, 2.4 was obtained in 60% yield and 77:23 er (entry 2). Therefore, HCN is not an effective 
cyanide source for the oxocarbenium ion addition, and it leads lower enantioselectivity as 
previously observed by Shibasaki and co-workers.53 Additionally, when TMSCN is present in 
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the reaction mixture, HCN is not the real nucleophile that is involved in this chiral Brønsted 
acid-mediated asymmetric hydrocyanation reaction. However, HCN can serve as the proton 
source for this reaction. When HCN was added slowly to the reaction mixture over 20 h, an 
improved enantioselectivity was observed (entry 3). This implied that the low selectivity 
pathway involving HCN as the nucleophile is suppressed by slow addition, and in this protocol 
HCN functions as a proton source instead of the nucleophile. Lowering temperature to −60 °C 
gave no further selectivity improvement (entry 4).  
Solvent screening revealed that PhCF3 was the optimal solvent in terms of 
enantioselectivity and the chemical yield (entries 5-6). iPrOH was also tested as the proton 
source instead of PhOH, but it led to decreased yield because of competitive mixed acetal 
formation (entry 7). Hence, PhOH was identified as a better proton source than alkyl alcohols. 
The selectivity was improved at −25 °C to give an er of 80.5:19.5 while PhOH was added slowly 
to minimize side reactions such as the mixed acetal formation (entry 8). Replacing TMSCN with 
bulky TBSCN resulted in decreased selectivity and chemical yield (entry 9). After optimization 
of the reaction conditions, optimal catalyst 2.55 was used to give 2.4 in 85% chemical yield with 
an er of 85:15 (entry 10).  Even though the minimum reaction temperature for PhCF3 is −25 °C, 
the selectivity and the yield obtained under this condition is better than using CH2Cl2 as solvent 
at −40 °C (entry 11). When HCN was used as the proton source, a similar selectivity and yield 
can be achieved (entry 12). However, PhOH is a better proton source for the reaction due to 
safety and availability. Enantioselectivity was not improved by increasing the loading of the 
catalyst to 10 mol% (entry 13). Reducing the loading of the catalyst to 0.5 mol% did not 
influence the selectivity and the chemical yield (entry 14). Even though synthesis of catalyst 2.55 
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takes several steps, the low catalyst loading will greatly facilitate further application of this 
protocol. 
 
Table 2.3 Condition optimizationa 
 
 
The absolute stereochemistry of the major isomer of cyanohydrin ether 2.4 was 
determined by comparison with the authentic material that was prepared by methyl lactate 
(Scheme 2.10). (S)-2-(Benzyloxy)propanoate (2.66) was first transformed to a primary amide, 
which was then oxidized under Swern conditions to give the cyanohydrin ether 2.4. The optical 
rotation of this authentic sample is −169.1 (c 1.0, CHCl3), and the HPLC analysis showed the 
purity of this sample is over 99:1 er. The cyanohydrin ether 2.4 obtained by asymmetric 
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cyanation (Table 2.3, entry 14) has an optical rotation of −123.3 (c 1.0, CHCl3), and hence, the 
absolute stereochemistry of the major isomer is S. This result was also confirmed by HPLC 
retention time comparison. 
 
 
Scheme 2.10 Determination of the absolute stereochemistry of 2.4 
 
The scope of this reaction was further explored, and the results are summarized in Table 
2.4. The reaction was insensitive to alkoxy group changes. Similar levels of stereocontrol were 
observed for alkoxy groups with longer chains (entries 1 and 2), branching (entry 4), and larger 
aromatic groups (entry 7). Functional groups such as alkenes (entry 3), esters (entry 5) and 
sulfides (entry 6) are compatible with the reaction conditions. It is worth noting that ester 2.25 
was obtained in higher yield in this protocol than the cyanation of α-chloroethers (entry 9, Table 
2.1). This result implied that the hydrocyanation of vinyl ethers mediated by a chiral Brønsted 
acid is more efficient than the cyanation of α-chloroethers. Unfortunately, vinyl ethers with 
alkoxy groups that can fragment to form a stable carbocation following oxocarbenium ion 
formation, such as tert-butyl vinyl ether (2.75), do not yield the cyanohydrin ether product (entry 
8). Extending the alkenyl group caused a reduction in enantioselectivity that was more 
pronounced at greater chain lengths (entries 9 and 10). (Z)-Enol ethers proved to be superior 
substrates relative to the corresponding (E)-enol ethers, though identical levels of stereocontrol 
were observed regardless of the substrate alkene geometry (entries 10 and 11). This implies that 
the same reactive intermediate was formed from either isomer. The (Z)-isomer more readily 
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Table 2.4 Substrate scope for the asymmetric reactiona 
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undergoes the hydrocyanation process because it is presumably protonated more rapidly than the 
(E)-isomer. Chiral substrates can show matched or mismatched selectivity in these reactions, as 
demonstrated by the reaction of the methylbenzyl vinyl ether enantiomers in entries 12 and 13. 
Reactions with these compounds under HCl-mediated conditions showed little stereocontrol 
(entry 5, Table 2.1). However, the reaction of (R)-enantiomer 2.79 in the presence of 2.55 proved 
to be highly diastereoselective. The reaction of (S)-enantiomer 2.16 showed little 
diastereoselectivity, similar to the HCl-mediated process. 
The stereochemistry of 2.80 was determined by the conversion to the corresponding 
cyanohydrin through cleavage of the methylbenzyl group. Posner and Greene showed that 
benzylic C-O bonds of chiral secondary alcohols can be cleaved by trifluoroacetic acid without 
loss of the stereochemistry of the hydroxyl group (Scheme 2.11, reactions 1 and 2).54 Baklouti 
and co-workers demonstrated that the ring opening fluorination of the cyanohydrin ether 
derivative 2.86 went through the SN1 pathway under acidic conditions (Scheme 2.11, reaction 
3).55 Therefore, trifluoroacetic acid was used to cleave the methylbenzyl group of 2.80 to give 
cyanohydrin 2.88 in 22% yield (Scheme 2.12, reaction 1). The low yield is possibly due to the 
volatility of cyanohydrin 2.88. The measured optical rotation for 2.88 is −32 (c 0.23, CHCl3), 
which is consistent with the reported value56 for the (S)-lactonitrile ([α]D25 = −30 (c 1.0, CHCl3)). 
Therefore, the stereochemistry of the cyanohydrin ether group of 2.80 was determined to be S. 
The diastereoselectivity for the asymmetric cyanation of 2.79 was determined by HPLC using a 
Lux cellulose-3 column. 2.80 and its diastereomer 2.89 were synthesized through cyanation of 
the α-chloroether (Scheme 2.12, reaction 2), and these two diastereomers can be readily 
separated by flash chromatography. The retention times for both of the diastereomers were 
recorded, and the diastereoselectivity for the chiral Brønsted acid catalyzed hydrocyanation 
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reaction was determined to be 28:1 by comparison of the crude product with the purified 
samples.  
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Scheme 2.11 Cleavage of C-O benzylic bonds under acidic unditions 
 
 
Scheme 2.12 Determination of the absolute stereochemistry and diatereoselectivity of 2.80 
 
Acetals can also be used as substrates for the preparation of enantiomerically enriched 
cyanohydrin ethers (Scheme 2.12). Dibenzyl acetal 2.90 reacts with TMSCN in the presence of 
2.55 to give (S)-2.4 in 85% yield and with an er of 82.5:17.5. Dimethyl acetal 2.91 reacts under 
these conditions to yield (S)-2.19 in 91% yield and with an er of 73:27. Both enantioselectivity 
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and chemical yield are similar to the results in vinyl ether series, and hence, the choice of a vinyl 
ether or acetal substrate is determined by synthetic accessibility. Acetals, however, are clearly 
superior substrates to poorly reactive (E)-vinyl ethers in these processes.  
 
 
Scheme 2.13 Application to acetal substrates 
 
A plausible mechanism for this process is shown in Scheme 2.14. The silylated 
thiophosphoryl triflimide possibly serves as the active catalyst in these processes. NMR studies 
showed that thiophosphoryl triflimides were silylated by TMSCN to form a Lewis acid in the 
absence of phenol, consistent with observations by Yamamoto and List46-47 in reactions between 
chiral Brønsted acids and silylated substrates. Trimethylsilyl ethers were observed as products in 
accord with this hypothesis. Sammakia and co-workers demonstrated that Lewis acid-mediated 
cleavage of acetals and nucleophilic addition predominately undergoes SN1 pathway to generate 
oxocarbenium ions.57 Therefore, it can be postulated that one of the enantiotopic alkoxy groups 
is preferentially activated by the silylated chiral Brønsted acid to form a tight ion pair between 
the oxocarbenium ion and the departing alcohol, followed by nucleophilic addition (Scheme 
2.14, path I). However, the similarities between the outcomes of reactions with acetals and vinyl 
ethers suggest that they proceed through the same intermediates as shown in Scheme 2.8, 
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probably involving the direct interaction between the oxocarbenium ion and the conjugate base 
of the chiral Brønsted acid (Scheme 2.14, path II).  
 
 
Scheme 2.14 Possible pathways towards activation of acetals 
 
2.3.3 Computational studies 
Unlike carbonyl and imine containting compounds, which are widely used as substrates for chiral 
Brønsted acid catalyzed reactions, oxocarbenium ions do not possess Lewis basic sites for 
hydrogen bonding to the catalyst. As far as we know, there is no established model for the ion 
pair interaction between the oxocarbenium ion and the conjugate base of chiral Brønsted acid. 
Thus we initiated computational studies using density functional theory (DFT) to gain insight 
into the origins of the asymmetric induction and to explain the substrate scope. Mr. Xiaoge Su 
from Professor Jordan’s group at the University of Pittsburgh conducted these studies with 
Gaussian 09.58 B3LYP59 was used as the exchange correlation function. The interaction between 
the oxocarbenium ion of ethyl vinyl ether with the conjugate base of catalyst 2.26 was utilized to 
develop a model for these transformations. Peripheral atoms, which constitute the aromatic part 
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of the chiral Brønsted acid 2.26, were treated with the 3-21G60 basis set while contact atoms 
were treated with the 6-311G61 basis set. The phosphorus and sulfur atoms were described by the 
6-311G(3df, 3pd)62 basis set. Energy minima were determined by optimizing structures from 
several starting geometries, which were derived from the crystal structure of the sodium salt of 
2.26,45 and the minima were confirmed by frequency calculations. 
The lowest energy structure for the ion pair is shown as model A in Figure 2.1. This 
structure shows interactions between the sulfur of the catalyst and the carbon of the 
oxocarbenium ion. Additionally, the nitrogen of the triflimide group in the catalyst interacts with 
the hydrogen on the electrophilic carbon of the oxocarbenium ion. Corey postulated that this type 
of interaction can be important in structures between aldehydes and Lewis acids.63 Recent work 
in chiral phosphoric acid-catalyzed additions to aldehydes indicated that these interactions are 
essential for stereocontrol.64 The Mulliken charge on the hydrogen was calculated to be +0.22, 
supporting the postulated electrostatic attraction. Additionally the fluorine atoms of the 
trifluoromethyl group in the catalyst are proximal to the hydrogen atoms of the electron deficient 
carbon of the alkoxy group. Even though the existence of defined C–H•••F–C hydrogen bonds is 
debatable,65 electrostatic and van der Waals attractions between organofluorine compounds and 
electron deficient hydrogens are well established,66 thus these interactions could contribute to 
defining the orientation of the substrate in the catalyst. The Mulliken charges on these hydrogens 
were calculated to be +0.2, again supporting the possibility for an electrostatic interaction. Model 
A shows that the Si-face of the oxocarbenium ion is blocked by a triisopropylphenyl group of the 
catalyst and the Re-face is open for nucleophilic attack. Thus, the (S)-stereoisomer is predicted to 
be the major product, and this result is consistent with the experimental result. Additionally, 
extending the length of the alkenyl group results in a steric clash with a triisopropylpenyl group 
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of the catalyst, while the alkoxy group of the substrate can be lengthened without 
impediment. This explains whey the stereoselectivity is insensitive to alkoxy group changes, but 
it diminishes when the alkenyl group of the substrate is extended. 
Figure 2.1 Modeled structure of the ion pair from the reaction of ethyl vinyl ether with catalyst 2.26. 
Hydrogens have been removed for clarity. Green = carbon, red = oxygen, gold = sulfur, light blue = fluorine, 
darkblue = nitrogen.  
The substantial diastereoselectivity differences in the matched and mismatched outcomes 
from the α-methylbenzyl vinyl ether substrates were not expected based on the minimal 
diastereocontrol that was obtained through the HCl-mediated pathway. This result can be 
rationalized by model A. Overlapping methylbenzyl vinyl ethers with ethyl vinyl ether in model 
A, the models for the ion pair between the conjugate base of 2.26 and the oxocarbenium ions of 
methylbenzyl vinyl ethers were obtained. The methyl group of (R)-substrate 2.78 fills a pocket of 
the catalyst (Figure 2.2, model B) leaving an open Re-face for the nucleophilic addition. In 
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contrast, the trajectory of the nucleophile towards the Re-face of (S)-substrate 2.16 was blocked 
by the methyl group (Figure 2.2, model C). Rotation of the methyl group to avoid the interaction 
with the nucleophile will lead to a steric clash between the phenyl group and the catalyst. 
Therefore, neither face of the oxocarbenium ion is open for nucleophilic attack and the reaction 
most likely proceeds through an intermediate that is not intimately associated with the chiral 
counterion. 
 
B C  
Figure 2.2 Modeled structures of the ion pairs derived from 2.79 (B) and 2.16 (C) with catalyst 2.26. 
Hydrogens have been removed for clarity. 
2.4 CONCLUSIONS 
We have shown that cyanohydrin alkyl ethers could be effectively synthesized by acid mediated 
hydrocyanation of vinyl ethers. Racemic product formation proceeds smoothly through 
49
conversion of vinyl ethers to chloroethers followed by Brønsted acid-mediated oxocarbenium ion 
formation and subsequent TMSCN addition. The enantiomerically enriched products can be 
achieved by asymmetric cyanation of the oxocarbenium ion, which was generated by protonation 
of vinyl ethers with a chiral Brønsted acid. Only a catalytic amount of the chiral Brønsted acid 
is needed for the transformation, and the silylated catalyst can be regenerated by using phenol 
as the proton source. In addition to vinyl ethers, acetals can also be used as substrates 
for oxocarbenium ion formations and the similar level of enantiocontrol was achieved. 
These processes represent the first examples of chiral Brønsted acid mediated asymmetric 
addition of silylated nucleophiles with vinyl ethers and acetals. Computational studies 
revealed the unique ion pair interaction between the conjugate base of the chiral Brønsted acid 
and the oxocarbenium ion, which well explained many experimental observations. The protocol 
that was developed for the asymmetric addition of TMSCN to oxocarbenium ions, as well as 
the model for novel chiral ion pair interactions will benefit further studies towards asymmetric 
addition of other silylated nucleophiles to oxocarbenium ions.  
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APPENDIX A 
STEREOSELECTIVE SYNTHESIS OF SPIROOXINDOLE AMIDES THROUGH 
NITRILE HYDROZIRCONATION (SUPPORTING INFORMAITON) 
General Information Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, a Bruker 
Avance 400 spectrometer at 400 MHz and 100 MHz, a Bruker Avance 500 spectrometer at 500 
MHz, a Bruker Avance 600 spectrometer at 600 MHz if specified. The chemical shifts are 
reported in parts per million (ppm) on the delta (δ) scale. The solvent peak was used as a 
reference value, for 1H NMR: CDCl3 = 7.27 ppm, DMSO = 2.50, for 13C NMR: CDCl3 = 77.23, 
DMSO = 39.52. Data are reported as follows: (s = singlet; d = doublet; t = triplet; q = quartet; 
sept = septet; dd = doublet of doublets; ddd = doublet of doublet of doublets; dddd = doublet of 
doublet of doublet of doublet; td = triplet of doublets; dtd = doublet of triplet of doublets; br = 
broad). High resolution and low resolution mass spectra were recorded on a VG 7070 
spectrometer. Infrared (IR) spectra were collected on a Mattson Cygnus 100 spectrometer. 
Samples for IR were prepared as a thin film on a NaCl plate by dissolving the compound in 
CH2Cl2 and then evaporating the CH2Cl2. Tetrahydrofuran and diethyl ether were distilled from 
sodium and benzophenone. Methylene chloride was distilled under N2 from CaH2. The Schwartz 
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reagent was prepared following the reported procedure,67 and stored under argon atmosphere in 
freezer. All acid chlorides were freshly distilled prior to use. Analytical TLC was performed on 
E. Merck pre-coated (25 mm) silica gel 60F-254 plates. Visualization was done under UV (254 
nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica gel. Reagent grade 
ethyl acetate, diethyl ether, toluene and hexanes (commercial mixture) were purchased from EM 
Science and used as is for chromatography. All reactions were performed in oven or flame-dried 
glassware under argon with magnetic stirring unless otherwise noted. All the reactions that use 
the Schwartz reagent were performed under argon unless otherwise specified. All products in this 
manuscript are racemic mixtures but are drawn and named as single enantiomers to indicate their 
relative stereochemistry. 
 
 
 
 
 
 
 52 
3-((tert-Butyldiphenylsilyl)oxy)propanal (1.32) 
To a solution of 1,6-hexanediol (18.92g, 160 mmol) in dry THF (160 mL) 
at 0°C was added NaH (60% dispersion in mineral oil, 6.4g, 160 mmol), 
and the suspension was stirred at rt for 1 h. TBDPSCl (40.9 mL, 160 mmol) was added dropwise 
over 10 min at 0°C, and then the solution was stirred at rt overnight followed by quenching the 
reaction with H2O. Extract the solution with ether (2x), and then dry the combined organic layer 
over Na2SO4. After removing the solvent under reduced pressure, the residue was purified by 
flash chromatography (10% to 45% EtOAc in Hexane) to give mono-TBDPS protected 1,6-
hexanediol as colorless oil (30.747g, 54%). To a solution of oxalyl chloride (5.56 mL, 64.7 
mmol) in anhydrous CH2Cl2 (250 mL) under argon atmosphere at –78 °C was added DMSO 
(6.12 mL, 86.2 mmol) in CH2Cl2 (35 mL) dropwise. The resulting solution was stirred at that 
temperature for 30 min, and then the above alcohol (15.37 g, 43.1 mmol) in CH2Cl2 (50 mL) was 
added dropwise. 30 min later, triethylamine (30.2 mL, 215.5 mmol) was added to the solution. 
The solution was allowed to stir for another 30 min, before warming up to room temperature. 
The solution was then stirred at room temperature for 30 min, and quenched with brine. The 
mixture was extracted with CH2Cl2 (2x), and the combined organic layer was washed with brine. 
The organic layer was dried over Na2SO4, concentrated at reduced pressure, and purified by flash 
chromatography (10% EtOAc in hexane) to give 1.32 as colorless oil (27.04g, 88%).1H NMR 
(500 MHz, CDCl3)  9.76 (s, 1H), 7.67-7.66 (m, 4H), 7.43-7.37 (m, 6H), 3.67 (t, 2H, J = 6.0 Hz), 
2.41 (t, 2H, J = 7.0 Hz), 1.65-1.52 (m, 4H), 1.44-1.41 (m, 2H), 1.05 (s, 9H). 
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(3,3-bis(Benzyloxy)propoxy)(tert-butyl)diphenylsilane (1.33) 
To a solution of 1.32 (1.00 g, 2.82 mmol) in CH2Cl2 (5.6 mL) was added 
BnOH (730 L, 7.05 mmol), p-toluenesulfonic acid monohydrate 
(PTSA•H2O) (6 mg, 0.03 mmol) and Na2SO4 (800.0 mg, 5.6 mmol). After stirring at room 
temperature overnight, the solution was diluted with CH2Cl2 and then filtered. Wash the filtrate 
with brine, and dry over Na2SO4. After removing the solvent at reduced pressure, the residue was 
purified by flash chromatography (3% to 5% EtOAc in Hexane) to give 1.33 as colorless oil (854 
mg, 55%, 85% brsm), and recover aldehyde 1.32 (345 mg). 1H NMR (500 MHz, CDCl3)  7.69 
(d, 4H, J = 6.5 Hz), 7.44-7.36 (m, 11H), 7.32-7.29 (m, 5H), 4.75 (t, 1H, J = 5.5 Hz), 4.67 (d, 2H, 
J = 12.0 Hz), 4.58 (d, 2H, J = 12.0 Hz), 3.66 (t, 2H, J = 6.0 Hz), 1.78-1.75 (m, 2H), 1.59-1.57 
(m, 2H), 1.41-1.39 (m, 4H), 1.07 (s, 9H). 
 
2-(Benzyloxy)-4-((tert-butyldiphenylsilyl)oxy)butanenitrile (1.34) 
To a solution of 1.33 (851 mg, 1.54 mmol) in CH2Cl2 (1.6 mL) was added 
TMSCN (307 L, 2.30 mmol) and BiBr3 (67 mg, 0.15 mmol) at room 
temperature. The solution was stirred for 3 h, and then quenched with saturated NaHCO3 
solution. The mixture was extracted with CH2Cl2 (2x), and the combined organic layer was 
washed with brine. The organic layer was dried over Na2SO4, filtered, and concentrated at 
reduced pressure, and purified by flash chromatography (5% to 10% EtOAc in hexane) to give 
1.34 as a colorless oil (663 mg, 91%). 1H NMR (500 MHz, CDCl3)  7.66 (d, 4H, J = 7.0 Hz), 
7.43-7.36 (m, 11H), 4.85 (d, 1H, J = 11.5 Hz), 4.52 (d, 1H, J = 11.5 Hz), 4.12 (t, 1H, J = 6.5 Hz), 
3.65 (t, 2H, J = 6.5 Hz), 1.87-1.82 (m, 2H), 1.57-1.55 (m, 2H), 1.49-1.44 (m, 2H), 1.39-1.05 (m, 
2H), 1.07 (s, 9H). 
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2-(Benzyloxy)-7-oxoheptanenitrile (1.35) 
To a solution of 1.34 (6.05 g, 12.8 mmol) in THF (125 mL) was added 
TBAF (1 M solution in THF, 15.4 mL) dropwise at room temperature. The 
solution was stirred for 1.5 h, and the solvent was removed under reduced pressure. The resulting 
residue was purified by flash chromatography to give the desired alcohol as colorless oil (2.85 g, 
95%).  To a solution of oxalyl chloride (1.57 mL, 18.3 mmol) in anhydrous CH2Cl2 (70 mL) 
under argon atmosphere at –78 °C was added DMSO (1.73 mL, 24.4 mmol) in CH2Cl2 (10 mL) 
dropwise. The resulting solution was stirred at that temperature for 30 min, and then the above 
alcohol (2.85 g, 12.2 mmol) in CH2Cl2 (15 mL) was added dropwise. After 30 min, triethylamine 
(8.5 mL, 61 mmol) was added to the solution. The solution was allowed to stir for another 30 
min, before warming to room temperature. The solution was then stirred at room temperature for 
30 min, and quenched with brine. The mixture was extracted with CH2Cl2 (2x), and the 
combined organic layer was washed with brine. The organic layer was dried over Na2SO4, 
concentrated at reduced pressure, and purified by flash chromatography (15% to 30% EtOAc in 
hexane) to give 1.35 as light yellow oil (2.356g, 83%). 1H NMR (400 MHz, CDCl3)  9.77 (t, 
1H, J = 1.6 Hz), 7.41-7.33 (m, 5H), 4.86 (d, 1H, J = 11.6 Hz), 4.53 (d, 1H, J = 11.6 Hz), 4.17 (t, 
1H, J = 6.4 Hz), 2.47 (dt, 2H, J = 1.6, 6.8 Hz), 1.93-1.87 (m, 2H), 1.70-1.61 (m, 2H), 1.58-1.53 
(m, 2H). 
 
2-(Benzyloxy)-5-(1H-indol-3-yl)pentanenitrile (1.36) 
To a solution of 1.35 (925 mg, 4.00 mmol) in HOAc (20 mL) was added phenylhydrazine (397 
L, 4.00 mmol). The solution was stirred at 105 °C overnight under N2. The solution was cooled 
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to rt and the solvent was removed under reduced pressure. The residue was diluted with EtOAc 
and washed with saturated NaHCO3 solution (2x). The organic layer 
was dried over Na2SO4, concentrated under reduced pressure, and 
purified by flash chromatography (10% to 25% EtOAc in hexane) to 
give 1.36 as a slightly red oil (746 mg, 61%).1H NMR (500 MHz, CDCl3)  7.94 (s, 1H), 7.57 (d, 
1H, J = 8.0 Hz), 7.38-7.35 (m, 6H), 7.21 (t, 1H, J = 7.5 Hz), 7.11 (t, 1H, J = 7.5 Hz), 6.98 (s, 
1H), 4.84 (d, 1H, J = 11.5 Hz), 4.50 (d, 1H, J = 11.5 Hz), 4.17 (t, 1H, J = 6.0 Hz), 2.81 (t, 2H, J 
= 6.5 Hz), 1.96-1.94 (m, 4H). 
 
5-(1-Benzyl-2-chloro-1H-indol-3-yl)-2-(benzyloxy)pentanenitrile (1.37) 
To a solution of 1.36 (660 mg, 2.17 mmol) in CCl4 (15 mL) was added N-
chlorosuccinimide (NCS) (292 mg, 2.19 mmol) at room temperature. The 
solution was stirred for 2 h, and then the solvent was removed under reduced 
pressure. The residue was purified by flash chromatography (8% to 20% 
EtOAc in hexane) to give 2-chloroindole as slightly yellow oil (556 mg, 76%). 1H NMR (500 
MHz, CDCl3)  7.97 (s, 1H), 7.50 (d, 1H, J = 8.0 Hz), 7.40-7.36 (m, 5H), 7.30 (d, 1H, J = 8.0 
Hz), 7.22 (t, 1H, J = 7.5 Hz), 7.16 (t, 1H, J = 7.5 Hz), 4.85 (d, 1H, J = 11.5 Hz), 4.52 (d, 1H, J = 
11.5 Hz), 4.18 (t, 1H, J = 6.0 Hz), 2.80 (t, 2H, J = 6.5 Hz), 1.95-1.92 (m, 4H). To a solution of 
the above 2-chloroindole (204 mg, 0.6 mmol) in DMF (6.5 mL) was added NaH (60% in mineral 
oil, 31 mg, 0.78 mmol) at 0 °C under argon. After that, the ice bath was removed, and the 
suspension was allowed to stir at rt for another 30 min followed by addition of BnBr (107 L, 
0.9 mmol). The solution was stirred for 5 h, and then carefully quenched by ice water. The 
mixture was extracted with EtOAc (2x), and the combined organic layer was washed with brine. 
N
Bn
Cl
OBn
CN
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The organic layer was dried over Na2SO4, concentrated at reduced pressure, and purified by flash 
chromatography (10% to 25% EtOAc in hexane) to give 1.37 as slightly yellow oil (177 mg, 
69%). 1H NMR (500 MHz, CDCl3)  7.51 (d, 1H, J = 7.5 Hz), 7.37-7.33 (m, 4H), 7.29-7.22 (m, 
5H), 7.17 (t, 1H, J = 7.5 Hz), 7.12 (t, 1H, J = 7.0 Hz), 7.08 (d, 2H, J = 7.0 Hz), 5.38 (s, 2H), 4.83 
(d, 1H, J = 11.5 Hz), 4.49 (d, 1H, J = 11.5 Hz), 4.17 (t, 1H, J = 5.5 Hz), 2.84 (app s, 2H), 1.95-
1.91 (m, 4H); 13C NMR (75 MHz, CDCl3)  137.3, 136.1, 135.6, 128.9, 128.8, 128.6, 128.4, 
127.6, 126.9, 126.5, 123.6, 122.3, 120.2, 118.4, 118.4, 111.0, 109.9, 72.4, 67.6, 47.0, 33.0, 25.0, 
23.5; IR (neat) 3060, 3031, 2928, 2865, 1456, 1334, 1102, 739, 697 cm-1; HRMS (EI) m/z calcd 
for C27H25N2OCl [M]+ 428.1655, found 428.1647. 
 
2-(Benzyloxy)oct-7-enenitrile (1.40) 
To a solution of 6-heptenal (1.39) (168 mg, 1.50 mmol) and BnOTMS (649 
mg, 3.60 mmol) in CH2Cl2 (2.5 mL) was added BiBr3 (34 mg, 0.075 mmol). 
The suspension was stirred overnight, and then TMSCN (394 L, 3.1 mmol) and BiBr3 (32 mg, 
0.075 mmol) were added. The suspension was stirred for another 4 h and then quenched with 
saturated NaHCO3. The mixture was extracted with EtOAc (3x), and the combined organic layer 
was washed with brine. The organic layer was dried over Na2SO4, concentrated at reduced 
pressure, and purified by flash chromatography (5% to 10% EtOAc in hexane) to give 1.40 as a 
colorless oil (277 mg, 81%). 1H NMR (300 MHz, CDCl3)  7.38-7.35 (m, 5H), 5.79 (ddt, 1H, J = 
6.6, 10.2, 17.1 Hz), 5.02 (d, 1H, J = 17.1 Hz), 4.97 (d, 1H, J = 9.6 Hz), 4.86 (d, 1H, J = 11.7 Hz), 
4.53 (d, 1H, J = 11.7 Hz), 4.16 (t, 1H, J = 6.6 Hz), 2.05 (q, 2H, J = 6.6 Hz), 1.91-1.85 (m, 2H), 
1.54-1.48 (m, 2H), 1.46-1.37 (m, 2H); 13C NMR (75 MHz, CDCl3)  138.4, 136.1, 128.8, 128.6, 
CN
OBn
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128.3, 118.4, 115.0, 72.3, 67.7, 33.5, 33.4, 28.3, 24.3; IR (neat) 3068, 3033, 2930, 2864, 1640, 
1456, 1100, 913, 740 cm-1; HRMS (EI) m/z calcd for C15H19NO [M]+ 229.1467, found 229.1460. 
 
5-(1-Benzyl-1H-indol-3-yl)-2-(benzyloxy)pentanenitrile (1.41) 
To a solution of 1.40 (1.90 g, 8.3 mmol) in CH2Cl2 (84 mL) was treated with 
O3 at −78 °C until the blue color persisted. PPh3 (8.7 g, 33.1 mmol) was then 
added and the solution was allowed to warm to rt. After stirring for 1 hour, 
the solvent was removed under reduced pressure, and the residue was purified by flash 
chromatography (5% to 40% EtOAc in hexane) to give the aldehyde 1.35 as colorless oil (1.48 g, 
78%), and all spectral data for this compound were identical to those from TBDPS deprotection 
of 1.34 followed by Swern oxidation. To a solution of the aldehyde (400 mg, 1.73 mmol) in 
HOAc (9 mL), was added 1-benzyl-1-phenylhydrazine hydrochloride (406 mg, 1.73 mmol). The 
solution was stirred at 100 °C for 1 h under N2. The solution was cooled to rt and the solvent was 
removed under reduced pressure. The residue was diluted with EtOAc and washed with saturated 
NaHCO3 solution (2x). The organic layer was dried over Na2SO4, concentrated under reduced 
pressure, and purified by flash chromatography (5% to 10% EtOAc in hexane) to give 1.41 as a 
slightly red oil (610 mg, 89%). 1H NMR (300 MHz, CDCl3)  7.58 (d, 1H, J = 7.5 Hz), 7.37-7.25 
(m, 9H), 7.18 (t, 1H, J = 7.2 Hz), 7.13-7.08 (m, 3H), 6.89 (s, 1H), 5.28 (s, 2H), 4.83 (d, 1H, J = 
11.4 Hz), 4.49 (d, 1H, J = 11.4 Hz), 4.17 (t, 1H, J = 6.0 Hz), 2.80 (t, 2H, J = 6.3 Hz), 1.95-1.91 
(m, 4H); 13C NMR (75 MHz, CDCl3)  137.8, 136.8, 136.1, 128.9, 128.8, 128.5, 128.4, 128.1, 
127.7, 126.9, 125.7, 121.9, 119.1, 118.5, 114.8, 109.8, 72.3, 67.7, 50.0, 33.3, 25.4, 24.5; IR 
(neat) 3030, 2926, 2866, 1466, 1454, 1331, 1101, 739 cm-1; HRMS (EI) m/z calcd for C27H26N2O 
[M]+ 394.2045, found 394.2043. 
N
CN
OBn
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5-(1-Benzyl-2-chloro-1H-indol-3-yl)-2-(benzyloxy)pentanenitrile (1.37) through modified 
sequence 
To a solution of 1.41 (250 mg, 0.63 mmol) in CH2Cl2 (5.3 mL) was added N-
chlorosuccinimide (NCS) (85 mg, 0.63 mmol) at room temperature. The 
solution was stirred for 1 h, and then the solvent was removed under reduced 
pressure. The residue was purified by flash chromatography (5% to 10% EtOAc in hexane) to 
give 1.37 as slightly yellow oil (217 mg, 80%). All spectral data were consistent with products 
that had previously been prepared. 
 
5-(1-Benzyl-2-((triisopropylsilyl)oxy)-1H-indol-3-yl)-2-(benzyloxy)pentanenitrile (1.42) 
To a solution of 1.41 (135 mg, 0.34 mmol) in premixed solvent (4:1; 
AcOH:concentrated HCl; v:v) was added DMSO (468 L, 6.8 mmol) dropwise 
at room temperature. The solution was stirred for 1.5 h, and then poured into 
saturated NaHCO3 solution. The mixture was extracted with EtOAc (2x), and the combined 
organic layer was dried over Na2SO4. After removal of the solvent under reduced pressure, the 
residue was purified by chromatography (10% to 30% EtOAc in hexane) to give the oxindole as 
yellow oil (84 mg, 60%). 1H NMR (400 MHz, CDCl3)  7.38-7.20 (m, 11H), 7.18 (t, 1H, J = 7.6 
Hz), 7.03 (t, 1H, J = 7.6 Hz), 6.74 (d, 1H, J = 7.6 Hz), 4.97 (d, 1H, J = 12.0 Hz), 4.86 (dd, 1H, J 
= 4.0, 11.6 Hz), 4.83 (d, 1H, J = 12.0 Hz), 4.51 (dd, 1H, J = 3.6, 11.6 Hz), 4.13 (dt, 1H, J = 3.2, 
6.4 Hz), 3.54 (t, 1H, J = 6.0 Hz), 2.04-1.92 (m, 2H), 1.91-1.90 (m, 2H), 1.60-1.56 (m, 2H). To a 
solution of the oxindole (838 mg, 2.04 mmol) in CH2Cl2 (17 mL) under argon at 0 °C were 
added Et3N (566 L, 4.08 mmol) and TIPSOTf (553 L, 2.04 mmol). The ice bath was removed 
and the solution was stirred at rt for 1.5 h. The reaction was quenched with saturated NaHCO3 
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solution. The aqueous layer was extracted with CH2Cl2 (2x), and then the combined organic layer 
was dried over Na2SO4. The mixture was filtered and concentrated, then the resulting residue 
was purified by flash chromatography (4% to 10% EtOAc in hexane with 0.5% Et3N) to give 
1.42 as a slightly yellow oil (1.09 g, 95%). 1H NMR (400 MHz, CDCl3)  7.40 (d, 1H, J = 7.2 
Hz), 7.38-7.32 (m, 5H), 7.24 (app d, 2H, J = 7.6 Hz), 7.20 (d, 1H, J = 7.2 Hz), 7.06-6.98 (m, 
5H), 5.22 (s, 2H), 4.80 (d, 1H, J = 11.6 Hz), 4.46 (d, 1H, J = 11.6 Hz), 4.15 (t, 1H, J = 6.0 Hz), 
2.73 (t, 2H, J = 7.0 Hz), 1.99-1.85 (m, 4H), 1.27 (septet, 3H, J = 7.6 Hz), 1.08 (d, 18H, J = 7.2 
Hz); 13C NMR (100 MHz, CDCl3)  145.2, 137.8, 136.1, 131.6, 128.6, 128.6, 128.2, 127.4, 
127.1, 126.3, 119.7, 119.4, 118.4, 117.5, 109.2, 93.1, 72.2, 67.8, 45.1, 33.5, 25.5, 23.2, 17.9, 
13.8; IR (neat) 3061, 3031, 2946, 2867, 1620, 1578, 1469, 1414, 1339, 1008, 769, 737 cm-1; 
HRMS (ESI) m/z calcd for C36H47N2O2Si [M+H]+ 567.3407, found 567.3363. 
 
2-(Benzyloxy)-5-(2-chloro-1-(methoxymethyl)-1H-indol-3-yl)pentanenitrile (1.43) 
To a solution of 1.36 (610 mg, 2.00 mmol) in CCl4 (15 mL) was added N-
chlorosuccinimide (NCS) (268 mg, 2.00 mmol) at room temperature under 
argon atmosphere. The solution was stirred for 2 hours, and then the solvent 
was removed under reduced pressure. The residue was purified by flash 
chromatography (8% to 20% EtOAc in hexane) to give the desired 2-chloroindole as slightly 
yellow oil (519 mg). To a solution of the above 2-chloroindole (519 mg, 1.53 mmol) in THF (16 
mL) was added NaH (60% in mineral oil, 80 mg, 2.0 mmol) at 0 °C under argon. After that, the 
ice bath was removed, and the suspension was allowed to stir at rt for another 30 min followed 
by addition of MOMCl (175 L, 2.3 mmol). The solution was stirred for 1 hour, and then 
quenched by ice water. The mixture was extracted with EtOAc (2x), and the combined organic 
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layer was washed with brine. The organic layer was dried over Na2SO4, concentrated at reduced 
pressure, and purified by flash chromatography (15% to 30% EtOAc in hexane) to give 1.43 as 
slightly yellow oil (481 mg, 63% over two steps). 1H NMR (300 MHz, CDCl3)  7.49 (d, 1H, J = 
8.0 Hz), 7.43 (d, 1H, J = 8.0 Hz), 7.36-7.35 (m, 5H), 7.24 (t, 1H, J = 7.2 Hz), 7.17 (t, 1H, J = 7.2 
Hz), 5.52 (s, 2H), 4.83 (d, 1H, J = 11.4 Hz), 4.50 (d, 1H, J = 11.4 Hz), 4.17 (t, 1H, J = 6.0 Hz), 
3.29 (s, 3H), 2.80 (t, 2H, J = 6.0 Hz), 1.92-1.88 (m, 4H); 13C NMR (75 MHz, CDCl3)  136.0, 
135.9, 128.7, 128.5, 128.3, 127.1, 123.3, 122.7, 120.8, 118.4, 118.3, 112.0, 109.9, 73.9, 72.3, 
67.5, 56.1, 32.9, 24.8, 23.3; IR (neat) 3032, 2935, 2360, 2340, 1455, 1322, 1099, 742, 698 cm-1; 
HRMS (EI) m/z calcd for C22H23N2O2Cl [M]+ 382.1448, found 382.1449. 
 
2-(Benzyloxy)-5-(2-bromo-1-(methoxymethyl)-1H-indol-3-yl)pentanenitrile (1.44) 
To a solution of 1.36 (400 mg, 1.30 mmol) in CH2Cl2 (21 mL) was 
added N-bromosuccinimide (NBS) (234 mg, 1.30 mmol) in small 
portions at room temperature under argon atmosphere. The solution was 
stirred for 35 min, and then the solvent was removed under reduced pressure. The residue was 
purified by flash chromatography (100% toluene) to give the desired 2-bromoindole as slightly 
yellow oil. To a solution of the above 2-bromoindole (375 mg, 0.98 mmol) in THF (10 mL) was 
added NaH (60% in mineral oil, 51 mg, 1.27 mmol) at 0 °C under argon. After that, the ice bath 
was removed, and the suspension was allowed to stir at rt for another 30 min followed by 
addition of MOMCl (108 L, 1.43 mmol). The solution was stirred for 30 min, and then 
quenched by ice water. The mixture was extracted with EtOAc (2x), and the combined organic 
layer was washed with brine. The organic layer was dried over Na2SO4, concentrated at reduced 
pressure, and purified by flash chromatography (15% to 30% EtOAc in hexane) to give 1.44 as 
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slightly yellow oil (395 mg, 71% over two steps).1H NMR (500 MHz, CDCl3)  7.50 (d, 1H, J = 
7.5 Hz), 7.45 (d, 1H, J = 8.0 Hz), 7.37-7.33 (m, 5H), 7.24 (t, 1H, J = 7.5 Hz), 7.15 (t, 1H, J = 7.5 
Hz), 5.54 (s, 2H), 4.83 (d, 1H, J = 12.0 Hz), 4.50 (d, 1H, J = 12.0 Hz), 4.17 (t, 1H, J = 6.0 Hz), 
3.29 (s, 3H), 2.80 (t, 2H, J = 7.5 Hz), 1.93-1.90 (m, 4H) ; 13C NMR (75 MHz, CDCl3)  137.3, 
136.2, 128.9, 128.6, 128.5, 127.9, 122.8, 120.8, 118.5, 118.4, 115.7, 112.9, 110.2, 75.4, 72.5, 
67.7, 56.2, 33.1, 25.0, 24.6; IR (neat) 3031, 2932, 2867, 2360, 1592, 1453, 1318, 1093, 911, 741, 
698 cm-1; HRMS (EI) m/z calcd for C22H23N2O2Br (M+) 426.0943, found 426.0946. 
 
2-(Benzyloxy)-5-(6-chloro-1H-indol-3-yl)pentanenitrile (1.46) 
To a solution of 1.35 (1.35 g, 5.84 mmol) in HOAc (35 mL) was 
added 3-chlorophenylhydrazine hydrochloride (1.57, 8.8 mmol). 
The solution was refluxed for 3 hours under N2. The solution was 
cooled to rt and the solvent was removed under reduced pressure. The residue was diluted with 
EtOAc and washed with saturated NaHCO3 solution (2x). The organic layer was dried over 
Na2SO4, concentrated under reduced pressure, and purified by flash chromatography (10% to 
25% EtOAc in hexane) to give the desired product as a slightly yellow oil (898 mg, 45%, 
1.46:1.47 = 5:4) with 1.46 as the faster eluting product. 1H NMR (300 MHz, CDCl3) for 1.46  
7.94 (s, 1H), 7.46 (d, 1H, J = 8.4 Hz), 7.38-7.31 (m, 6H), 7.08 (dd, 1H, J = 1.8, 8.4 Hz), 6.96 
(app d, 1H, J = 2.4 Hz), 4.84 (d, 1 H, J = 11.4 Hz), 4.50 (d, 1H, J = 11.7 Hz), 4.16 (t, 1H, J = 6.0 
Hz), 2.77 (t, 2H, J = 6.3 Hz), 1.98-1.87 (m, 4H). 1H NMR (300 MHz, CDCl3) for 1.47  8.02 (s, 
1H), 7.36 (app s, 5H), 7.25-7.24 (m, 1H), 7.07 (app d, 2H, J = 5.1 Hz), 
6.98 (app d, 1H, J = 3.6 Hz), 4.85 (d, 1 H, J = 11.4 Hz), 4.52 (d, 1H, J = 
11.1 Hz), 4.18 (t, 1H, J = 6.0 Hz), 3.02 (t, 2H, J = 6.6 Hz), 2.06-1.90 (m, 4H). 
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2-(Benzyloxy)-5-(2,4-dichloro-1-(methoxymethyl)-1H-indol-3-yl)pentanenitrile (1.48) 
Follow the same procedure for the preparation of 1.43, and use 1.46 
instead of 1.36 give 1.48 as slightly yellow oil (258 mg, 47% over two 
steps). 1H NMR (300 MHz, CDCl3)  7.38-7.32 (m, 6H), 7.14 (app d, 1H, 
J = 1.5 Hz), 7.13 (app s, 1H), 5.51 (s, 2H), 4.84 (d, 1H, J = 11.7 Hz), 4.52 (d, 1H, J = 11.4 Hz), 
4.20 (t, 1H, J = 6.3 Hz), 3.29 (s, 3H), 3.02 (t, 2H, J = 6.9 Hz), 2.03-1.87 (m, 4H); 13C NMR (75 
MHz, CDCl3)  137.2, 136.1, 128.7, 128.4, 128.3, 125.6, 125.0, 123.9, 123.1, 122.0, 118.4, 
112.4, 108.7, 74.2, 72.3, 67.7, 56.1, 32.9, 26.5, 24.0; IR (neat) 3062, 3031, 2939, 2867, 1457, 
1430, 1323, 1187, 1102, 914, 739 cm-1; HRMS (EI) m/z calcd for C22H23N2O2Cl2 [M]+ 416.1058, 
found 416.1054. 
 
2-(Benzyloxy)-5-(2,6-dichloro-1-(methoxymethyl)-1H-indol-3-yl)pentanenitrile (1.49) 
Follow the same procedure for the preparation of 1.43, and use 1.47 instead of 
1.36 give 1.49 as slightly yellow oil (190 mg, 43% over two steps). 1H NMR 
(300 MHz, CDCl3)  7.43 (d, 1H, J = 1.5 Hz), 7.40-7.35 (m, 6H), 7.13 (dd, 
1H, J = 1.5, 8.4 Hz), 5.47 (s, 2H), 4.83 (d, 1H, J = 11.7 Hz), 4.50 (d, 1H, J = 11.4 Hz), 4.16 (t, 
1H, J = 5.7 Hz), 3.29 (s, 3H), 2.77 (t, 2H, J = 6.3 Hz), 1.89-1.88 (m, 4H); 13C NMR (75 MHz, 
CDCl3)  136.2, 136.0, 128.8, 128.6, 128.4, 125.7, 123.9, 121.6, 119.4, 118.3, 112.2, 110.2, 74.1, 
72.4, 67.5, 56.2, 33.0, 24.8, 23.4; IR (neat) 3064, 3032, 2935, 2868, 1465, 1394, 1334, 1099, 
913, 807, 741 cm-1; HRMS (ESI) m/z calcd for C22H22N2O2Cl2Na [M+Na]+ 439.0956, found 
439.0959. 
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N-((1S,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-yl)-3-
phenylpropanamide (1.52) 
To a solution of 1.37 (98 mg, 0.23 mmol) in CH2Cl2 (2.3 mL) was added 
Cp2Zr(H)Cl (74 mg, 0.29 mmol). The reaction mixture was stirred for 15 
min. Hydrocinnamoyl chloride (43 L, 0.29 mmol) was added and the 
mixture was stirred overnight. The mixture was quenched with saturated NaHCO3 solution, and 
extracted with EtOAc (3x). The combined organic layer was dried over Na2SO4 and concentrated 
under reduced pressure. The residue was purified by column chromatography (15% EtOAc in 
hexane to 100% EtOAc) to give product as two diastereomers (103 mg, 83%, 7.3:1). The faster 
eluting product 1.52 was the major diastereomer and was isolated as a white solid (mp 138.7 °C-
140.8 °C): 1H NMR (300 MHz, CDCl3) 7.39 (d, 1H, J = 7.5 Hz), 7.32-7.06 (m, 15H), 6.90 (d, 
2H, J = 7.8 Hz), 6.70 (d, 1H, J = 7.2 Hz), 4.92 (d, 1H, J = 15.6 Hz), 4.86 (d, 1H, J = 9.9 Hz), 
4.79 (d, 1H, J = 15.6 Hz), 4.67 (d, 1H, J = 12.0 Hz), 4.62 (t, 1H, J = 9.9 Hz), 4.45 (d, 1H, J = 
12.0 Hz), 4.24 (dt, 1H, J = 4.5, 10.8 Hz), 2.58-2.37 (m, 3H), 2.19 (qt, 1H, J = 3.9, 13.2 Hz), 
2.07-1.97 (m, 1H), 1.91-1.78 (m, 2H), 1.74-1.53 (m, 3H); 13C NMR (100 MHz, CDCl3)  178.7, 
171.9, 142.0, 141.1, 139.2, 136.3, 131.8, 129.0, 128.5, 128.5, 128.2, 127.9, 127.7, 127.4, 126.1, 
123.9, 123.3, 108.6, 76.3, 90.9, 55.4, 54.4, 43.6, 38.1, 35.2, 31.3, 31.0, 19.0; IR (neat) 3323, 
3060, 3029, 2931, 2864, 1699, 1655, 1611, 1543, 1492, 1366, 1027, 1100, 1028, 741 cm-1; 
HRMS (ESI) m/z calcd for C36H36N2O3Na [M+Na]+ 567.2624, found 567.2648.  
The slower eluting product was repurified by preparative TLC (10% 
EtOAc in CH2Cl2) to give minor diastereomer 1.53 as a white solid (mp 
171.2 °C-175.0 °C): 1H NMR (400 MHz, DMSO)  7.60 (d, 1H, J = 7.2 
Hz), 7.29-7.19 (m, 13H), 7.14-7.11 (m, 1H), 7.08-7.03 (m, 3H), 6.88 (d, 1H, J = 9.6 Hz), 6.86 (d, 
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1H, J = 7.6 Hz), 4.97 (d, 1H, J = 15.6 Hz), 4.68 (d, 1H, J = 15.6 Hz), 4.62 (d, 1H, J = 11.6 Hz), 
4.47 (t, 1H, J = 10.4 Hz), 4.45 (d, 1H, J = 11.6 Hz), 3.84 (dt, 1H, J = 4.4, 10.8 Hz), 2.55 (t, 2H, J 
= 8.4 Hz), 2.36 (app d, 1H, J = 9.6 Hz), 2.21-2.13 (m, 1H), 2.06-1.98 (m, 1H), 1.94-1.85 (m, 
2H), 1.81-1.77 (m, 1H), 1.50-1.42 (m, 2H); 13C NMR (75 MHz, DMSO)  177.2, 171.2, 142.9, 
141.4, 139.3, 136.6, 130.0, 128.4, 128.2, 128.0, 127.9, 127.2, 125.9, 125.7, 121.9, 108.9, 77.4, 
70.6, 54.8, 54.0, 42.6, 36.9, 33.7, 31.1, 30.9, 19.7; IR (neat) 3272, 3061, 3028, 2925, 2854, 1712, 
1650, 1609, 1546, 1464, 1363 cm-1; HRMS (ESI) m/z calcd for C36H36N2O3Na [M+Na]+ 
567.2624, found 567.2604.  
 
N-((1S,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)isobutyramide (1.55) 
To a solution of 1.37 (104 mg, 0.24 mmol) in CH2Cl2 (2.4 mL) was added 
Cp2Zr(H)Cl (78 mg, 0.30 mmol). The reaction mixture was stirred for 15 min. 
Isobutyryl chloride (31 L, 0.30 mmol) was added and the mixture was stirred overnight. The 
reaction was quenched with saturated NaHCO3 solution, and extracted with EtOAc (3x). The 
combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. The 
residue was purified by column chromatography (15% EtOAc in hexane to 100% EtOAc) to give 
product as two diastereomers (100 mg, 87%, 3.6:1).  The faster eluting product was the major 
diastereomer 1.55 and was isolated as a pale yellow oil: 1H NMR (500 MHz, CDCl3)  7.36 (d, 
1H, J = 7.5 Hz), 7.30-7.27 (m, 10H), 7.13 (t, 1H, J = 7.5 Hz), 7.05 (t, 1H, J = 7.5 Hz), 6.70 (d, 
1H, J = 7.5 Hz), 4.98 (d, 1H, J = 15.5 Hz), 4.83 (d, 1H, J = 9.5 Hz), 4.78 (d, 1H, J = 15.5 Hz), 
4.70 (d, 1H, J = 12.0 Hz), 4.60 (t, 1H, J = 10.0 Hz), 4.49 (t, 1H, J = 12.0 Hz), 4.28 (dt, 1H, J = 
4.0, 10.5 Hz), 2.40 (d, 1H, J = 11.5 Hz), 2.23 (app q, 1H, J = 13.5 Hz), 1.90 (t, 1H, J = 13.5 Hz), 
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1.81 (app d, 1H, J = 13.5 Hz), 1.74-1.70 (m, 2H), 1.63-1.57 (m, 1H), 0.78 (d, 3H, J = 6.5 Hz), 
0.42 (d, 3H, J = 6.5 Hz); 13C NMR (75 MHz, CDCl3)  178.8, 176.5, 142.0, 139.2, 136.4, 131.6, 
129.0, 128.4, 128.0, 127.7, 127.6, 127.5, 124.0, 123.3, 108.4, 76.2, 71.0, 55.0, 54.6, 43.7, 35.9, 
34.9, 31.2, 19.6, 19.1, 18.9; IR (neat) 3337, 3060, 3030, 2867, 1694, 1611, 1491, 1466, 1365, 
1208, 1173, 1098, 740, 698 cm-1; HRMS (EI) m/z calcd for C31H34N2O3 [M]+ 482.2569, found 
482.2569.  
The slower eluting product was minor diastereomer 1.64 and was isolated as 
a white solid (mp 158.1 °C-161.2 °C): 1H NMR (300 MHz, DMSO)  7.59 
(d, 1H, J = 7.5 Hz), 7.27-7.22 (m, 11H), 7.07 (t, 1H, J = 7.2 Hz), 6.84 (t, 1H, 
J = 7.5 Hz), 6.70 (d, 1H, J = 9.6 Hz), 4.86 (d, 1H, J = 15.9 Hz), 4.78 (d, 1H, J = 15.9 Hz), 4.62 
(d, 1H, J = 11.4 Hz), 4.47 (d, 1H, J = 11.4 Hz), 4.40 (t, 1H, J = 10.2 Hz), 3.86 (dt, 1H, J = 4.5, 
10.5 Hz), 2.37 (app d, 1H, J = 14.1 Hz), 2.12 (quintet, 1H, J = 6.9 Hz), 1.90-1.76 (m, 3H), 1.47-
1.41 (m, 2H), 0.74 (d, 3H, J = 6.6 Hz), 0.70 (d, 3H, J = 6.9 Hz); 13C NMR (75 MHz, DMSO)  
177.2, 175.6, 143.0, 139.2, 136.4, 130.0, 128.5, 127.9, 127.2, 127.0, 126.9, 125.9, 121.8, 108.8, 
77.1, 70.5, 54.4, 54.1, 42.7, 33.8, 33.5, 31.0, 19.8, 19.6, 18.9; IR (neat) 3345, 3060, 3032, 2934, 
2870, 1712, 1678, 1609, 1489, 1463, 1364, 1209, 1105, 743, 697 cm-1; HRMS (EI) m/z calcd for 
C31H34N2O3 [M]+ 482.2569, found 482.2579.  
 
N-((1S,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-yl)-2-
methoxyacetamide (1.56) 
To a solution of 1.37 (118 mg, 0.28 mmol) in CH2Cl2 (2.8 mL) was added 
Cp2Zr(H)Cl (89 mg, 0.34 mmol). The reaction mixture was stirred for 15 
min. Methoxyacetyl chloride (31 L, 0.34 mmol) was added and the mixture was stirred 
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overnight. The reaction was quenched with saturated NaHCO3 solution, and extracted with 
EtOAc (3x). The combined organic layer was dried over Na2SO4, and concentrated under 
reduced pressure. The residue was purified by column chromatography (15% EtOAc in hexane 
to 100% EtOAc) to give product as two diastereomers (61 mg, 46%, 9.1:1). The faster eluting 
product was major diastereomer 1.56 and was isolated as a white solid (mp 121.0 °C-123.8 °C): 
1H NMR (400 MHz, CDCl3) 7.38 (d, 1H, J = 7.2 Hz), 7.34-7.25 (m, 10H), 7.11 (t, 1H, J = 7.6 
Hz), 7.05 (d, 1H, J = 7.2 Hz), 6.61 (d, 1H, J = 7.2 Hz), 6.22 (d, 1H, J = 10.4 Hz), 4.99 (d, 1H, J = 
15.6 Hz), 4.83 (d, 1H, J = 15.6 Hz), 4.72 (d, 1H, J = 11.6 Hz), 4.64 (t, 1H, J = 10.4 Hz), 4.52 (d, 
1H, J = 11.6 Hz), 4.31 (dt, 1H, J = 4.4, 10.8 Hz), 3.61 (d, 1H, J = 15.2 Hz), 3.49 (d, 1H, J = 15.2 
Hz), 3.07 (s, 3H), 2.42 (d, 1H, J = 12.8 Hz), 2.23 (qt, 1H, J = 3.6, 13.6 Hz), 1.91 (app dt, 1H, J = 
4.0, 14.0 Hz), 1.84-1.80 (m, 1H), 1.71 (app dquint, 1H, J = 3.2, 13.6 Hz), 1.60-1.54 (m, 1H); 13C 
NMR (75 MHz, CDCl3)  178.3, 169.5, 141.9, 139.0, 135.8, 131.6, 128.8, 128.2, 128.0, 127.6, 
127.3, 127.2, 127.1, 123.5, 123.1, 108.6, 71.6, 71.2, 58.8, 54.8, 54.2, 43.6, 35.5, 30.9, 18.8; IR 
(neat) 3063, 3032, 2931, 1695, 1613, 1519, 1366, 1204, 1110, 1027, 741 cm-1; HRMS (ESI) m/z 
calcd for C30H32N2O4Na [M+Na]+ 507.2260, found 507.2279.  
The slower eluting syn-diastereomer was repurified by preparative TLC 
(10% EtOAc in CH2Cl2): 1H NMR (400 MHz, CDCl3)  7.37 (d, 1H, J = 
7.2 Hz), 7.33-7.24 (m, 10H), 7.16 (t, 1H, J = 8.0 Hz), 7.07 (d, 1H, J = 10.4 Hz), 6.97 (t, 1H, J = 
7.6 Hz), 6.70 (d, 1H, J = 7.6 Hz), 5.01 (d, 1H, J = 15.6 Hz), 4.80 (d, 1H, J = 15.6 Hz), 4.60 (dd, 
1H, J = 4.0, 10.0 Hz), 4.57 (d, 1H, J = 12.0 Hz), 4.44 (d, 1H, J = 12.0 Hz), 4.05 (quintet, 1H, J = 
4.0 Hz), 3.89 (d, 1H, J = 14.8 Hz), 3.82 (d, 1H, J = 14.8 Hz), 2.18-2.12 (m, 1H), 2.10-2.03 (m, 
1H), 1.99-1.95 (m, 1H), 1.91-1.81 (m, 2H), 1.66-1.63 (m, 1H); 13C NMR (100 MHz, CDCl3)  
176.8, 169.9, 142.6, 138.4, 136.1, 132.3, 129.0, 128.5, 128.1, 127.8, 127.7, 127.4, 124.9, 122.1, 
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109.5, 73.6, 72.2, 70.5, 59.5, 51.3, 49.4, 44.1, 29.9, 27.3, 19.0; IR (neat) 3061, 2938, 1711, 1681, 
1610, 1465, 1360, 1110, 1026, 918 cm-1; HRMS (ESI) m/z calcd for C30H32N2O4Na [M+Na]+ 
507.2260, found 507.2239. 
  
N-((1S,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)acrylamide (1.57) 
To a solution of 1.37 (109 mg, 0.25 mmol) in CH2Cl2 (2.5 mL) was added 
Cp2Zr(H)Cl (82 mg, 0.32 mmol). The reaction mixture was stirred for 15 min. 
Acryloyl chloride (26 L, 0.32 mmol) was added and the mixture was stirred 
overnight. The reaction was quenched with saturated NaHCO3 solution, and extracted with 
EtOAc (3x). The combined organic layer was dried over Na2SO4 and concentrated under reduced 
pressure. The residue was purified by column chromatography (15% EtOAc in hexane to 100% 
EtOAc) to give product as two diastereomers (62 mg, 53%, 20:1). The faster eluting product was 
major diastereomer 1.57 and was isolated as a white solid (mp 157.0 °C-161.2 °C): 1H NMR 
(400 MHz, CDCl3)  7.40 (d, 1H, J = 7.6 Hz), 7.32-7.21 (m, 10H), 7.13 (dt, 1H, J = 3.6, 7.6 Hz), 
7.07 (dt, 1H, J = 3.6, 7.6 Hz), 6.67 (d, 1H, J = 7.6 Hz), 5.95 (dd, 1H, J = 3.6, 16.8 Hz), 5.60 (dd, 
1H, J = 10.4, 17.2 Hz), 5.43 (dd, 1H, J = 3.6, 7.6 Hz), 4.99-4.95 (m, 2H), 4.80 (d, 1H, J = 15.6 
Hz), 4.69 (d, 1H, J = 12.0 Hz), 4.67 (t, 1H, J = 10.0 Hz), 4.47 (d, 1H, J = 12.0 Hz), 4.25 (dt, 1H, 
J = 4.8, 10.4 Hz), 2.41 (app d, 1H, J = 3.2, 12.8 Hz), 2.18 (qt, 1H, J = 4.0, 13.6 Hz), 1.90 (dt, 1H, 
J = 4.0, 14.0 Hz), 1.81 (app d, 1H, J = 12.8 Hz), 1.72 (app dt, 1H, J = 3.2, 13.6 Hz), 1.65-1.55 
(m, 1H); 13C NMR (100 MHz, CDCl3)  178.7, 165.4, 142.0, 139.1, 136.2, 131.8, 130.8, 129.1, 
128.5, 128.2, 127.9, 127.8, 127.2, 126.4, 123.8, 123.5, 108.7, 76.6, 91.0, 55.4, 54.4, 43.5, 35.4, 
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30.9, 19.1; IR (neat) 3289, 3060, 3031, 2930, 2863, 1701, 1611, 1540, 1492, 1365, 1206, 986, 
739 cm-1; HRMS (ESI) m/z calcd for C30H30N2O3Na [M+Na]+ 489.2154, found 489.2176.  
The slower eluting product was repurified by preparative TLC (10 % EtOAc 
in CH2Cl2) to give minor diastereomer 1.66 as a white solid (mp 222.6 °C-
226.9 °C): 1H NMR (400 MHz, DMSO)  7.63 (d, 1H, J = 7.6 Hz), 7.32-7.17 
(m, 12H), 7.07 (d, 1H, J = 7.2 Hz), 6.78 (d, 1H, J = 8.0 Hz), 6.14 (dd, 1H, J = 9.6, 16.8 Hz), 6.01 
(dd, 1H, J = 2.0, 16.8 Hz), 5.52 (dd, 1H, J = 2.4, 10.0 Hz), 5.08 (d, 1H, J = 16.0 Hz), 4.63-4.55 
(m, 3H), 4.46 (d, 1H, J = 11.6 Hz), 3.90 (dt, 1H, J = 4.0, 10.8 Hz), 2.38 (app d, 1H, J = 11.6 Hz), 
1.92-1.78 (m, 3H), 1.52-1.43 (m, 2H); 13C NMR (100 MHz, DMSO)  177.1, 164.6, 142.8, 
139.2, 136.2, 132.0, 129.9, 128.5, 128.0, 128.0, 127.2, 127.1, 126.8, 126.0, 125.0, 121.9, 109.0, 
77.3, 70.7, 55.0, 54.0, 42.5, 33.8, 31.1, 30.7, 19.7; IR (neat) 3245, 3061, 2934, 2856, 1709, 1658, 
1610, 1551, 1465, 1361, 734 cm-1; HRMS (ESI) m/z calcd for C30H30N2O3Na [M+Na]+ 
489.2154, found 489.2141.  
 
N-((1S,2R,3R)-3-(Benzyloxy)-1'-(methoxymethyl)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)isobutyramide (1.58) 
To a solution of 1.43 (99 mg, 0.26 mmol) in CH2Cl2 (2.6 mL) was added 
Cp2Zr(H)Cl (84 mg, 0.32 mmol). The reaction mixture was stirred for 15 
min. Isobutyryl chloride (34 L, 0.32 mmol) was added and the mixture was stirred overnight. 
The reaction was quenched with saturated NaHCO3 solution, and extracted with EtOAc (3x). 
The combined organic layer was dried over Na2SO4 and concentrated under reduced pressure. 
The residue was purified by column chromatography (15% EtOAc in hexane to 100% EtOAc) to 
give the product as two diastereomers (59 mg, 51%, 11.8:1). The faster eluting isomer was major 
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product 1.58: 1H NMR (500 MHz, CDCl3)  7.38 (d, 1H, J = 7.5 Hz), 7.37-7.30 (m, 5H), 7.22 (t, 
1H, J = 8.0 Hz), 7.12 (t, 1H, J = 7.5 Hz), 6.92 (d, 1H, J = 7.5 Hz), 5.12 (d, 1H, J = 10.5 Hz), 5.09 
(d, 1H, J = 11.0 Hz), 4.90 (d, 1H, J = 10.0 Hz), 4.69 (d, 1H, J = 11.5 Hz), 4.60 (t, 1H, J = 10.0 
Hz), 4.48 (d, 1H, J = 12.0 Hz), 4.22 (dt, 1H, J = 4.5, 10.5 Hz), 3.34 (s, 3H), 2.39 (d, 1H, J = 9.5 
Hz), 2.15 (q, 1H, J = 13.5 Hz), 1.93-1.86 (m, 2H), 1.79 (app d, 1H, J = 14.0 Hz), 1.70 (app d, 
1H, J = 14.0 Hz), 1.63-1.60 (m, 1H), 0.84 (d, 3H, J = 6.5 Hz), 0.60 (d, 3H, J = 6.5 Hz); 13C NMR 
(75 MHz, CDCl3)  179.6, 176.7, 141.3, 139.2, 131.2, 128.6, 128.5, 127.7, 127.6, 124.2, 123.8, 
108.9, 76.3, 71.4, 71.1, 56.6, 55.2, 54.9, 36.0, 35.3, 31.1, 19.9, 19.1, 19.0; IR (neat) 3333, 3059, 
2931, 2869, 1710, 1667, 1523, 1490, 1467, 1361, 1089, 744 cm-1; HRMS (EI) m/z calcd for 
C26H32N2O4 [M]+ 436.2362, found 436.2366.  
Slower eluting minor product: 1H NMR (500 MHz, DMSO)  7.60 (d, 
1H, J = 7.5 Hz), 7.34 (t, 1H, J = 7.5 Hz), 7.29-7.22 (m, 5H), 7.13 (t, 1H, 
J = 7.5 Hz), 7.07 (d, 1H, J = 8.0 Hz), 6.68 (d, 1H, J = 10.0 Hz), 4.99 (s, 
2H), 4.60 (d, 1H, J = 11.5 Hz), 4.46 (d, 1H, J = 11.5 Hz), 4.33 (t, 1H, J = 10.0 Hz), 3.83 (dt, 1H, 
J = 5.0, 11.5 Hz), 3.14 (s, 3H), 2.35 (app d, 1H, J = 6.0 Hz), 2.09 (quintet, 1H, J = 6.5 Hz), 1.87-
1.81 (m, 2H), 1.74 (m, 1H), 1.45-1.41 (m, 2H), 0.74 (d, 3H, J = 6.5 Hz), 0.67 (d, 3H, J = 7.0 Hz); 
13C NMR (75 MHz, DMSO)  177.8, 175.6, 142.3, 139.2, 129.6, 128.0, 127.9, 127.2, 127.1, 
125.9, 122.3, 109.1, 77.0, 70.7, 70.5, 55.6, 54.5, 54.3, 33.6, 33.5, 31.0, 19.7, 19.6, 18.9; IR (neat) 
3322, 3060, 2936, 2871, 1723, 1659, 1527, 1465, 1358, 1241, 1095, 915, 742, 698 cm-1; HRMS 
(EI) m/z calcd for C26H32N2O4 [M]+ 436.2362, found 436.2360. 
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N-((1S,2R,3R)-3-(Benzyloxy)-1'-(methoxymethyl)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)-3-phenylpropanamide (1.59) 
To a solution of 1.43 (83 mg, 0.26 mmol) in CH2Cl2 (2.6 mL) was added 
Cp2Zr(H)Cl (81 mg, 0.31 mmol). The reaction mixture was stirred for 15 
min. Hydrocinnamoyl chloride (46 L, 0.31 mmol) was added and the 
mixture was stirred overnight. The reaction was quenched with saturated NaHCO3 solution, and 
extracted with EtOAc (3x). The combined organic layer was dried over Na2SO4 and concentrated 
under reduced pressure. The residue was purified by column chromatography (15% EtOAc in 
hexane to 100% EtOAc) to give product as two diastereomers (83 mg, 64%, 15:1). The faster 
eluting product was major diastereomer 1.59 and was isolated as a white solid (mp 163.0 °C-
164.8 °C): 1H NMR (300 MHz, CDCl3) 7.41 (d, 1H, J = 7.2 Hz), 7.31-7.23 (m, 6H), 7.20-7.12 
(m, 4H), 6.95-6.91 (m, 3H), 5.09 (d, 1H, J = 10.5 Hz), 5.04 (d, 1H, J = 10.5 Hz), 4.94 (d, 1H, J = 
9.6 Hz), 4.67 (d, 1H, J = 12.0 Hz), 4.62 (t, 1H, J = 9.9 Hz), 4.44 (d, 1H, J = 12.0 Hz), 4.19 (dt, 
1H, J = 4.5, 10.2 Hz), 3.27 (s, 3H), 2.55 (app dt, 1H, J = 3.0, 9.5 Hz), 2.38 (app d, 1H, J = 17.4 
Hz), 2.19-2.08 (m, 1H), 2.06-1.93 (m, 2H), 1.87 (dd, 1H, J = 3.6, 12.9 Hz), 1.80-1.75 (m, 1H), 
1.72-1.55 (m, 2H); 13C NMR (75 MHz, CDCl3)  179.4, 172.0, 141.1, 139.1, 131.3, 128.6, 
128.5, 128.3, 128.2, 127.7, 127.6, 124.0, 123.8, 109.0, 76.4, 71.2, 71.0, 56.3, 55.2, 55.0, 38.4, 
35.7, 31.5, 30.9, 19.0; IR (neat) 3251, 3058, 2932, 2865, 1709, 1645, 1551,1492, 1362, 1088, 
743 cm-1; HRMS (ESI) m/z calcd for C31H34N2O4Na [M+Na]+ 521.2416, found 521.2448.  
The slower eluting product was isolated as a white solid (mp 193.1 
°C-196.8 °C): 1H NMR (300 MHz, DMSO)  7.62 (d, 1H, J = 7.5 
Hz), 7.35 (d, 1H, J = 7.2 Hz), 7.27-7.07 (m, 10H), 7.02 (app d, 1H, J 
= 6.9 Hz),  6.92 (d, 1H, J = 9.9 Hz), 4.99 (s, 2H), 4.62 (d, 1H, J = 11.7 Hz), 4.45 (d, 1H, J = 11.7 
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Hz), 4.40 (t, 1H, J = 10.2 Hz), 3.83 (dt, 1H, J = 3.9, 10.5 Hz), 3.10 (s, 3H), 2.36 (app d, 1H, J = 
12.3 Hz), 2.11-1.99 (m, 2H), 1.87-1.75 (m, 4H), 1.47-1.40 (m, 2H); 13C NMR (75 MHz, DMSO) 
 177.7, 171.2, 142.2, 141.4, 139.3, 129.6, 128.1, 128.0, 127.9, 127.2, 125.9, 125.7, 122.3, 109.3, 
77.2, 70.7, 70.6, 55.3, 54.8, 54.3, 36.9, 33.7, 31.1, 31.0, 19.6; IR (neat) 3260, 3061, 3025, 2935, 
2855, 1723, 1648, 1549, 1465, 1357, 1082, 741 cm-1; HRMS (ESI) m/z calcd for C31H34N2O4Na 
[M+Na]+ 521.2416, found 521.2440. 
 
N-((1S,2R,3R)-3-(Benzyloxy)-1'-(methoxymethyl)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)acrylamide (1.60) 
To a solution of 1.43 (98 mg, 0.26 mmol) in CH2Cl2 (2.6 mL) was added 
Cp2Zr(H)Cl (79 mg, 0.31 mmol). The reaction mixture was stirred for 15 
min at room temperature. Acryloyl chloride (26 L, 0.32 mmol) was added and the mixture was 
stirred for 30 min. Sc(OTf)3 (13 mg, 0.026 mmol) was added and the solution was stirred for 
another 1.5 hours. The reaction was quenched with saturated NaHCO3 solution. The mixture was 
extracted with EtOAc (3x), and the combined organic layer was dried over Na2SO4. After 
removal of the solvent under reduced pressure, the residue was purified by column 
chromatography (15% EtOAc in hexane to 100% EtOAc) to give product as two diastereomers 
(49 mg, 46%, 8.2:1). The faster eluting product was major diastereomer 1.60 and was isolated as 
a white solid (mp 126.5 °C-128.8 °C): 1H NMR (300 MHz, CDCl3) 7.41 (d, 1H, J = 7.2 Hz), 
7.31-7.20 (m, 6H), 7.12 (t, 1H, J = 7.2 Hz), 6.93 (d, 1H, J = 7.8 Hz), 6.01 (d, 1H, J = 16.8 Hz), 
5.70 (dd, 1H, J = 10.5, 17.1 Hz), 5.45 (d, 1H, J = 10.2 Hz), 5.10 (app s, 2H), 5.04 (d, 1H, J = 9.9 
Hz), 4.69 (d, 1H, J = 12.0 Hz), 4.67 (t, 1H, J = 10.0 Hz), 4.47 (d, 1H, J = 12.0 Hz), 4.22 (dt, 1H, 
J = 4.8, 10.8 Hz), 3.30 (s, 3H), 2.40 (app d, 1H, J = 12.3 Hz), 2.11 (dt, 1H, J = 3.6, 13.2 Hz), 
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1.89 (dt, 1H, J = 3.6, 13.8 Hz), 1.81-1.52 (m, 3H); 13C NMR (75 MHz, CDCl3)  179.4, 165.5, 
141.0, 139.0, 131.0, 130.8, 128.5, 128.4, 127.8, 127.6, 126.4, 123.9, 109.1, 76.6, 71.3, 71.0, 56.4, 
55.2, 54.9, 35.9, 30.9, 19.0; IR (neat) 3291, 3059, 2934, 2864, 1711, 1664, 1612, 1540, 1362, 
1230, 1089, 914, 744 cm-1; HRMS (ESI) m/z calcd for C25H28N2O4Na [M+Na]+ 443.1947, found 
443.1939.  
The slower eluting product was repurified by chromatography (10% to 
25% EtOAc in CH2Cl2) to provide the minor diastereomer: 1H NMR (300 
MHz, CDCl3)  7.37 (d, 1H, J = 7.5 Hz), 7.32-7.26 (m, 6H), 7.06 (app t, 2H, J = 7.5 Hz), 6.18 
(dd, 1H, J = 1.8, 17.1 Hz), 6.08 (d, 1H, J = 9.9 Hz), 6.03 (d, 1H, J = 9.9 Hz), 5.60 (dd, 1H, J = 
1.8, 10.2 Hz), 5.15 (d, 1H, J = 11.1 Hz), 5.10 (d, 1H, J = 11.1 Hz), 4.64 (dd, 1H, J = 4.2, 9.9 Hz), 
4.55 (d, 1H, J = 11.7 Hz), 4.46 (d, 1H, J = 11.7 Hz), 4.02 (quintet, 1H, J = 4.2 Hz), 3.32 (s, 3H), 
2.17-2.11 (m, 1H), 2.06-1.96 (m, 1H), 1.91-1.82 (m, 3H), 1.69-1.64 (m, 1H); 13C NMR (75 
MHz, CDCl3)  177.4, 165.6, 141.6, 138.3, 132.0, 131.1, 128.6, 128.6, 128.1, 127.8, 126.6, 
124.7, 122.8, 109.8, 73.7, 71.6, 70.7, 56.4, 51.7, 50.2, 30.6, 27.4, 18.6; IR (neat) 3323, 3059, 
2939, 1723, 1660, 1610, 1539, 1466, 1349, 1240, 1086, 744 cm-1; HRMS (ESI) m/z calcd for 
C25H28N2O4Na [M+Na]+ 443.1947, found 443.1955. 
 
N-((1S,2R,3R)-3-(Benzyloxy)-1'-(methoxymethyl)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)-3-bromopropanamide (1.61) 
To a solution of 1.43 (113 mg, 0.30 mmol) in CH2Cl2 (3.0 mL) was added 
Cp2Zr(H)Cl (95 mg, 0.37 mmol). The reaction mixture was stirred for 15 
min. 3-Bromopropionyl chloride (37 L, 0.37 mmol) was added and the 
mixture was stirred for 15 min, followed by addition of Sc(OTf)3 (15 mg, 0.03 mmol). The 
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solution was stirred for another 30 min, then was quenched with saturated NaHCO3 solution. The 
mixture was extracted with EtOAc (3x), and the combined organic layer was dried over Na2SO4. 
After removal of the solvent under reduced pressure the residue was purified by column 
chromatography (15% EtOAc in hexane to 100% EtOAc) to give the product as two 
diastereomers (80 mg, 54%, 6.7:1). The faster eluting product was the major diastereomer 1.61 
and was isolated as a white solid (mp 169.8 °C-174.5 °C): 1H NMR (300 MHz, CDCl3) 7.33 (d, 
1H, J = 7.5 Hz), 7.30-7.21 (m, 6H), 7.18 (d, 1H, J = 7.5 Hz), 7.08 (d, 1H, J = 7.5 Hz), 6.89 (d, 
1H, J = 7.5 Hz), 5.06 (s, 2H), 5.01 (d, 1H, J = 9.9 Hz), 4.67 (d, 1H, J = 12.0 Hz), 4.54 (t, 1H, J = 
9.9 Hz), 4.44 (d, 1H, J = 12.0 Hz), 4.18 (dt, 1H, J = 4.5, 10.5 Hz), 3.29 (s, 3H), 3.19 (t, 2H, J = 
7.5 Hz), 2.43-2.33 (m, 2H), 2.21-2.13 (m, 1H), 2.11-2.02 (m, 1H), 1.85 (dt, 1H, J = 3.6, 14.1 
Hz), 1.77-1.46 (m, 3H); 13C NMR (75 MHz, CDCl3)  179.1, 169.1, 141.0, 138.9, 130.9, 128.4, 
128.2, 127.6, 127.5, 123.7, 123.6, 109.0, 76.2, 71.1, 71.0, 56.3, 55.1, 54.7, 39.8, 35.5, 30.8, 26.9, 
18.8; IR (neat) 3251, 3063, 2932, 1703, 1647, 1558, 1490, 1361, 1115, 1089 cm-1; HRMS (ESI) 
m/z calcd for C25H29N2O4BrNa [M+Na]+ 523.1208, found 523.1210.  
The slower eluting product was repurified by preparative TLC (20% 
EtOAc in CH2Cl2) to provide the minor diastereomer 1.61’. 1H NMR 
(300 MHz, CDCl3)  7.36 (d, 1H, J = 7.2 Hz), 7.33-7.30 (m, 6H), 7.06 
(app t, 2H, J = 7.5 Hz), 6.00 (d, 1H, J = 9.6 Hz), 5.15 (d, 1H, J = 10.8 Hz), 5.09 (d, 1H, J = 10.8 
Hz), 4.55 (dd, 1H, J = 4.2, 10.2 Hz), 4.52 (d, 1H, J = 11.7 Hz), 4.46 (d, 1H, J = 11.7 Hz), 4.00 
(quintet, 1H, J = 4.2 Hz), 3.50 (t, 2H, J = 6.9 Hz), 3.33 (s, 3H), 2.76-2.59 (m, 2H), 2.18-2.12 (m, 
1H), 2.03-1.81 (m, 4H), 1.68-1.61 (m, 1H); 13C NMR (75 MHz, CDCl3)  177.5, 169.8, 141.6, 
138.3, 131.8, 128.7, 128.6, 128.2, 127.9, 124.8, 122.8, 109.8, 73.6, 71.6, 70.7, 56.5, 51.6, 50.3, 
39.9, 30.6, 27.5, 27.3, 18.5; IR (neat) 3340, 3059, 2939, 2876, 1720, 1655, 1611, 1541, 1466, 
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1349, 1245, 1086, 914, 746 cm-1; HRMS (ESI) m/z calcd for C25H29N2O4BrNa [M+Na]+ 
523.1208, found 523.1165. 
 
N-((1S,2R,3R)-3-(Benzyloxy)-6'-chloro-1'-(methoxymethyl)-2'-oxospiro[cyclohexane-1,3'-
indolin]-2-yl)-3-phenylpropanamide (1.62) 
To a solution of 1.48 (95 mg, 0.23 mmol) in CH2Cl2 (2.3 mL) was 
added Cp2Zr(H)Cl (73 mg, 0.28 mmol). The reaction mixture was 
stirred for 15 min. Hydrocinnamoyl chloride (42 L, 0.28 mmol) was 
added and the mixture was stirred overnight at rt. The reaction was quenched with saturated 
NaHCO3 solution and extracted with EtOAc (3x). The combined organic layer was dried over 
Na2SO4, and concentrated under reduced pressure. The residue was purified by column 
chromatography (15% EtOAc in hexane to 100% EtOAc) to give 1.62 as single diastereomer (61 
mg, 50%, white solid, mp 193.0 °C-195.2 °C). 1H NMR (300 MHz, CDCl3)  7.35-7.11 (m, 
10H), 6.95-6.93 (m, 3H), 5.01 (s, 2H), 4.95 (d, 1H, J = 9.6 Hz), 4.68 (d, 1H, J = 12.0 Hz), 4.58 
(d, 1H, J = 9.9 Hz), 4.40 (d, 1H, J = 12.0 Hz), 4.17 (dt, 1H, J = 4.5, 10.5 Hz), 3.24 (s, 3H), 2.66-
2.60 (m, 2H), 2.37 (app d, 1H, J = 9.9 Hz), 2.23-1.99 (m, 3H), 1.85 (dt, 1H, J = 3.9, 13.8 Hz), 
1.77-1.62 (m, 2H), 1.54-1.49 (m, 1H); 13C NMR (75 MHz, CDCl3)  179.1, 172.1, 142.1, 140.9, 
139.0, 134.0, 129.6, 128.6, 128.5, 127.7, 126.2, 125.1, 123.6, 109.9, 76.2, 71.2, 70.9, 56.3, 54.9, 
54.8, 38.2, 35.6, 31.3, 30.8, 18.9; IR (neat) 3249, 3057, 3028, 2935, 2869, 2362, 1707, 1647, 
1610, 1549, 1448, 1094 cm-1; HRMS (ESI) m/z calcd for C31H33N2O4ClNa [M+Na]+ 555.2027, 
found 555.2028. 
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N-((1S,2R,3R)-3-(Benzyloxy)-4'-chloro-1'-(methoxymethyl)-2'-oxospiro[cyclohexane-1,3'-
indolin]-2-yl)-3-phenylpropanamide (1.63) 
To a solution of 1.49 (82 mg, 0.20 mmol) in CH2Cl2 (2.0 mL) was added 
Cp2Zr(H)Cl (63 mg, 0.25 mmol). The reaction mixture was stirred for 15 
min. Hydrocinnamoyl chloride (37 L, 0.25 mmol) was added and the 
mixture was stirred overnight. The reaction was quenched with saturated 
NaHCO3 solution, and extracted with EtOAc (3x). The combined organic layer was dried over 
Na2SO4, and concentrated under reduced pressure. The residue was purified by column 
chromatography (15% EtOAc in hexane to 100% EtOAc, then 5% EtOAc in CH2Cl2) to give 
product 1.63 as single diastereomer (38 mg, 36%, white solid, mp 159.8 °C-161.6 °C): 1H NMR 
(300 MHz, CDCl3)  7.30-7.08 (m, 10H), 6.98 (app d, 2H, J = 7.8 Hz), 6.84 (d, 1H, J = 7.5 Hz), 
5.21 (t, 1H, J = 9.6 Hz), 5.06 (d, 1H, J = 10.8 Hz), 5.00 (d, 1H, J = 10.8 Hz), 4.88 (d, 1H, J = 9.3 
Hz), 4.69 (d, 1H, J = 12.0 Hz), 4.44 (d, 1H, J = 12.0 Hz), 4.15 (dt, 1H, J = 4.5, 11.1 Hz), 3.26 (s, 
3H), 2.72-2.60 (m, 3H), 2.37 (app d, 1H, J = 12.6 Hz), 2.21-1.97 (m, 3H), 1.75-1.54 (m, 3H); 13C 
NMR (75 MHz, CDCl3)  178.4, 171.8, 142.8, 141.0, 138.9, 131.8, 129.5, 128.4, 128.3, 128.1, 
127.6, 127.5, 126.6, 126.0, 125.3, 107.6, 76.5, 71.1, 70.7, 56.3, 56.2, 52.1, 38.2, 31.3, 30.4, 29.8, 
18.5; IR (neat) 3295, 3061, 3028, 2935, 2864, 1715, 1657, 1607, 1456, 1361, 1092 cm-1; HRMS 
(ESI) m/z calcd for C31H33N2O4ClNa [M+Na]+ 555.2027, found 555.2047.  
 
N-((1R,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)isobutyramide (1.64) 
To a solution of 1.42 (120 mg, 0.21 mmol) in CH2Cl2 (2.1 mL) was added 
Cp2Zr(H)Cl (68 mg, 0.26 mmol). The reaction mixture was stirred for 15 min. 
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Isobutyryl chloride (27 L, 0.26 mmol) was added and the mixture was stirred for 20 min, 
followed by addition of Sc(OTf)3 (103 mg, 0.21 mmol). After stirring overnight the reaction was 
quenched with saturated NaHCO3 solution and extracted with EtOAc (3x). 
The combined organic layer was dried over Na2SO4 and then concentrated 
under reduced pressure. The residue was purified by column 
chromatography (5% EtOAc in CH2Cl2 to 100%) to give the product as four diastereomers (69 
mg, 68%). The fastest eluting product was a mixture of two inseparable diastereomers (12 mg, 
1:0.72). By comparison to the available spectrum, they are 1.55 and its epimer at the benzyloxy 
position. The second fastest eluting product was repurified by preparative TLC (35% EtOAc in 
hexane) to yield the minor diastereomer (10 mg): 1H NMR (400 MHz, CDCl3)  7.92 (d, 1H, J = 
7.6 Hz), 7.38-7.21 (m, 10H), 7.15 (t, 1H, J = 7.6 Hz), 6.88 (t, 1H, J = 7.6 Hz), 6.71 (d, 1H, J = 
7.6 Hz), 5.23 (d, 1H, J = 9.6 Hz), 4.96 (d, 1H, J = 15.6 Hz), 4.79 (d, 1H, J = 15.6 Hz), 4.74 (d, 
1H, J = 11.6 Hz), 4.70 (dd, 1H, J = 3.6, 10.0 Hz), 4.37 (d, 1H, J = 11.2 Hz), 3.97-3.95 (m, 1H), 
2.29 (app dt, 1H, J = 3.2, 14.4 Hz), 2.10-1.95 (m, 3H), 1.77-1.63 (m, 3H), 0.85 (d, 3H, J = 7.2 
Hz), 0.81 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3)  179.4, 175.7, 143.5, 138.4, 136.3, 
130.0, 128.9, 128.7, 128.4, 128.1, 128.0, 128.0, 127.7, 127.6, 122.0, 108.9, 76.0, 72.0, 53.3, 51.4, 
44.2, 35.5, 34.3, 27.6, 19.5, 19.4, 15.9; IR (neat) 3349, 3060, 3031, 2929, 2869, 1715, 1678, 
1609, 1494, 1466, 1364, 1207, 1089, 751 cm-1; HRMS (EI) m/z calcd for C31H34N2O3 [M]+ 
482.2569, found 482.2567. The third eluting product 1.64 was the major diastereomer (47 mg, 
46%). All spectral data for this compound were identical to the minor product from the 
cyclization of 1.37. 
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N-((1R,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-yl)-2-
methoxyacetamide (1.65) 
To a solution of 1.42 (114 mg, 0.20 mmol) in CH2Cl2 (2.0 mL) was added 
Cp2Zr(H)Cl (65 mg, 0.25 mmol). The reaction mixture was stirred for 15 
min. Methoxyacetyl chloride (23 L, 0.25 mmol) was added and the mixture was stirred for 20 
min, followed by addition of Sc(OTf)3 (96 mg, 0.20 mmol). After stirring overnight, the reaction 
was quenched with saturated NaHCO3 solution and extracted with EtOAc (3x). The combined 
organic layer was dried over Na2SO4, and then concentrated under 
reduced pressure. The residue was purified by column chromatography 
(5% EtOAc in CH2Cl2 to 100% EtOAc) to give product as four 
diastereomers (65 mg, 67%). The fastest eluting product was minor diastereomer 1.56 (3 mg). 
The second fastest eluting product was the minor diastereomer (2 mg) which was the epimer of 
1.56 at the benzyloxyl position as shown before. The last eluting fraction was a mixture of two 
inseparable diastereomers (60 mg, 1:2.1), which were repurified by preparative TLC (10% 
EtOAc in CH2Cl2) for characterization purpose, and give the third eluting product as the minor 
diastereomer, 1H NMR (600 MHz, CDCl3)  7.90 (d, 1H, J = 7.2 Hz), 7.34-7.23 (m, 10H), 7.15 
(t, 1H, J = 7.8 Hz), 6.87 (t, 1H, J = 7.2 Hz), 6.72 (d, 1H, J = 7.8 Hz), 6.45 (d, 1H, J = 10.2 Hz), 
5.10 (d, 1H, J = 15.0 Hz), 4.75 (dd, 1H, J = 3.6, 10.2 Hz), 4.73 (d, 1H, J = 11.4 Hz), 4.42 (d, 1H, 
J = 11.4 Hz), 3.94 (m, 1H), 3.68 (d, 1H, J = 15.0 Hz), 3.49 (d, 1H, J = 15.0 Hz), 2.28 (app d, 1H, 
J = 13.8 Hz), 2.10-1.98 (m, 2H), 1.74 (app t, 1H, J = 13.2 Hz), 1.68 (app d, 2H, J = 11.9 Hz). 
The slow eluting product was the major diastereomer 1.65 and was isolated as a white solid (mp 
164.2 °C-165.8 °C): 1H NMR (600 MHz, DMSO)  7.61 (d, 1H, J = 7.8 Hz), 7.31-7.28 (m, 5H), 
7.26-7.22 (m, 6H), 7.06 (d, 1H, J = 7.2 Hz), 6.92 (d, 1H, J = 7.8 Hz), 6.11 (d, 1H, J = 10.2 Hz), 
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5.00 (d, 1H, J = 15.6 Hz), 4.70 (d, 1H, J = 15.6 Hz), 4.64 (d, 1H, J = 12.0 Hz), 4.45 (d, 1H, J = 
12.0 Hz), 4.43 (t, 1H, J = 10.8 Hz), 3.86 (dt, 1H, J = 4.2, 10.8 Hz), 3.57 (d, 1H, J = 15.6 Hz), 
3.43 (d, 1H, J = 15.6 Hz), 2.81 (s, 3H), 2.41 (app d, 1H, J = 15.6 Hz), 1.93-1.78 (m, 3H), 1.51-
1.44 (m, 2H); 13C NMR (100 MHz, DMSO)  177.1, 168.2, 142.9, 139.1, 136.4, 129.4, 128.5, 
128.4, 128.0, 127.3, 127.2, 127.1, 125.6, 122.0, 109.2, 77.2, 71.1, 70.2, 58.2, 54.1, 53.8, 42.7, 
33.5, 30.7, 19.6; IR (neat) 3271, 3060, 3031, 2929, 2853, 1714, 1608, 1521, 1464, 1364, 1113, 
1070, 737 cm-1; HRMS (ESI) m/z calcd for C30H32N2O4Na [M+Na]+ 507.2260, found 507.2251.   
 
N-((1R,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)acrylamide (1.66) 
To a solution of 1.42 (105 mg, 0.19 mmol) in CH2Cl2 (1.9 mL) was added 
Cp2Zr(H)Cl (60 mg, 0.23 mmol). The reaction mixture was stirred for 15 
min. Acryloyl chloride (19 L, 0.23 mmol) was added and the mixture was stirred for 20 min, 
followed by addition of Sc(OTf)3 (93 mg, 0.20 mmol). After stirring overnight, the reaction was 
quenched with saturated NaHCO3 solution and extracted with EtOAc (3x). The combined 
organic layer was dried over Na2SO4, and then concentrated under reduced pressure. The residue 
was purified by column chromatography (5% EtOAc in CH2Cl2 to 100% EtOAc) to give product 
as four diastereomers (33 mg, 38%). The fastest eluting product 1.57 was the minor diastereomer 
(1 mg). The second fastest eluting product was a mixture of two inseparable diastereomers (6 
mg, 1:1). The third eluting product 1.66 was the major diastereomer (26 mg). This product 
showed identical spectral data to the minor product from the cyclization of 1.37.  
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N-((1R,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-yl)-3-
phenylpropanamide (1.53) 
To a solution of 1.42 (113 mg, 0.20 mmol) in CH2Cl2 (2.0 mL) was added 
Cp2Zr(H)Cl (65 mg, 0.25 mmol). The reaction mixture was stirred for 15 
min. Hydrocinnamoyl chloride (37 L, 0.25 mmol) was added and the 
mixture was stirred for 20 min, followed by addition of Sc(OTf)3 (98 mg, 0.20 mmol). After 
stirring overnight, the reaction was quenched with saturated NaHCO3 solution and extracted with 
EtOAc (3x). The combined organic layer was dried over Na2SO4 and then concentrated under 
reduced pressure. The residue was purified by column chromatography (5% to 100% EtOAc in 
CH2Cl2) to give product as four diastereomers (72 mg, 66%). The fastest eluting product was a 
mixture of two inseparable diastereomers (13 mg, 1:1). By comparing with the available spectra, 
they are 1.52 and its epimer at the benzyloxy position. 
The second fastest eluting product was syn-diastereomer 1.67 (8 mg), 
1H NMR (400 MHz, CDCl3)  7.90 (d, 1H, J = 7.6 Hz), 7.35-7.12 (m, 
14H), 7.03 (app d, 2H, J = 7.2 Hz), 6.87 (dt, 1H, J = 3.6, 7.6 Hz), 6.71 
(d, 1H, J = 8.0 Hz), 5.16 (d, 1H, J = 9.6 Hz), 5.05 (d, 1H, J = 15.6 Hz), 4.75 (dd, 1H, J = 4.0, 
10.0 Hz), 4.68 (d, 1H, J = 15.6 Hz), 4.64 (d, 1H, J = 11.2 Hz), 4.20 (d, 1H, J = 11.2 Hz), 3.87-
3.86 (m, 1H), 2.75-2.61 (m, 2H), 2.25 (d, 1H, J = 14.0 Hz), 2.20-2.12 (m, 1H), 2.09-1.93 (m, 
3H), 1.76-1.72 (m, 1H), 1.66-1.62 (m, 2H); 13C NMR (100 MHz, CDCl3)  179.3, 171.0, 143.4, 
141.0, 138.4, 136.3, 129.9, 128.9, 128.7, 128.6, 128.4, 128.4, 128.2, 128.0, 128.0, 127.8, 127.6, 
126.3, 122.1, 109.0, 76.2, 71.9, 53.2, 51.7, 44.2, 38.0, 34.3, 31.3, 27.7, 15.9; IR (neat) 3087, 
3029, 2936, 2866, 1711, 1670, 1609, 1494, 1466, 1364, 733 cm-1; HRMS (ESI) m/z calcd for 
C36H36N2O3Na [M+Na]+ 567.2624, found 567.2598. The third eluting product 1.53 was the 
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major diastereomer (51 mg). All spectral data for this compound were identical to those from the 
minor isomer of the cyclization of 1.37. 
 
N-((1R,2R,3S)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-yl)-3-
phenylpropanamide (1.67) 
To a solution of 1.42 (62 mg, 0.11 mmol) in CH2Cl2 (1.1 mL) was 
added Cp2Zr(H)Cl (35 mg, 0.13 mmol). The reaction mixture was 
stirred for 15 min. Hydrocinnamoyl chloride (19 L, 0.13 mmol) was 
added and the mixture was stirred for 20 min, followed by addition of ZnCl2 (0.13 mL 1M 
solution). After stirring overnight at room temperature, the reaction was quenched with saturated 
NaHCO3 solution and extracted with EtOAc (3x). The combined organic layer was dried over 
Na2SO4, and then concentrated under reduced pressure. The residue was purified by column 
chromatography (5% EtOAc in CH2Cl2 to 100% EtOAc) to give the product as four 
diastereomers (33 mg, 66%). The fastest eluting product was a mixture of two inseparable 
diastereomers (2 mg, 3:2). By comparing with the available spectrum, they are 1.52 and its 
epimer at the benzyloxy position. The second fastest eluting material was the major product 1.67 
(22 mg) and the third eluting product 1.53 as the minor product (11 mg). All spectral data were 
consistent with products that had previously been prepared. 
 
N-((1S,2R,3R)-1'-Benzyl-3-(benzyloxy)-5'-bromo-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)-3-phenylpropanamide (1.68) 
To a solution of 1.52 (250 mg, 0.46 mmol) in CH2Cl2 (9 mL) was added NBS (82 mg, 0.46 
mmol) at 0 °C. The ice bath was removed and the mixture was stirred for 1h. NBS (20 mg, 0.11 
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mmol) was added and after 40 min the solvent was removed under 
reduced pressure. The residue was purified by chromatography (15% to 
30% EtOAc in hexane) to give the aryl bromide as white solid 1.68 (170 
mg, 59%). 1H NMR (400 MHz, CDCl3) 7.51 (d, 1H, J = 2.0 Hz), 7.34-
7.11 (m, 14H), 6.92 (app d, 2H, J = 6.8 Hz), 6.53 (d, 1H, J = 8.0 Hz), 4.89 (d, 1H, J = 16.0 Hz), 
4.88 (d, 1H, J = 8.4 Hz), 4.74 (d, 1H, J = 15.6 Hz), 4.67 (d, 1H, J = 12.0 Hz), 4.57 (t, 1H, J = 
10.0 Hz), 4.44 (d, 1H, J = 12.0 Hz), 4.21 (dt, 1H, J = 4.4, 10.4 Hz), 2.56 (t, 2H, J = 8.0 Hz), 2.39 
(app dd, 1H, J = 3.2, 12.8 Hz), 2.16 (qt, 1H, J = 3.6, 9.2 Hz), 2.06 (quint, 1H, J = 7.6 Hz), 1.93 
(app dd, 1H, J = 7.6, 14.8 Hz), 1.84 (dt, 1H, J = 4.0, 12.8 Hz), 1.79 (app d, 1H, J = 12.8 Hz), 
1.71 (app dt, 1H, J = 3.2, 14.0 Hz), 1.62-1.52 (m, 1H); 13C NMR (100 MHz, CDCl3)  178.1, 
171.9, 141.0, 140.9, 139.0, 135.8, 133.9, 131.1, 129.1, 128.5, 128.4, 128.2, 127.6, 127.6, 127.3, 
127.2, 126.1, 115.9, 110.0, 76.2, 70.7, 55.0, 54.6, 43.6, 38.0, 35.1, 31.2, 30.7, 18.9; IR (neat) 
3306, 3062, 3029, 2931, 2864, 1702, 1606, 1484, 1426, 1358, 1205, 1169, 1098, 737 cm-1; 
HRMS (ESI) m/z calcd for C36H35N2O3NaBr [M+Na]+ 645.1729, found 645.1726. 
 
N-((1S,2R,3R)-1'-Benzyl-3-(benzyloxy)-5'-(4-methoxyphenyl)-2'-oxospiro[cyclohexane-1,3'-
indolin]-2-yl)-3-phenylpropanamide (1.69) 
To a solution (40 mg, 0.06 mmol) of the aryl bromide 1.68 in 
THF/H2O (1 mL, 3:1) in a sealed tube was added (PPh3)4Pd (7 mg, 
0.006 mmol), 4-methoxyphenylboronic acid (20 mg, 0.13 mmol), 
and Na2CO3 (27 mg, 0.26 mmol). The atmosphere was exchanged 
for argon then the tube was sealed and immersed in a preheated oil 
bath (66 °C). The reaction stirred at 66 °C for 5 h, then the solution was extracted with EtOAc 
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(2x). The combined organic layer was dried over Na2SO4. After removal of the solvent under 
reduced pressure, the residue was purified by flash chromatography (15% to 30% EtOAc in 
hexane) to give biaryl 1.69 (37 mg, 89%): 1H NMR (300 MHz, CDCl3) 7.60 (d, 1H, J = 1.8 Hz), 
7.52 (app d, 2H, J = 8.7 Hz), 7.35-7.21 (m, 11H), 7.15-7.10 (m, 3H), 6.97 (app d, 2H, J = 8.7 
Hz), 6.87 (app d, 2H, J = 7.8 Hz), 6.74 (d, 1H, J = 8.1 Hz), 5.00 (d, 1H, J = 10.2 Hz), 4.94 (d, 
1H, J = 15.6 Hz), 4.84 (d, 1H, J = 15.6 Hz), 4.74 (t, 1H, J = 10.2 Hz), 4.71 (d, 1H, J = 12.0 Hz), 
4.47 (d, 1H, J = 12.0 Hz), 4.29 (dt, 1H, J = 4.2, 10.5 Hz), 3.85 (s, 3H), 2.56-2.37 (m, 3H), 2.22 
(qt, 1H, J = 3.6, 12.6 Hz), 2.14-2.04 (m, 1H), 2.00-1.83 (m, 3H), 1.80-1.69 (m, 2H), 1.61-1.56 
(m, 1H); 13C NMR (75 MHz, CDCl3)  178.7, 172.0, 159.1, 141.0, 140.8, 139.2, 136.3, 136.3, 
133.8, 132.3, 129.1, 128.5, 128.5, 128.3, 128.2, 127.9, 127.5, 127.3, 126.6, 126.1, 122.9, 114.4, 
108.7, 76.4, 70.8, 55.5, 55.3, 54.6, 43.7, 38.2, 35.4, 31.5, 31.0, 19.0; IR (neat) 3324, 3062, 3030, 
2933, 2864, 1696, 1612, 1543, 1491, 1453, 1365, 1247, 1100, 1027, 909, 813, 732 cm-1; HRMS 
(EI) m/z calcd for C43H42N2O4 [M]+ 650.3144, found 650.3148. 
 
(E)-N-((1S,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-yl)-4-
phenylbut-2-enamide (1.70) 
To a solution of 1.57 (23 mg, 0.05 mmol) in CH2Cl2 (1 mL) in a sealed 
tube were added the second generation Hoveyda-Grubbs catalyst (2 
mg) and allylbenzene (19 L, 0.15 mmol). The atmosphere was 
exchanged with argon, then the tube was immersed in a preheated oil bath (41 °C). The reaction 
was stirred for 18 h, then the solvent was removed under reduced pressure and the residue was 
purified by preparative TLC (5% EtOAc in CH2Cl2) to yield 1.70 (11 mg, 40%, 51% brsm) and 
starting material (5 mg): 1H NMR (400 MHz, CDCl3)  7.40 (d, 1H, J = 7.6 Hz), 7.33-7.22 (m, 
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13H), 7.16-7.06 (m, 4H), 6.75 (dt, 1H, J = 6.8, 15.2 Hz), 6.66 (d, 1H, J = 7.6 Hz), 5.27 (d, 1H, J 
= 15.2 Hz), 4.96 (d, 1H, J = 15.6 Hz), 4.91 (d, 1H, J = 10.0 Hz), 4.80 (d, 1H, J = 15.6 Hz), 4.70 
(d, 1H, J = 12.0 Hz), 4.68 (t, 1H, J = 10.0 Hz), 4.47 (d, 1H, J = 12.0 Hz), 4.24 (dt, 1H, J = 4.4, 
10.4 Hz), 3.39 (t, 1H, J = 6.4 Hz), 2.41 (d, 1H, J = 10.0 Hz), 2.19 (q, 1H, J = 13.2 Hz), 1.91 (dt, 
1H, J = 3.6, 14.0 Hz), 1.82 (app d, 1H, J = 14.0 Hz), 1.74-1.70 (m, 1H), 1.62-1.55 (m, 1H); 13C 
NMR (100 MHz, CDCl3)  178.8, 165.7, 143.1, 142.0, 139.1, 138.2, 136.2, 131.9, 129.0, 129.0, 
128.9, 128.4, 128.1, 127.8, 127.8, 127.5, 127.2, 126.7, 124.6, 123.8, 123.4, 108.7, 76.7, 70.9, 
55.3, 54.4, 43.5, 38.3, 35.5, 30.9, 19.1; IR (neat) 3416, 3060, 3029, 2931, 2864, 1696, 1640, 
1612, 1537, 1493, 1365, 1174, 1098, 980 cm-1; HRMS (ESI) m/z calcd for C37H36N2O3Na 
[M+Na]+ 579.2624, found 579.2679.  
 
N-((1S,2R,3R)-1'-Benzyl-3-(benzyloxy)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)cinnamamide (1.71) 
To a solution of 1.57 (30 mg, 0.06 mmol) in DMF (0.5 mL) in a sealed 
tube was added Pd(OAc)2 (0.7 mg), PPh3 (1.7 mg, 0.0064 mmol), 
iodobenzene (7.2 L, 0.06 mmol) and Cs2CO3 (23 mg, 0.07 mmol). The 
atmosphere was exchanged with argon, then the tube was sealed and immersed in a preheated oil 
bath (120 °C). The reaction stirred for 12 h, then the mixture was diluted with EtOAc and 
washed with brine (2x). The organic layer was dried over Na2SO4 and the solvent was removed 
under reduced pressure. The residue was purified by chromatography (10% to 50% EtOAc in 
hexane) to yield 1.71 as a slightly red solid (25 mg, 72%, mp 185.4 °C-189.8 °C). 1H NMR (400 
MHz, CDCl3)  7.44 (d, 1H, J = 8.0 Hz), 7.39-7.35 (m, 6H), 7.31-7.24 (m, 9H), 7.16-7.08 (m, 
2H), 6.68 (d, 1H, J = 8.0 Hz), 5.82 (d, 1H, J = 15.6 Hz), 5.00 (app d, 2H, J = 15.6 Hz), 4.83 (d, 
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1H, J = 15.6 Hz), 4.76-4.71 (m, 2H), 4.49 (d, 1H, J = 12.0 Hz), 4.29 (dt, 1H, J = 4.8, 10.8 Hz), 
2.44 (d, 1H, J = 12.8 Hz), 2.23 (qt, 1H, J = 3.6, 13.6 Hz), 1.94 (dt, 1H, J = 4.0, 14.0 Hz), 1.85 
(app d, 1H, J = 14.0 Hz), 1.78-1.73 (m, 1H), 1.66-1.59 (m, 1H); 13C NMR (75 MHz, CDCl3)  
178.8, 165.6, 142.0, 141.0, 139.1, 136.3, 134.9, 131.9, 129.8, 129.0, 128.9, 128.5, 128.2, 128.0, 
127.9, 127.8, 127.5, 127.3, 123.8, 123.4, 120.5, 108.8, 76.7, 71.0, 55.4, 54.5, 43.5, 35.3, 31.0, 
19.1; IR (neat) 3304, 3060, 3030, 2932, 2864, 1699, 1663, 1612, 1492, 1366, 1209, 1027, 1098, 
978, 910, 734 cm-1; HRMS (ESI) m/z calcd for C36H34N2O3Na [M+Na]+ 565.2467, found 
565.2432.  
 
N-((1S,2R,3R)-3-(Benzyloxy)-1'-(methoxymethyl)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-
yl)-3-(propylthio)propanamide (1.72) 
To a suspension of NaH (6 mg, 0.15 mmol) in THF (0.6 mL) at 0 °C 
under argon was added 1-propanethiol (10 L, 0.11 mmol). After 15 min 
a solution of 1.60 (31 mg, 0.074 mmol) in THF (0.6 mL) was added dropwise at 0 °C. The ice 
bath was removed and the reaction stirred at for 1 h. The reaction mixture was quenched with 
water and extracted with EtOAc (2x). The combined organic layer was dried over Na2SO4 and 
the solvent was removed under reduced pressure. The residue was purified by chromatography 
(5% to 15% EtOAc in CH2Cl2) to give sulfide 1.72 (26 mg, 71%): 1H NMR (400 MHz, CDCl3)  
7.36 (d, 1H, J = 7.2 Hz), 7.32-7.24 (m, 5H), 7.22 (d, 1H, J = 7.6 Hz), 7.11 (t, 1H, J = 7.6 Hz), 
6.93 (d, 1H, J = 7.6 Hz), 5.25 (d, 1H, J = 9.6 Hz), 5.11 (d, 1H, J = 10.8 Hz), 5.08 (d, 1H, J = 10.8 
Hz), 4.70 (d, 1H, J = 12.0 Hz), 4.58 (t, 1H, J = 10.0 Hz), 4.49 (d, 1H, J = 12.0 Hz), 4.21 (dt, 1H, 
J = 4.8, 10.8 Hz), 3.23 (s, 3H), 2.43-2.36 (m, 2H), 2.30-2.23 (m, 3H), 2.15-2.06 (m, 2H), 2.01-
1.93 (m, 1H), 1.88 (dt, 1H, J = 3.6, 14.0 Hz), 1.78 (app d, 1H, J = 14.4 Hz), 1.71-1.68 (m, 1H), 
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1.60-1.55 (m, 1H), 1.47 (sextet, 2H, J = 7.2 Hz), 0.91 (t, 3H, J = 7.2 Hz); 13C NMR (75 MHz, 
CDCl3)  179.3, 171.2, 141.2, 139.1, 131.2, 128.5, 128.3, 127.7, 127.6, 123.9, 123.7, 109.0, 76.4, 
71.3, 71.1, 56.4, 55.3, 54.9, 37.0, 35.6, 34.2, 31.0, 27.6, 22.9, 19.0, 13.6; IR (neat) 3247, 3061, 
2932, 2869, 1706, 1643, 1555, 1491, 1362, 1294, 1116, 1088, 740 cm-1; HRMS (ESI) m/z calcd 
for C28H36N2O4NaS [M+Na]+ 519.2293, found 519.2319. 
 
N-((1S,2R,3R)-3-Hydroxy-1'-(methoxymethyl)-2'-oxospiro[cyclohexane-1,3'-indolin]-2-yl)-
3-phenylpropanamide (1.73) 
To a solution of 1.59 (50 mg, 0.10 mmol) in EtOH/EtOAc (2 mL, 1:1) 
was added Pd/C (7 mg). The atmosphere was exchanged with H2 and the 
mixture was stirred for 24 h. The suspension was diluted with EtOAc 
then was filtered through a short pad of silica gel. Removal of the solvent provided the alcohol as 
a white solid 1.73 (29 mg, 71%, mp 219.2 °C-220.8 °C) that was directly used for next step 
without further purification: 1H NMR (300 MHz, DMSO)  7.30 (d, 2H, J = 7.5 Hz), 7.22-6.89 
(m, 7H), 5.08 (d, 1H, J = 10.8 Hz), 4.98 (d, 1H, J = 11.1 Hz), 4.40 (d, 1H, J = 5.1 Hz), 4.25-4.15 
(m, 2H), 3.19 (s, 3H), 2.31-2.23 (m, 2H), 2.11-2.00 (m, 4H), 1.92-1.83 (m, 1H), 1.62-1.45 (m, 
3H); 13C NMR (75 MHz, DMSO)  178.1, 171.7, 141.5, 141.4, 131.4, 128.2, 127.9, 127.4, 
125.6, 123.7, 122.2, 108.4, 70.5, 66.7, 56.9, 55.5, 53.9, 37.1, 34.8, 34.2, 31.3, 18.7; IR (neat) 
3424, 3269, 2938, 1694, 1640, 1554, 1453, 1369, 1077 cm-1; HRMS (ESI) m/z calcd for 
C24H28N2O4Na [M+Na]+ 431.1947, found 431.1955.  
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(1S,2R,3R)-1'-(Methoxymethyl)-2'-oxo-2-(3-phenylpropanamido)spiro[cyclohexane-1,3'-
indolin]-3-yl benzoate (1.74) 
To a solution of the alcohol 1.73 (11mg, 0.027 mmol) and a catalytic amout of DMAP in 
pyridine (0.5 mL) was added benzoyl chloride (31 L, 0.27 mmol). The 
mixture was stirred for 30 h, then another portion of benzoyl choride (31 
L, 0.27 mmol) was added. After 18 h the temperature was raised to 60 
°C. After stirring for 4 h the mixture was diluted with EtOAc, and then 
washed with saturated NaHCO3 solution. After removal of the solvent, the residue was purified 
by flash chromatography (20% to 40% EtOAc in hexane) to yield benzoate 1.74 (10 mg, 72%): 
1H NMR (400 MHz, CDCl3)  8.12 (d, 1H, J = 7.2 Hz), 8.02 (d, 2H, J = 7.2 Hz), 7.62 (t, 1H, J = 
7.6 Hz), 7.55 (t, 1H, J = 7.6 Hz), 7.48 (t, 1H, J = 7.6 Hz), 7.45-7.40 (m, 3H), 7.16 (t, 1H, J = 7.6 
Hz), 7.11-7.04 (m, 3H), 6.96 (d, 1H, J = 7.6 Hz), 6.80-6.78 (m, 2H), 5.97 (dt, 1H, J = 4.8, 10.8 
Hz), 5.50 (d, 1H, J = 10.0 Hz), 5.12 (d, 1H, J = 10.8 Hz), 5.09 (d, 1H, J = 10.8 Hz), 4.83 (t, 1H, J 
= 10.4 Hz), 2.46-2.37 (m, 2H), 2.35-2.26 (m, 2H), 2.03-1.93 (m, 3H), 1.89-1.75 (m, 3H); 13C 
NMR (100 MHz, CDCl3)  178.8, 172.3, 167.0, 141.3, 140.8, 133.8, 133.4, 130.7, 130.4, 130.1, 
130.0, 128.7, 128.6, 128.5, 128.0, 126.1, 123.9, 123.8, 109.3, 71.9, 71.3, 56.4, 55.1, 54.8, 38.3, 
35.5, 31.5, 31.2, 19.0; IR (neat) 3350, 3062,3030, 2935, 1713, 1613, 1537, 1361, 1273, 1117, 
713 cm-1; HRMS (ESI) m/z calcd for C31H32N2O5Na [M+Na]+ 535.2209, found 535.2236. 
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APPENDIX B 
STEREOCONTROLLED CYANOHYDRIN ETHER SYNTHESIS THROUGH CHIRAL 
BRØNSTED ACID-MEDIATED VINYL ETHER HYDROCYANATION (SUPPORTING 
INFORMATION) 
General Information Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance 
spectra were recorded on a Bruker Avance 300 spectrometer at 300 MHz and 75 MHz, a Bruker 
Avance 400 spectrometer at 400 MHz and 100 MHz, and a Bruker Avance 500 spectrometer at 
500 MHz. The chemical shifts are reported in parts per million (ppm) on the delta (δ) scale. The 
solvent peak was used as a reference value, for 1H NMR: CDCl3 = 7.27 ppm, CD2Cl2 = 5.32 
ppm, for 13C NMR: CDCl3 = 77.23 ppm. Data are reported as follows: (s = singlet; d = doublet; t 
= triplet; q = quartet; quin = quintet; dd = doublet of doublets; ddd = doublet of doublet of 
doublets; td = triplet of doublets). High resolution and low resolution mass spectra were recorded 
on a VG 7070 spectrometer. Infrared (IR) spectra were collected on a Mattson Cygnus 100 
spectrometer. Samples for IR were prepared as a thin film on a NaCl plate by dissolving the 
compound in CH2Cl2 and then evaporating the CH2Cl2. High performance liquid 
chromatography (HPLC) was performed on a Shimadzu UFLC Series with a refractive index 
detector using chiral stationary columns (0.46 cm x 25 cm) from Daicel (OD) or Phenomenex 
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(Lux 5 cellulose-3). Optical rotations were recorded on a Perkin-Elmer 241 digital polarimeter 
with sodium lamp at ambient temperature as follows: [α]λ (c, g/100 mL). Tetrahydrofuran and 
diethyl ether were distilled from sodium and benzophenone. Methylene chloride was distilled 
under N2 from CaH2. α,α,α-Trifluorotoluene was used commercially available dehydrated 
solvent from Aldrich and used under Ar atmosphere. Trimethylsilyl cyanide was freshly 
fractionally distilled prior to use. Hydrogen chloride solution (2.0 M in diethyl ether) was used 
commercially available from Aldrich and used under Ar atmosphere. Analytical TLC was 
performed on E. Merck pre-coated (25 mm) silica gel 60F-254 plates. Visualization was done 
under UV (254 nm). Flash chromatography was done using ICN SiliTech 32-63 60 Å silica gel. 
Reagent grade ethyl acetate, diethyl ether, toluene and hexanes (commercial mixture) were 
purchased from EM Science and used as is for chromatography. All reactions were performed in 
oven or flame-dried glassware under argon with magnetic stirring unless otherwise noted. 
Substrate 2.3 was prepared according to Tanner’s protocol.68 Substrate 2.10 was prepared 
according to Rutjes’ protocol.69 Substrate 2.67 was prepared according to Taylor’s protocol.70 
Substrate 2.69 was prepared according to the Maruoka’s protocol.71 Substrate 2.79 was prepared 
according to Boger’s protocol. 72 
 
General procedure for the preparation of vinyl ether substrate33 
 
 
Scheme S2.1 General vinyl ether substrate synthesis 
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To a solution of the alcohol (1.0 equiv) in ethyl vinyl ether (10 equiv) was added 
Hg(OAc)2 (0.1 equiv). The reaction mixture was reflux under N2 for 24 h, and the excess ethyl 
vinyl ether was removed under vacuum. The crude product was purified by flash 
chromatography using CH2Cl2 and hexanes as eluent. 
 
(3-(Vinyloxy)propyl)benzene (2.8) 
The general procedure for the vinyl ether formation was followed with ethyl 
vinyl ether (10.80 mL, 110 mmol), 3-phenylpropan-1-ol (1.50 mL, 11 mmol), and Hg(OAc)2 
(176 mg, 0.55 mmol). The crude product was purified by flash chromatography (20% CH2Cl2 in 
hexane) to give 2.8 as a colorless oil (1.04 g, 58%). 1H NMR (400 MHz, CDCl3)  7.33-7.29 (m, 
2H), 7.22-7.20 (m, 3H), 6.50 (dd, 1H, J = 14.4, 6.8 Hz), 4.19 (dd, 1H, J = 14.4, 2.0 Hz), 4.00 
(dd, 1H, J = 6.8, 2.0 Hz), 3.71 (t, 2H, J = 6.4 Hz), 2.75 (t, 2H, J = 7.2 Hz), 2.04-1.97 (m, 2H); 
13C NMR (100 MHz, CDCl3)  152.0, 141.7, 128.6, 128.6, 126.1, 86.6, 67.1, 32.3, 30.9; IR 
(neat) 3116, 3027, 2946, 2870, 1614, 1319, 1203, 1083, 815, 747, 699 cm-1; HRMS (ESI) m/z 
calcd for C11H15O [M+H]+ 163.11174, found 163.11085. 
 
tert-Butyldiphenyl((5-(vinyloxy)pentyl)oxy)silane (2.12) 
The general procedure for the vinyl ether formation was followed with 
ethyl vinyl ether (6.9 mL, 72 mmol), 5-((tert-
butyldiphenylsilyl)oxy)pentan-1-ol (2.5 g, 7.2 mmol), and Hg(OAc)2 (115 mg, 0.375 mmol). The 
crude product was purified by flash chromatography (20% to 40% CH2Cl2 in hexane) to give 
2.12 as a colorless oil (1.67 g, 63%). 1H NMR (500 MHz, CDCl3)  7.69-7.67 (m, 4H), 7.45-7.37 
(m, 6H), 6.47 (dd, 1H, J = 14.0, 6.5 Hz), 4.18 (dd, 1H, J = 14.5, 2.0 Hz), 3.98 (dd, 1H, J = 6.5, 
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2.0 Hz), 3.68 (t, 2H, J = 6.5 Hz), 3.67 (t, 2H, J = 7.0 Hz), 1.69-1.64 (m, 2H), 1.63-1.58 (m, 2H), 
1.50-1.44 (m, 2H), 1.06 (s, 9H); 13C NMR (125 MHz, CDCl3)  152.2, 135.8, 134.3, 129.7, 
127.8, 86.4, 68.1, 63.9, 32.4, 29.0, 27.1, 22.5, 19.4; IR (neat) 3071, 3049, 2934, 2859, 1612, 
1428, 1203, 1111, 822, 703 cm-1; HRMS (ESI) m/z calcd for C23H33O2Si [M+H]+ 369.22443, 
found 369.22317. 
 
Benzyl(2-(vinyloxy)ethyl)sulfane (2.14) 
The general procedure for the vinyl ether formation was followed with ethyl 
vinyl ether (2.3 mL, 23 mmol), 2-(benzylthio)ethan-1-ol (390 mg, 2.3 mmol), and Hg(OAc)2 (73 
mg, 0.23 mmol). The crude product was purified by flash chromatography (15% CH2Cl2 in 
hexane) to give 2.14 as a colorless oil (347 mg, 78%). 1H NMR (400 MHz, CDCl3)  7.35-7.25 
(m, 5H), 6.46 (dd, 1H, J = 14.0, 6.8 Hz), 4.19 (dd, 1H, J = 14.0, 2.0 Hz), 4.04 (dd, 1H, J = 6.8, 
2.0 Hz), 3.82 (t, 2H, J = 6.8 Hz), 3.80 (s, 2H), 2.71 (t, 2H, J = 6.8 Hz); 13C NMR (100 MHz, 
CDCl3)  151.6, 138.3, 129.1, 128.7, 127.2, 87.1, 67.7, 36.8, 30.1; IR (neat) 3114, 3062, 3028, 
2921, 2870, 1616, 1454, 1320, 1194, 1070, 819, 702 cm-1; HRMS (EI) m/z calcd for C11H14OS 
[M]+ 194.0765, found 194.0794. 
 
(S)-(1-(Vinyloxy)ethyl)benzene (2.16) 
The general procedure for the vinyl ether formation was followed with ethyl vinyl 
ether (8.0 mL, 83 mmol), (S)-phenylethanol (1.00 mL, 8.3 mmol), and Hg(OAc)2 
(262 mg, 0.83 mmol). The crude product was purified by flash chromatography (15% CH2Cl2 in 
hexane) to give 2.16 as a colorless oil (763 mg, 62%). 1H NMR (400 MHz, CDCl3)  7.38-7.29 
(m, 5H), 6.33 (dd, 1H, J = 14.0, 6.4 Hz), 4.91 (q, 1H, J = 6.4 Hz), 4.27 (d, 1H, J = 14.4 Hz), 4.00 
O
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(d, 1H, J = 6.8 Hz), 1.54 (d, 3H, J = 6.4 Hz); 13C NMR (100 MHz, CDCl3)  150.7, 143.1, 128.7, 
127.7, 125.9, 89.4, 77.5, 23.8; IR (neat) 3030, 2980, 2931, 1637, 1188, 1085, 759, 699 cm-1; 
HRMS (EI) m/z calcd for C10H12NO [M]+ 148.0888, found 148.0898. [α]D25 = ‒71.1 (c 1.0, 
CHCl3). 
 
(E)-(3-methoxyallyl)benzene (2.18) and (Z)-(3-methoxyallyl)benzene (2.78) 
Prepared following Nigishi’s protocol,73 and the crude product was purified by 
MPLC (medium pressure liquid chromatography, 100% hexane to 10% CH2Cl2 in hexane) for 
three times. The faster eluent is the minor isomer 2.78: 1H NMR (400 MHz, CD2Cl2)  7.28-7.24 
(m, 2H), 7.21-7.19 (m, 2H), 7.17-7.14 (m, 1H), 6.02 (d, 1H, J = 6.0 Hz), 4.55 (q, 1H, J = 7.6 
Hz), 3.62 (s, 3H), 3.38 (d, 2H, J = 7.6 Hz); 13C NMR (100 MHz, CDCl3)  146.9, 141.9, 128.5, 
128.5, 125.9, 105.7, 59.8, 30.3. 
The slower eluent gives the major isomer 2.18: 1H NMR (300 MHz, CDCl3)  
7.33-7.28 (m, 2H), 7.24-7.18 (m, 3H), 6.43 (d, 1H, J = 12.6 Hz), 4.91 (dt, 1H, J = 
12.6, 7.5 Hz), 3.55 (s, 3H), 3.28 (d, 2H, J = 7.5 Hz); 13C NMR (100 MHz, CDCl3)  148.3, 
141.9, 128.6, 128.5, 126.2, 102.1, 56.1, 34.2.  
 
(E)-(Dec-1-en-1-yloxy)cyclohexane (2.20)36 
To a solution of (E)-1-iododec-1-ene (798 mg, 3 mmol) and cyclohexenol 
(632 L, 6 mmol) in toluene (1.5 mL) was added CuI (57 mg, 0.3 mmol), 
Cs2CO3 (1.46g, 4.5 mmol) and tetramethyl-1,10-phenanthroline (141 mg, 0.6 mmol). The 
reaction tube was sealed with a screw cap, and stirred at 85 °C for 20 h. The resulting suspension 
was cooled to room temperature, and passed through a short pad of silica gel eluting with Et2O. 
OMePh
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The filtrate was then concentrated under vacuum, and the crude product was purified by flash 
chromatography (100% hexane to 5% Et2O in hexane) to give 2.20 as a colorless oil (385 mg, 
54%). 1H NMR (300 MHz, CDCl3)  6.09 (d, 1H, J = 12.3 Hz), 4.89 (dt, 1H, J = 12.3, 7.2 Hz), 
3.65-3.56 (m, 1H), 1.90-1.88 (m, 4H), 1.76-1.74 (m, 2H), 1.56-1.51 (m, 1H), 1.43-1.27 (m, 18H), 
0.89 (t, 3H, J = 6.6 Hz); 13C NMR (125 MHz, CDCl3)  144.7, 106.6, 78.1, 32.3, 32.1, 30.8, 
29.7, 29.5, 29.3, 27.9, 25.8, 24.0, 22.9, 14.3; IR (neat) 2928, 2855, 1671, 1452, 1164, 922 cm-1; 
HRMS (ASAP) m/z calcd for C16H31O [M+H]+ 239.2375, found 239.2377.  
 
3-(Vinyloxy)propyl benzoate (2.24) 
The general procedure for the vinyl ether formation was followed with ethyl 
vinyl ether (12 mL, 126 mmol), 3-hydroxypropyl benzoate (2.273 g, 12.6 
mmol), and Hg(OAc)2 (401 mg, 1.26 mmol). The crude product was purified by flash 
chromatography (5% EtOAc in hexane) to give 2.24 as a colorless oil (1.510 g, 58 %). 1H NMR 
(400 MHz, CDCl3)  8.05 (d, 2H, J = 6.8 Hz), 7.57 (t, 1H, J = 6.6 Hz),7.45 (t, 2H, J = 7.6 Hz), 
6.49 (dd, 1H, J = 14.0, 6.8 Hz), 4.45 (t, 2H, J = 6.4 Hz), 4.22 (dd, 1H, J = 14.4, 2.0 Hz), 4.03 
(dd, 1H, J = 6.8, 2.0 Hz), 3.86 (t, 2H, J = 6.0 Hz), 2.15 (quin, 2H, J = 6.4 Hz); 13C NMR (100 
MHz, CDCl3)  166.6, 151.8, 133.0, 130.4, 129.7, 128.5, 86.8, 64.5, 61.9, 28.6; IR (neat) 3117, 
3064, 2962, 2881, 1721, 1617, 1452, 1275, 1199, 1112, 820, 712 cm-1; HRMS (EI) m/z calcd for 
C12H14O3 [M]+ 206.0943, found 206.0937. 
 
2-((Vinyloxy)methyl)naphthalene (2.73) 
The general procedure for the vinyl ether formation was followed with ethyl 
vinyl ether (1.92 mL, 20 mmol), 2-napthalenemethanol (316 mg, 2 mmol), 
O O Ph
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and Hg(OAc)2 (32 mg, 0.1 mmol). The crude product was purified by flash chromatography 
(10% to 20% CH2Cl2 in hexane) to give 2.73 as the desired product (152 mg, 41%). 1H NMR 
(400 MHz, CDCl3)  7.88-7.84 (m, 4H), 7.51-7.47 (m, 3H), 6.64 (dd, 1H, J = 14.4, 6.8 Hz), 4.95 
(s, 2H), 4.38 (dd, 1H, J = 14.4, 2.0 Hz), 4.13 (dd, 1H, J = 6.8, 2.0 Hz); 13C NMR (100 MHz, 
CDCl3)  151.9, 134.6, 133.5, 133.2, 128.5, 128.1, 127.9, 126.6, 126.4, 126.3, 125.6, 87.8, 70.4; 
IR (neat) 3055, 2923, 2867, 1616, 1319, 1196, 959, 816, 752 cm-1; HRMS (EI) m/z calcd for 
C13H12O [M]+ 184.0888, found 184.0896. 
 
(Z)-((Prop-1-en-1-yloxy)methyl)benzene (2.76)74 
To a solution of allyl benzyl ether (592 mg, 4 mmol) in DMSO (40 mL) was 
added t-BuOK (1.12 g, 10 mmol) under Ar atmosphere. After stirring at 60 °C for 
2 h, the reaction mixture was diluted with Et2O, washed with H2O (3x), dried over Na2SO4, and 
concentrated under vacuum. The crude product was purified by flash chromatography (3% 
EtOAc in hexane) to give 2.76 as a colorless oil (460 mg, 78%, Z:E = 97:3). 1H NMR (300 MHz, 
CDCl3)  7.41-7.29 (m, 5H), 6.05 (dq, 1H, J = 6.0, 1.5 Hz), 4.81 (s, 2H), 4.46 (app quin, 1H, J = 
6.6 Hz), 1.64 (dd, 3H, J = 6.9, 1.5 Hz); 13C NMR (125 MHz, CDCl3)  145.4, 138.0, 128.6, 
127.9, 127.4, 101.9, 73.6, 9.5. These data are consistent with reported literature values.75  
 
General procedure for the cyanation of α-chloroether: 
 
To a one neck round bottom flask with a magnetic stirring bar, a solution of the vinyl ether (1.0 
equiv) in freshly distilled methylene chloride (0.1 M) was added under Ar. After cooling to ‒40 
°C (cooling bath temperature), a solution of HCl (1.1 equiv, 2.0 M in diethyl ether) was added 
O
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dropwise to the reaction over 20 sec. After 5 min, TMSCN (2 equiv) was added dropwise to the 
reaction mixture over about 30 sec. The mixture was stirred at this temperature for 1 h, and it 
was then quenched at ‒40 °C by Et3N (0.3 mL) followed by saturated NaHCO3 solution (0.5 
mL). After warming to room temperature, the reaction mixture was diluted with CH2Cl2 (10 mL) 
and saturated NaHCO3 solution (6 mL), and transfered to a separatory funnel.  After separation, 
the aqueous layer was extracted with CH2Cl2 again (10 mL). The combined organic layer was 
dried over Na2SO4, and concentrated under vacuum. The crude product was purified by flash 
chromatography.   
 
2-(Benzyloxy)propanenitrile (2.4) 
The general procedure for hydrocyanation was followed with 2.3 (54 mg, 0.4 mmol), 
HCl solution (220 L, 0.44 mmol), TMSCN (100 L, 0.8 mmol), and CH2Cl2 (4 
mL). The crude product was purified by flash chromatography (3% EtOAc in hexane) to give 2.4 
as a colorless oil (52 mg, 81%). For characterization data see the procedure for preparing 
enantioenriched material. 
 
2-(3-Phenylpropoxy)propanenitrile (2.9) 
The general procedure for hydrocyanation was followed with 2.8 (49 mg, 0.3 
mmol), HCl solution (165 L, 0.33 mmol), TMSCN (75 L, 0.6 mmol), and 
CH2Cl2 (3 mL). The crude product was purified by flash chromatography (4% EtOAc in hexane) 
to give 2.9 as a colorless oil (52 mg, 92%). For characterization data see the procedure for 
preparing enantioenriched material.  
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2-(Hex-5-en-1-yloxy)propanenitrile (2.11) 
The general procedure for hydrocyanation was followed with 2.10 (38 mg, 0.3 
mmol), HCl solution (165 L, 0.33 mmol), TMSCN (75 L, 0.6 mmol), and 
CH2Cl2 (3 mL). The crude product was purified by flash chromatography (10% Et2O in pentane) 
to give 2.11 as a colorless oil (35 mg, 76%). 1H NMR (300 MHz, CDCl3)  5.81 (ddt, 1H, J = 
17.1, 10.2, 6.6 Hz), 5.06-4.95 (m, 2H), 4.22 (q, 1H, J = 6.9 Hz), 3.76 (dt, 1H, J = 8.7, 6.3 Hz), 
3.47 (dt, 1H, J = 8.7, 6.3 Hz), 2.09 (q, 2H, J = 6.9 Hz), 1.69-1.60 (m, 2H), 1.57 (d, 3H, J = 6.6 
Hz), 1.53-1.43 (m, 2H); 13C NMR (100 MHz, CDCl3)  138.6, 119.3, 115.0, 70.6, 64.7, 33.5, 
28.9, 25.4, 20.0; IR (neat) 3078, 2941, 2870, 1641, 1443, 1331, 1113, 1077, 997, 912 cm-1; 
HRMS (ESI) m/z calcd for C9H16ON [M+H]+ 154.12264, found 154.12182. 
 
2-((5-((tert-Butyldiphenylsilyl)oxy)pentyl)oxy)propanenitrile (2.13) 
The general procedure for hydrocyanation was followed with 2.12 (74 mg, 
0.2 mmol), HCl solution (110 L, 0.22 mmol), TMSCN (50 L, 0.4 mmol), 
and CH2Cl2 (2 mL). The crude product was purified by flash chromatography (3% to 5% EtOAc 
in hexane) to give 2.13 as a colorless oil (76 mg, 96%). 1H NMR (500 MHz, CDCl3)  7.69-7.67 
(m, 4H), 7.45-7.37 (m, 6H), 4.20 (q, 1H, J = 6.5 Hz), 3.74 (dt, 1H, J = 9.0, 6.5 Hz), 3.68 (t, 2H, J 
= 6.5 Hz), 3.44 (dt, 1H, J = 9.0, 6.5 Hz), 1.64-1.58 (m, 4H), 1.56 (d, 3H, J = 7.0 Hz), 1.48-1.42 
(m, 2H), 1.06 (s, 9H); 13C NMR (125 MHz, CDCl3)  135.8, 134.3, 129.7, 127.8, 119.3, 70.7, 
64.7, 63.9, 32.4, 29.2, 27.1, 22.4, 20.0, 19.4; IR (neat) 3050, 2997, 2941, 1589, 1473, 1113, 823, 
706, 613 cm-1; HRMS (ESI) m/z calcd for C24H34O2NSi [M+H]+ 396.23533, found 396.23431. 
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2-(2-(Benzylthio)ethoxy)propanenitrile (2.15) 
The general procedure for hydrocyanation was followed with vinyl ether 2.14 
(58 mg, 0.3 mmol), HCl solution (165 L, 0.33 mmol), TMSCN (75 L, 0.6 
mmol), and CH2Cl2 (3 mL). The crude product was purified by flash chromatography (4% 
EtOAc in hexane) to give 2.15 as a colorless oil (60 mg, 85%). For characterization data see the 
procedure for preparing enantioenriched material. 
 
2-((S)-1-Phenylethoxy)propanenitrile (2.17) 
The general procedure for hydrocyanation was followed with 2.16 (104 mg, 0.7 
mmol), HCl solution (385 L, 0.77 mmol), TMSCN (175 L, 1.4 mmol), and 
CH2Cl2 (7 mL). The crude product was purified by flash chromatography (3% EtOAc in hexane) 
to give two diastereomers (112 mg, 91%, d.r. = 1.2:1). The faster eluting product was the major 
diastereomer 2.81: 1H NMR (400 MHz, CDCl3)  7.41-7.31 (m, 5H), 4.75 (q, 1H, J = 6.4 Hz), 
3.97 (q, 1H, J = 6.8 Hz), 1.52 (d, 3H, J = 6.4 Hz), 1.51 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, 
CDCl3)  141.4, 129.1, 128.6, 126.6, 119.4, 77.9, 61.7, 24.1, 20.1; IR (neat) 3032, 2982, 2887, 
1453, 1057, 763, 702 cm-1; HRMS (EI) m/z calcd for C11H13NO [M]+ 175.0997, 
found 175.1016. [α]D25 = ‒323.3 (c 1.0, CHCl3). 
The slower eluting product  was the minor diastereomer: 1H NMR (400 MHz, 
CDCl3)  7.41-7.31 (m, 5H), 4.68 (q, 1H, J = 6.8 Hz), 4.31 (q, 1H, J = 6.8 Hz), 1.58 
(d, 3H, J = 6.4 Hz), 1.51 (d, 3H, J = 6.4 Hz); 13C NMR (125 MHz, CDCl3)  141.9, 128.8, 128.5, 
126.6, 119.4, 78.2, 62.2, 22.6, 20.4; IR (neat) 3032, 2981, 2889, 1453, 1029, 762, 701 cm-1; 
HRMS (EI) m/z calcd for C11H13NO [M]+ 175.0997, found 175.1018. [α]D25 = ‒8.7 (c 1.0, 
CHCl3). 
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2-Methoxy-4-phenylbutanenitrile (2.19) 
The general procedure for the cyanation of α-chloroether was followed with 2.18 
(30 mg, 0.2 mmol), HCl solution (110 L, 0.22 mmol), TMSCN (50 L, 0.4 
mmol), and CH2Cl2 (2 mL) at 0 °C. The crude product was purified by flash chromatography 
(4% EtOAc in hexane) to give 2.19 as a colorless oil (29 mg, 83%). For characterization data see 
the procedure for preparing enantioenriched material. 
 
2-(Cyclohexyloxy)undecanenitrile (2.21) 
The general procedure for hydrocyanation was followed by using vinyl 
ether 2.20 (72 mg, 0.3 mmol), HCl solution (165 L, 0.33 mmol), 
TMSCN (75 L, 0.6 mmol), and CH2Cl2 (3 mL). The crude product was purified by flash 
chromatography (4% EtOAc in hexane) to give 2.21 as a colorless oil (75 mg, 94%). 1H NMR 
(400 MHz, CDCl3)  4.21 (t, 1H, J = 6.8 Hz), 3.58-3.52 (m, 1H), 1.96-1.71(m, 6H), 1.55-1.38 
(m, 4H), 1.30-1.27(m, 16H), 0.89 (t, 3H, J = 6.8 Hz); 13C NMR (100 MHz, CDCl3)  119.6, 
77.9, 66.0, 34.2, 32.8, 32.0, 31.1, 29.6, 29.5, 29.4, 29.2, 25.7, 25.1, 24.0, 23.9, 22.9, 14.3; IR 
(neat) 2930, 2857, 1453, 1337, 1099 cm-1; HRMS (ASAP) m/z calcd for C17H31NO [M]+ 
265.2406, found 265.2394. 
 
Tetrahydro-2H-pyran-2-carbonitrile (2.23) 
The general procedure for hydrocyanation was followed with 2.22 (72 mg, 0.8 mmol), 
HCl solution (440 L, 0.88 mmol), TMSCN (200 L, 1.6 mmol), and CH2Cl2 (8 mL). 
The crude product was purified by flash chromatography (6% EtOAc in hexane) to give 2.23 as a 
colorless oil (58 mg, 65%). 1H NMR (300 MHz, CDCl3)  4.64 (t, 1H, J = 4.5 Hz), 3.94-3.86 (m, 
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1H), 3.81-3.74 (m, 1H), 1.96-1.80 (m, 3H), 1.78-1.74 (m, 1H), 1.68-1.63 (m, 2H). These data are 
consistent with reported literature values.76  
 
General procedure for the asymmetric cyanide addition to vinyl ethers: 
 
To a single neck round bottom flask equiped with a magnetic stirring bar, a solution of catalyst 
2.55 (0.03 equiv) in anhydrous trifluorotoluene was added at room temperature under Ar 
atmosphere followed by TMSCN. The reaction mixture was stirred at room temperature for 10 
min, then was cooled to ‒25 °C (cooling bath temperature). A solution of vinyl ether (1.0 equiv) 
in trifluorotoluene (0.3 mL) was added to the reaction mixture dropwise over 30 sec. The vial 
containing vinyl ether was rinsed with trifluorotoluene (0.3 mL) and the rinses were also 
transferred to the reaction mixture to give 0.1 M solution. After 5 min, phenol (1.0 equiv) in 
trifluorotoluene (0.6 mL) was added via a syringe pump using a 3 mL syringe at a rate of 0.03 
mL/h over 20 h. The reaction mixture was allowed to stir for another 4 h at this temperature. The 
reaction mixture was then quenched with Et3N (0.3 mL) and saturated NaHCO3 solution (0.5 
mL) at ‒25 °C. After warming to room temperature, the reaction mixture was diluted with Et2O 
and saturated NaHCO3 solution, and transfered to a separatory funnel. After separation, the 
aqueous layer was extracted with Et2O again. The combined organic layer was dried over 
Na2SO4, and concentrated under vacuum. The crude product was purified by flash 
chromatography.   
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(S)-2-(Benzyloxy)propanenitrile ((S)-2.4) 
The general asymmetric hydrocyanation procedure was followed with 2.3 (107 mg, 
0.8 mmol), catalyst 2.55 (5 mg, 0.0004 mmol, 0.005 equiv), TMSCN (200 L, 1.6 
mmol), phenol (76 mg, 0.8 mmol) and trifluorotoluene (6 mL). The crude product was purified 
by flash chromatography (3% EtOAc in hexane) to give (S)-2.4 as a colorless oil (108 mg, 84%). 
1H NMR (300 MHz, CDCl3)  7.40-7.35 (m, 5H), 4.86 (d, 1H, J = 11.4 Hz), 4.55 (d, 1H, J = 
11.4 Hz), 4.27 (q, 1H, J = 6.6 Hz), 1.60 (d, 3H, J = 6.6 Hz); 13C NMR (100 MHz, CDCl3)  
136.1, 128.9, 128.6, 128.4, 119.0, 72.3, 63.5, 20.0; IR (neat) 3066, 3034, 2996, 2872, 1455, 
1330, 1111, 746, 699 cm-1; HRMS (EI) m/z calcd for C10H11NO [M]+ 161.0841, found 161.0828. 
These data are consistent with reported literature values.77 HPLC (Lux cellulose-3), hexane/i-
PrOH 90:10, 1 mL/min, tmajor = 7.7 min, tminor = 8.7 min. er = 85:15. [α]D25 = ‒123.3 (c 1.0, 
CHCl3).  
The absolute configuration was assigned by comparison of HPLC retention times with a 
sample of known configuration which was obtained by alternative synthesis (see determination 
of absolute configurations section). 
  
(S)-2-Phenethoxypropanenitrile (2.68) 
The general asymmetric hydrocyanation procedure was followed with 2.67 (45 
mg, 0.3 mmol), catalyst 2.55 (11 mg, 0.0009 mmol), TMSCN (76 L, 0.6 mmol), 
phenol (28 mg, 0.3 mmol) and trifluorotoluene (3 mL). The crude product was purified by flash 
chromatography (4% EtOAc in hexane) to give 2.68 as a colorless oil (41 mg, 78%).1H NMR 
(300 MHz, CDCl3)  7.35-7.22 (m, 5H), 4.22 (q, 1H, J = 6.9 Hz), 4.00 (dt, 1H, J = 8.7, 6.9 Hz), 
3.67 (dt, 1H, J = 8.7, 6.9 Hz), 2.94 (t, 2H, J = 6.9 Hz), 1.56 (d, 3H, J = 6.9 Hz); 13C NMR (100 
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MHz, CDCl3)  138.2, 129.1, 128.7, 126.7, 119.1, 71.4, 64.8, 36.1, 20.0; IR (neat) 3029, 2995, 
2871, 1497, 1475, 1330, 1115, 750, 700 cm-1; HRMS (EI) m/z calcd for C11H13NO [M]+ 
175.0997, found 175.1014. HPLC (Lux cellulose-3), hexane/i-PrOH 90:10, 1 mL/min, tmajor = 
10.0 min, tminor = 13.6 min. er = 87.5:12.5. [α]D25 = ‒61.3 (c 1.0, CHCl3). Racemic material was 
prepared through the cyanation of the α-chloroether. 
 
 (S)-2-(3-Phenylpropoxy)propanenitrile ((S)-2.9) 
The general asymmetric cyanation procedure was followed with 2.8 (49 mg, 0.3 
mmol), catalyst 2.55 (11 mg, 0.0009 mmol), TMSCN (76 L, 0.6 mmol), phenol 
(28 mg, 0.3 mmol) and trifluorotoluene (3 mL). The crude product was purified by flash 
chromatography (4% EtOAc in hexane) to give (S)-2.9 as a colorless oil (51 mg, 90%). 1H NMR 
(300 MHz, CDCl3)  7.33-7.28 (m, 2H), 7.23-7.19 (m, 3H), 4.20 (q, 1H, J = 6.9 Hz), 3.77 (dt, 
1H, J = 9.3, 6.3 Hz), 3.46 (dt, 1H, J = 9.0, 6.3 Hz), 2.72 (t, 2H, J = 7.5 Hz), 2.00-1.91 (m, 2H), 
1.58 (d, 3H, J = 6.9 Hz); 13C NMR (100 MHz, CDCl3)  141.5, 128.7, 128.6, 126.2, 119.3, 69.9, 
64.8, 32.3, 31.1, 20.1; IR (neat) 3027, 2941, 2870, 1453, 1329, 1116, 748, 701 cm-1; HRMS 
(ASAP) m/z calcd for C12H15NO [M]+ 189.1154, found 189.1147. HPLC (Lux cellulose-3), 
hexane/i-PrOH 90:10, 1 mL/min, tmajor = 8.8 min, tminor = 10.2 min. er = 86:14. [α]D25 = ‒46.6 (c 
1.0, CHCl3). 
 
(S)-2-(Cinnamyloxy)propanenitrile (2.70) 
The general asymmetric cyanation procedure was followed with 2.69 (48 mg, 
0.3 mmol), catalyst 2.55 (11 mg, 0.0009 mmol), TMSCN (76 L, 0.6 mmol), 
phenol (28 mg, 0.3 mmol) and trifluorotoluene (3 mL). The crude product was purified by flash 
O Ph
CN
O Ph
CN
 101 
chromatography (4% to 5% EtOAc in hexane) to give 2.70 as a colorless oil (43 mg, 77%).1H 
NMR (300 MHz, CDCl3)  7.43-7.28 (m, 5H), 6.70 (d, 1H, J = 15.9 Hz), 6.26 (ddd, 1H, J = 
15.9, 6.9, 5.4 Hz), 4.47 (ddd, 1H, J = 12.0, 5.4, 1.2 Hz), 4.35 (q, 1H, J = 6.9 Hz), 4.21 (ddd, 1H, 
J = 12.3, 6.9, 1.2 Hz), 1.61 (d, 3H, J = 6.6 Hz); 13C NMR (100 MHz, CDCl3)  136.2, 134.9, 
128.8, 128.4, 126.9, 123.7, 119.1, 71.0, 63.4, 20.0; IR (neat) 3027, 2995, 2941, 2863, 1449, 
1329, 1111, 969, 747, 693 cm-1; HRMS (EI) m/z calcd for C12H13NO [M]+ 187.0997, found 
187.1012. HPLC (Lux cellulose-3), hexane/i-PrOH 90:10, 1 mL/min, tmajor = 15.2 min, tminor = 
20.8 min. er = 82:18. [α]D25 = ‒96.9 (c 1.0, CHCl3). The racemates were prepared through the 
cyanation of α-chloroether. 
 
(S)-2-(Cyclohexyloxy)propanenitrile (2.72) 
The general asymmetric cyanation procedure was followed with 2.71 (50 mg, 0.4 
mmol), catalyst 2.55 (14.6 mg, 0.0012 mmol), TMSCN (101 L, 0.8 mmol), phenol 
(37 mg, 0.4 mmol) and trifluorotoluene (4 mL). The crude product was purified by flash 
chromatography (3% to 5% EtOAc in hexane) to give 2.72 as a colorless oil (44 mg, 72%). 1H 
NMR (400 MHz, CDCl3)  4.36 (q, 1H, J = 6.8 Hz), 3.60-3.54 (m, 1H), 1.97-1.89 (m, 2H), 1.80-
1.71 (m, 2H), 1.56 (d, 3H, J = 6.8 Hz), 1.45-1.17 (m, 6H); 13C NMR (100 MHz, CDCl3)  120.0, 
77.9, 61.5, 32.9, 31.2, 25.7, 24.1, 24.0, 20.7; IR (neat) 2936, 2860, 1451, 1375, 1113, 1070, 981 
cm-1; HRMS (EI) m/z calcd for C9H15NO [M]+ 153.1154, found 153.1162. [α]D25 = ‒72.5 (c 1.0, 
CHCl3). The enantiomeric ratio was determined by the obtained reduction and acylation product 
on HPLC. Racemic material was prepared through cyanation of the α-chloroether. 
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(S)-N-(2-(Cyclohexyloxy)propyl)benzamide 
Cyanohydrin ether 2.72 (19 mg, 0.13 mmol) in anhydrous Et2O (0.2 mL) was 
added to an LiAlH4 solution (0.13 mL of 1 M solution in Et2O, 0.13 mmol) at 0 °C 
under Ar, and then the ice bath was removed. The reaction mixture was stirred at room 
temperature for 45 min, and it was then carefully quenched with H2O followed by 20% NaOH 
solution. The mixture was extracted with EtOAc (2x), dried over Na2SO4, and concentrated 
under vacuum. The crude product was then dissolved in CH2Cl2 (1 mL), followed by addition of 
Et3N (42 L) and benzoyl chloride (14 L) at room temperature. The reaction mixture was 
stirred for 30 min, and then quenched with H2O. The mixture was then exacted with CH2Cl2 
(2x), dried over Na2SO4, and concentrated under vacuum. The crude product was purified by 
flash chromatography (10% to 20% EtOAc in hexane) to give the product as a colorless oil (16 
mg, 47% over two steps). 1H NMR (400 MHz, CDCl3)  7.88-7.76 (m, 2H), 7.53-7.49 (m, 1H), 
7.47-7.43 (m, 2H), 6.57 (s, 1H), 3.81-3.73 (m, 2H), 3.37-3.31 (m, 1H), 3.22-3.15 (m, 1H), 1.89-
1.87 (m, 2H), 1.77-1.72 (m, 2H), 1.56-1.54 (m, 1H), 1.34-1.22 (m, 5H), 1.19 (d, 3H, J = 6.0 Hz); 
13C NMR (100 MHz, CDCl3)  167.5, 135.0, 131.6, 128.8, 127.0, 75.8, 71.5, 45.4, 33.9, 32.9, 
25.9, 24.6, 24.5, 18.7; IR (neat) 3325, 3064, 2931, 2856, 1643, 1544, 1144, 1093, 802, 696 cm-1; 
HRMS (ESI) m/z calcd for C16H24NO2 [M+H]+ 262.1807, found 262.1797. HPLC (OD), 
hexane/i-PrOH 95:5, 1 mL/min, tminor = 8.3 min, tmajor = 9.9 min. er = 84:16. [α]D25 = +32.2 (c 
1.0, CHCl3). 
 
(S)-3-(1-Cyanoethoxy)propyl benzoate ((S)-2.25) 
The general asymmetric cyanation procedure was followed with 2.24 (62 
mg, 0.3 mmol), catalyst 2.55 (11 mg, 0.0009 mmol), TMSCN (76 L, 0.6 O O Ph
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mmol), phenol (28 mg, 0.3 mmol) and trifluorotoluene (3 mL). The crude product was purified 
by flash chromatography (2% EtOAc in toluene) to give (S)-2.25 as a colorless oil (61 mg, 87%). 
1H NMR (400 MHz, CDCl3)  8.05 (d, 2H, J = 7.6 Hz), 7.57 (t, 1H, J = 7.2 Hz),7.45 (t, 2H, J = 
7.6 Hz), 4.50-4.38 (m, 2H), 4.25 (q, 1H, J = 6.8 Hz), 3.94 (dt, 1H, J = 9.2, 6.0 Hz), 3.63 (dt, 1H, 
J = 9.2, 6.0 Hz), 2.10 (quin, 2H, J = 6.4 Hz), 1.57 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, 
CDCl3)  166.7, 133.2, 130.4, 129.8, 128.6, 119.0, 67.2, 64.9, 61.8, 29.0, 20.0; IR (neat) 3064, 
2962, 1719, 1276, 1115, 713 cm-1; HRMS (ASAP) m/z calcd for C13H16NO3 [M+H]+ 234.1130, 
found 234.1122. HPLC (Lux cellulose-3), hexane/i-PrOH 90:10, 1 mL/min, tmajor = 14.5 min, 
tminor = 16.1 min. er = 83:17. [α]D25 = ‒37.8 (c 1.0, CHCl3). Racemic material was prepared 
through the cyanation of the α-chloroether. 
 
(S)-2-(2-(Benzylthio)ethoxy)propanenitrile ((S)-2.15) 
The general asymmetric cyanation procedure was followed with 2.14 (58 mg, 
0.3 mmol), catalyst 2.55 (11 mg, 0.0009 mmol), TMSCN (76 L, 0.6 mmol), 
phenol (28 mg, 0.3 mmol) and trifluorotoluene (3 mL). The crude product was purified by flash 
chromatography (4% EtOAc in hexane) to give (S)-2.15 as a colorless oil (50 mg, 71%).1H NMR 
(400 MHz, CDCl3)  7.35-7.25 (m, 5H), 4.23 (q, 1H, J = 6.8 Hz), 3.88 (dt, 1H, J = 9.6, 6.4 Hz), 
3.79 (s, 2H), 3.57 (dt, 1H, J = 9.2, 6.8 Hz), 2.66 (t, 2H, J = 6.4 Hz), 1.58 (d, 3H, J = 6.8 Hz); 13C 
NMR (100 MHz, CDCl3)  138.3, 129.1, 128.8, 127.4, 118.9, 70.1, 64.8, 36.9, 30.4, 20.0; IR 
(neat) 3062, 3028, 2920, 2870, 1453, 1329, 1114, 1073, 1016, 704 cm-1; HRMS (EI) m/z calcd 
for C12H15NOS [M]+ 221.0874, found 221.0893. [α]D25 = ‒39.6 (c 1.0, CHCl3). The enantiomeric 
ratio was determined by the obtained reduction and acylation product on HPLC.  
 
O
S Ph
CN
 104 
(S)-N-(2-(2-(Benzylthio)ethoxy)propyl)benzamide 
Cyanohydrin ether (S)-2.15 (25 mg, 0.11 mmol) in anhydrous Et2O (0.3 mL) 
was added to an LiAlH4 solution (0.11 mL of 1 M solution in Et2O, 0.11 
mmol) at 0 °C under Ar, and then the ice bath was removed. The reaction mixture was stirred at 
room temperature for 45 min, and it was then carefully quenched with H2O followed by 20% 
NaOH solution. The mixture was extracted with EtOAc (2x), dried over Na2SO4, and 
concentrated under vacuum. The crude product was then dissolved in CH2Cl2 (1 mL), followed 
by addition of Et3N (35 L) and benzoyl chloride (12 L) at room temperature. The reaction 
mixture was stirred for 30 min, and then quenched with H2O. The mixture was then exacted with 
CH2Cl2 (2x), dried over Na2SO4, and concentrated under vacuum. The crude product was 
purified by flash chromatography (15% to 25% EtOAc in hexane) to give the product as a 
colorless oil (25 mg, 69% over two steps). 1H NMR (400 MHz, CDCl3)  7.86-7.84 (m, 2H), 
7.52-7.49 (m, 1H), 7.43-7.40 (m, 2H), 7.31-7.23 (m, 5H), 6.88 (s, 1H), 3.82 (ddd, 1H, J = 14.0, 
7.0, 3.5 Hz), 3.77 (dt, 1H, J = 10.0, 6.0 Hz), 3.72 (s, 2H), 3.68-3.58 (m, 1H), 3.44 (ddd, 1H, J = 
10.0, 8.0, 6.0 Hz), 3.24 (ddd, 1H, J = 14.0, 8.0, 4.0 Hz), 2.71-2.61 (m, 2H), 1.21 (d, 3H, J = 6.0 
Hz); 13C NMR (125 MHz, CDCl3)  167.4, 138.1, 134.5, 131.4, 128.9, 128.6, 128.5, 127.1, 
127.1, 74.6, 67.2, 44.7, 36.7, 31.8, 17.4; IR (neat) 3334, 3061, 3028, 2971, 2925, 2868, 1644, 
1336, 1290, 1120, 707 cm-1; HRMS (ASAP) m/z calcd for C19H24NO2S [M+H]+ 330.1528, found 
330.1520. HPLC (Lux cellulose-3), hexane/i-PrOH 80:20, 1 mL/min, tminor = 9.8 min, tmajor = 
10.6 min. er = 83:17. [α]D25 = ‒2.2 (c 1.0, CHCl3). 
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(S)-2-(Naphthalen-2-ylmethoxy)propanenitrile (2.74) 
The general asymmetric cyanation procedure was followed with 2.73 (55 mg, 
0.3 mmol), catalyst 2.55 (11 mg, 0.0009 mmol), TMSCN (76 L, 0.6 mmol), 
phenol (28 mg, 0.3 mmol) and trifluorotoluene (3 mL). The crude product was purified by flash 
chromatography (7% EtOAc in hexane) to give 2.74 as a colorless oil (56 mg, 88%). 1H NMR 
(400 MHz, CDCl3)  7.89-7.84 (m, 4H), 7.54-7.47 (m, 3H), 5.02 (d, 1H, J = 12.0 Hz), 4.71 (d, 
1H, J = 12.0 Hz), 4.30 (q, 1H, J = 6.8 Hz), 1.62 (d, 3H, J = 6.8 Hz); 13C NMR (100 MHz, 
CDCl3)  133.5, 133.5, 133.4, 128.8, 128.2, 127.9, 127.6, 126.6, 126.6, 125.9, 119.0, 72.4, 63.4, 
20.0; IR (neat) 3049, 2990, 2919, 1463, 1336, 1136, 863, 824, 748 cm-1; HRMS (EI) m/z calcd 
for C14H13NO [M]+ 211.0997, found 211.1007. HPLC (Lux cellulose-3), hexane/i-PrOH 65:35, 1 
mL/min, tmajor = 12.9 min, tminor = 19.3 min. er = 84.5:15.5. [α]D25 = ‒117.5 (c 1.0, CHCl3). 
Racemic material was prepared through the cyanation of the α-chloroether. 
 
(S)-2-(Benzyloxy)butanenitrile (2.77) 
The general asymmetric cyanation procedure was followed with 2.76 (44 mg, 0.3 
mmol), catalyst 2.55 (11 mg, 0.0009 mmol), TMSCN (76 L, 0.6 mmol), phenol 
(28 mg, 0.3 mmol) and trifluorotoluene (3 mL). The crude product was purified by flash 
chromatography (2% EtOAc in hexane) to give 2.77 as a colorless oil (39 mg, 74%). 1H NMR 
(500 MHz, CDCl3)  7.41-7.33 (m, 5H), 4.87 (d, 1H, J = 11.5 Hz), 4.55 (d, 1H, J = 11.5 Hz), 
4.12 (t, 1H, J = 6.5 Hz), 1.91 (quin, 2H, J = 7.5 Hz), 1.09 (t, 3H, J = 7.5 Hz); 13C NMR (125 
MHz, CDCl3)  136.3, 128.9, 128.6, 128.4, 118.4, 72.4, 69.1, 27.1, 9.4; IR (neat) 3033, 2974, 
2938, 2880, 1455, 1335, 1110, 742, 699 cm-1; HRMS (EI) m/z calcd for C11H13NO [M]+ 
175.0997, found 175.0980. HPLC (Lux cellulose-3), hexane/i-PrOH 95:5, 1 mL/min, tmajor = 7.3 
O
CN
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min, tminor = 8.7 min. er = 80.5:19.5. [α]D25 = ‒94.5 (c 1.0, CHCl3). Racemic material was 
prepared through cyanation of the α-chloroether. 
 
(S)-2-Methoxy-4-phenylbutanenitrile ((S)-2.19) 
The general asymmetric cyanation procedure was followed with 2.78 (24 mg, 
0.16 mmol), catalyst 2.55 (17.6 mg, 0.014 mmol), TMSCN (80 L, 0.64 mmol), 
phenol (15 mg, 0.16 mmol) and trifluorotoluene (1.6 mL). The crude product was purified by 
flash chromatography (4% EtOAc in hexane) to give (S)-2.19 as a colorless oil (24 mg, 86%). 1H 
NMR (400 MHz, CDCl3)  7.32 (t, 2H, J = 7.2 Hz), 7.24 (t, 1H, J = 7.2 Hz), 7.20 (d, 2H, J = 7.2 
Hz), 3.98 (t, 1H, J = 6.4 Hz), 3.50 (s, 3H), 2.83 (t, 2H, J = 7.6 Hz), 2.24-2.09 (m, 2H); 13C NMR 
(100 MHz, CDCl3)  139.9, 128.9, 128.7, 126.7, 118.2, 69.7, 58.2, 35.1, 30.9. These data are 
consistent with reported literature values.78 HPLC (Lux cellulose-3), hexane/i-PrOH 90:10, 1 
mL/min, tmajor = 7.6 min, tminor = 8.4 min. er = 74:26. [α]D25 = +17.1 (c 1.0, CHCl3). 
When using (E)-vinyl ether 2.18 (44 mg, 0.3 mmol), catalyst 2.55 (33 mg, 0.027 mmol), 
TMSCN (152 L, 1.2 mmol), phenol (28 mg, 0.3 mmol) and trifluorotoluene (3.0 mL). The 
crude product was purified by flash chromatography (4% EtOAc in hexane) to give (S)-2.19 as a 
colorless oil (7 mg, 13%, 22% conversion based on crude NMR). er =74:26. 
 
(S)-2-((R)-1-phenylethoxy)propanenitrile (2.80) 
The general asymmetric cyanation procedure was followed with 2.79 (59 mg, 0.4 
mmol), catalyst 2.55 (14.6 mg, 0.0012 mmol), TMSCN (101 L, 0.8 mmol), phenol 
(37 mg, 0.4 mmol) and trifluorotoluene (4 mL). The crude product was passed through a short 
pad of silica gel (5% EtOAc in hexane) to remove the catalyst. The eluent was then concentrated 
O (R) Ph(S)
CN
OMe
CN
Ph
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under vacuum for HPLC analysis. HPLC (Lux cellulose-3), hexane/i-PrOH 90:10, 1 mL/min, 
tminor, RR = 6.3 min, tmajor, SR = 7.2 min. d.r. = 28:1. The crude product was further purified by flash 
chromatography (3% EtOAc in hexane) to give 2.80 as a colorless oil (56 mg, 80%). 1H NMR 
(500 MHz, CDCl3)  7.41-7.30 (m, 5H), 4.68 (q, 1H, J = 6.5 Hz), 4.31 (q, 1H, J = 7.0 Hz), 1.57 
(d, 3H, J = 7.0 Hz), 1.51 (d, 3H, J = 6.5 Hz); 13C NMR (125 MHz, CDCl3)  141.9, 128.8, 128.5, 
126.6, 119.4, 78.2, 62.2, 22.6, 20.4; IR (neat) 3034, 2980, 2933, 1453, 1377, 1109, 762, 700 cm-
1; HRMS (EI) m/z calcd for C11H13NO [M]+ 175.0997, found 175.0986. [α]D25 = +9.4 (c 1.0, 
CHCl3). 
The absolute configuration of cyanohydrin ether was assigned by comparison of optical 
rotation with the known cyanohydrin which was obtained by cleavage of the 1-phenylethanol 
group (see determination of absolute configurations section). 
 
The general procedure for the cyanation of the α-chloroether was followed to 
generate both of the diastereomers by using (R)-(1-vinyloxy)ethyl)benzene 2.79 
(104 mg, 0.7 mmol), HCl solution (385 L, 0.77 mmol), TMSCN (175 L, 1.4 mmol), and 
CH2Cl2 (7 mL). The crude product was purified by flash chromatography (3% EtOAc in hexane) 
to give as two diastereomers (103 mg, 84%, d.r. = 1.2:1). The faster eluting product was the 
major diastereomer: 1H NMR (300 MHz, CDCl3)  7.42-7.31 (m, 5H), 4.75 (q, 1H, J = 6.6 Hz), 
3.97 (q, 1H, J = 6.6 Hz), 1.52 (d, 3H, J = 6.6 Hz), 1.51 (d, 3H, J = 6.9 Hz); 13C NMR (100 MHz, 
CDCl3)  141.4, 129.1, 128.6, 126.6, 119.4, 77.9, 61.7, 24.1, 20.1; IR (neat) 3033, 2981, 2887, 
1454, 1110, 1057, 763, 702 cm-1; HRMS (EI) m/z calcd for C11H13NO [M]+ 175.0997, found 
175.0990. [α]D25 = +306.0 (c 1.0, CHCl3). HPLC (Lux cellulose-3), hexane/i-PrOH 90:10, 1 
mL/min, tRR = 6.4 min. 
O (R) Ph(R)
CN
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The slower eluting product was the minor diastereomer 2.80: For characterization, see 
above. HPLC (Lux cellulose-3), hexane/i-PrOH 90:10, 1 mL/min, tSR = 7.1 min.  
 
(S)-2-((S)-1-phenylethoxy)propanenitrile (2.81) 
The general asymmetric cyanation procedure was followed with 2.16 (59 mg, 0.4 
mmol), catalyst 2.55 (14.6 mg, 0.0012 mmol), TMSCN (101 L, 0.8 mmol), phenol 
(37 mg, 0.4 mmol) and trifluorotoluene (4 mL). The crude product was purified by flash 
chromatography (3% EtOAc in hexane) to give two diastereomers (57 mg, 81%, d.r. = 1.2:1, 
crude NMR ratio 1.4:1). The faster eluting product was the major diastereomer 2.81. For 
characterization data see the procedure for preparing 2.17. 
 
General procedure for the asymmetric cyanide addition to acetals: 
 
To a single neck round bottom flask equiped with a magnetic stirring bar, a solution of catalyst 
2.55 (0.03 equiv) in anhydrous trifluorotoluene was added at room temperature under Ar 
atmosphere followed by addition of TMSCN. The reaction mixture was stirred at room 
temperature for 15 min and then cooled to ‒25 °C (cooling bath temperature). A solution of the 
acetal (1.0 equiv) in trifluorotoluene (0.6 mL) was added to the reaction mixture via a syringe 
pump using a 3 mL syringe at a rate of 0.03 mL/h over 20 h. The reaction mixture was allowed 
to stir for another 4 h at this temperature after addition. The reaction mixture was then quenched 
with Et3N (0.3 mL) and saturated NaHCO3 solution (0.5 mL) at ‒25 °C. After warming to room 
temperature, the reaction mixture was diluted with Et2O and saturated NaHCO3 solution, and 
transferred to a separatory funnel. After separation, the aqueous layer was extracted with Et2O 
O (S) Ph(S)
CN
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again. The combined organic layer was dried over Na2SO4, and concentrated under vacuum. The 
crude product was purified by flash chromatography.   
 
(S)-2-(Benzyloxy)propanenitrile ((S)-2.4) 
The general asymmetric acetal cyanation procedure was followed with 2.90 (73 mg, 
0.3 mmol), catalyst 2.55 (11 mg, 0.009 mmol, 0.03 equiv), TMSCN (76 L, 0.6 
mmol) and trifluorotoluene (2.5 mL). The crude product was purified by flash chromatography 
(3% EtOAc in hexane) to give (S)-2.4 as a colorless oil (41 mg, 85%), er = 82.5:17.5. Spectral 
and HPLC data are consistent with previously reported values. 
 
(S)-2-Methoxy-4-phenylbutanenitrile ((S)-2.19) 
The general asymmetric acetal cyanation procedure was followed with 2.91 (36 
mg, 0.2 mmol), catalyst 2.55 (7 mg, 0.006 mmol, 0.03 equiv), TMSCN (100 L, 
0.8 mmol) and trifluorotoluene (2 mL). The crude product was purified by flash chromatography 
(4% EtOAc in hexane) to give (S)-2.19 as a colorless oil (32 mg, 91%), er = 73:27. Spectral and 
HPLC data are consistent with previously reported values. 
 
 
 
 
 
 
 
O Ph
CN
OMe
CN
Ph
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Determination of the absolute stereochemistry: 
 
For (S)-2-(Benzyloxy)propanenitrile ((S)-2.4) 
 
 
Scheme S2.2 Determination of the absolute stereochemistry of 2.4 
 
To a solution of methyl (S)-2-(benzyloxy)propanoate (2.66)79 (194 mg, 1.0 mmol) in DMF (5 
mL) was added NH3•H2O (10 mL) at room temperature. The reaction mixture was stirred 
overnight, and then diluted with EtOAc and washed with H2O (3x). The organic layer was dried 
over Na2SO4, and concentrated under vacuum to give the pure amide as a white solid (176 mg, 
98%), which was directly used for the next step. To a solution of oxalyl chloride (39 L, 0.45 
mmol) in CH2Cl2 (3 mL) was added DMSO (43 L, 0.6 mmol) in CH2Cl2 at ‒78 °C under Ar. 
After 20 min, the amide (54 mg, 0.3 mmol) in CH2Cl2 (0.5 mL) was added to the reaction 
mixture dropwise. The reaction mixture was stirred for another 30 min, before adding Et3N (125 
L, 0.9 mmol). The solution was allowed to stir for another 30 min, and then warmed up to the 
room temperature. The reaction mixture was diluted with CH2Cl2, washed with saturated NH4Cl 
solution, dried over Na2SO4, and concentrated under vacuum. The crude product was purified 
with flash chromatography (3% EtOAc in hexane) to give the cyanohydrin ether (S)-2.4 (44 mg, 
91%). The spectra data are consistent with previous results. HPLC (Lux cellulose-3), hexane/i-
PrOH 90:10, 1 mL/min, tmajor = 7.3 min, tminor = 8.3 min. er > 99:1. [α]D25 = ‒169.1 (c 1.0, 
CHCl3). 
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For (S)-2-((R)-1-phenylethoxy)propanenitrile (2.88)54 
 
 
Scheme S2.3 Determination of the absolute stereochemistry of 2.80 
 
To a solution of 2.80 (26 mg, 0.15 mmol) in CH2Cl2 (1.5 mL) was added TFA (69 L, 0.9 mmol) 
at room temperature. The reaction mixture was stirred overnight, and then concentrated under 
vacuum. The crude product was purified by flash chromatography (7% to 25% EtOAc in hexane) 
to give (S)-lactonitrile (2.88) as a colorless oil (2.3 mg, 22%). 1H NMR (400 MHz, CDCl3)  
4.62 (app quin, 1H, J = 6.4 Hz), 2.32 (d, 1H, J = 5.6 Hz), 1.63 (d, 3H, J = 6.8 Hz). These data are 
consistent with reported literature values.80 [α]D25 = ‒32 (c 0.23, CHCl3). (Literature value56 for 
(S)-lactonitrile: [α]D25 = ‒30 (c 1.0, CHCl3), ee>98%) 
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Figure S2.1 HPLC tracer of 2.4 
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Figure S2.2 HPLC tracer of 2.68 
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Figure S2.3 HPLC tracer of 2.9 
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Figure S2.4 HPLC tracer of 2.70 
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Figure S2.5 HPLC tracer of the derivative of 2.72 
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Figure S2.6 HPLC tracer of 2.25 
 
 119 
 
 
Figure S2.7 HPLC tracer of the derivative of 2.15 
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Figure S2.8 HPLC tracer of 2.74 
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Figure S2.9 HPLC tracer of 2.77 
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Figure S2.10 HPLC tracer of 2.19 
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Figure S2.11 HPLC tracer of 2.80 
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APPENDIX C 
SPIROOXINDOLE LIBRARY COMPOUNDS AND THE PRELIMINARY HIGH 
THROUGHPUT SCREENING RESULTS 
The spirooxindole library compounds were deposited to NIH MLSMR (Molecular Libraries 
Small Molecule Repository) in April, 2012. Some of the library compounds have been identified 
to have some biological activity after preliminary high throughput screening. The compound 
number is provided in the following table, together with the name of the active bioassay.  
 Compounds MLS004342609, MLS004342611, and MLS004342628 are exosite 
inhibitors for ADAM10 (A Disintegrin and Metalloproteinase Domain-containing Protein 10), 
which is a major determinant of HER2 (Human Epidermal Growth Factor Receptor 2) shedding. 
The inhibition of ADAM10 may provide a therapeutic approach for treating cancers with active 
HER2 signaling, like breast cancer.81 Compounds MLS004342594 and MLS004342615 are 
inhibitors for MBD2 (Methyl-CpG-Binding Domain Protein 2), which mediates epigenetic gene 
silencing and relates to human cancers.82 The discovery of new MBD2 inhibitors could lead to 
restoring gene fuction by reactivating the silenced genes in cancer cells.   
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Table S3.1 Spirooxindole library and the related biological activity 
Structure Substrate SID Compound Name Active Bioassay Name
N R
OH
Bn
O
MLS004342589144097065
R = NHC(O)CH2CH2Ph
N R
O
Bn
O
O
O
N
144097066 MLS004342590
N R
O
Bn
O
O
N
N
MLS004342591144097067
R = NHC(O)CH2CH2Ph
R = NHC(O)CH2CH2Ph
N R
O
Bn
O
O
O
MLS004342592144097068
R = NHC(O)CH2CH2Ph
N RBn
O
OH
R = NHC(O)CH2CH2Ph
144097069 MLS004342593
N R
O
Bn
O
O
N
R = NHC(O)CH2CH2Ph
144097070 MLS004342594
TRFRET-based biochemical 
primary high throughput screening 
assay to identify inhibitors of 5-
meCpG-binding domain protein 2 
(MBD2)-DBD binding to 
methylated oligonucleotide
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Structure Substrate SID Compound Name Active Bioassay Name
MLS004342595144097071
144097072 MLS004342596
N RBn
O
MLS004342597144097073
R = NHC(O)CH2CH2Ph
MLS004342598144097074
R = NHC(O)CH2CH2Ph
144097075 MLS004342599
R = NHC(O)CH2CH2Ph
144097076 MLS004342600
O
O
N
N
N RBn
O
O
O
O
R = NHC(O)CH2CH2Ph
N RBn
O
O
O
N
O
N RBn
O
R = NHC(O)CH2CH2Ph
O
N RBn
O
O
O
NO2
N RBn
O
R = NHC(O)CH2CH2Ph
N
OH
 
 128 
 
 129 
 
 130 
Structure Substrate SID Compound Name Active Bioassay Name
MLS004342613144097089
144097090 MLS004342614
MLS004342615144097091
MLS004342616144097092
144099194 MLS004342617
144097093 MLS004342618
N O
Bn
O
HN O
Ph
O
N
N
N O
Bn
OBn
HN O
N
N O
Bn
OBn
HN O
S TRFRET-based biochemical 
primary high throughput 
screening assay to identify 
inhibitors of 5-meCpG-binding 
domain protein 2 (MBD2)-DBD 
binding to methylated 
oligonucleotide
N O
Bn
OBn
HN O
NN
N O
Bn
OBn
HN O
O
O
N O
Bn
OH
HN O
BocHN
Ph
Ph
Ph
Ph
Ph
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Structure Substrate SID Compound Name Active Bioassay Name
MLS004342619144097094
144097095 MLS004342620
MLS004342621144097096
MLS004342622144097097
144097098 MLS004342623
144099195 MLS004342624
N O
Bn
OBn
HN O
Ph
N
N O
Bn
RO
R = NHC(O)CH2CH2Ph
O
N
N
N O
Bn
O
N
Ph
N O
Bn
RO
R = NHC(O)CH2CH2Ph
O
N
N O
Bn
RO
R = NHC(O)CH2CH2Ph
O
ON
N O
Bn
RO
R = NHC(O)CH2CH2Ph
O
O
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Structure Substrate SID Compound Name Active Bioassay Name
MLS004342625144097099
144097100 MLS004342626
MLS004342627144097101
MLS004342628144097102
144097103 MLS004342629
N O
Bn
RO
R = NHC(O)CH2CH2Ph
O
N O
Bn
RO
R = NHC(O)CH2CH2Ph
O
N O
Bn
OAc
HN O
ON
Ph
QFRET-based biochemical 
primary high throughput 
screening assay to identify 
exosite inhibitors of ADAM10.
N O
Bn
OH
HN O
Ph
O
O
144097104 MLS004342630
N O
Bn
OH
HN O
Ph
N O
Bn
S
N
Ph
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